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A b s t r a c t
The role of Chx10 in the development of the vertebrate retina
Complex interactions between intrinsic and extrinsic factors regulate the 
development of the retina from multipotential progenitor cells to the highly 
organised, mature tissue. Many genes are known to be essential to this 
process. Chx10 is a homeodomain transcription factor that is essential for the 
development of the retina and eye in many vertebrate species. Based on 
previous work embracing ChxW  gene expression patterns and the analysis of 
the mutant mouse , which has a null mutation in ChxW, the
established roles of Chx10 in eye development include promotion of cellular 
proliferation in the neuroblastic retina, specification of bipolar interneurons in 
the differentiating retina, and maintenance of bipolar cells in the mature retina. 
In the first section of this thesis, I have explored the role of the human 
orthologue, CHX10, in the development of the eye, by examining gene 
expression patterns during embryonic human development.
In a comparative study between the Chx1(f'^^°^''^ and wild-type mouse, I 
have investigated the impact that the absence of Chx10 has on the expression 
of other genes that are required for normal eye development. Notably, the 
expression of the photoreceptor-specific transcription factor gene Crx is 
significantly delayed, which may lead to the observed photoreceptor phenotype 
in Chx10 is not expressed in photoreceptors, so, using a primary
cell culture of Chx1(f'^^°''''^ retinal neuroblasts, I investigated possible signalling
mechanisms by which interactions between Chx10 and Crx could be fulfilled, 
and have demonstrated that retinoic acid may be capable in vitro of inducing 
expression of photoreceptor-specific genes in the absence of Chx10.
In the final part of the thesis, I have identified, cloned and characterised 
a novel Chx10-\\ke human cDNA, found as a fragment of an expressed 
sequence tag (EST) on Human Genome Project databases. Data presented 
here demonstrates that this putative novel gene is retinal specific, expressed in 
the adult retina, and maps to human Chromosome 20.
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In t r o d u c t io n
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C h a p te r  1 
In t r o d u c t io n
1.1 T h e  eye , and  its o rig ins
The eye is a highly complex, multi-tissue sensory organ that transmits visual 
information from the world to the brain for processing.
In this introductory chapter, I aim to describe the structure, function and 
development of the eye, with specific reference to the genes that influence the 
development of the retina in the context of the data and discussions presented 
later in this thesis.
1.1.1 Evolution of the eye
The evolution of the eye has historically been a controversial issue for many 
evolutionary biologists, and was originally argued by the 19th century 
theologian William Paley as being such a complex and perfect organ, that it 
confounded theories of Darwinian evolution (Dawkins 1986, in The Blind 
Watchmaker). But, as described by Dawkins, selection of advantageous 
characteristics of photoreceptive biology is a stepwise process, and quite 
adequately explains the complexity of the human eye. Indeed, examination of 
many living animals reveals that not all photoreceptive organs are as 
complicated as vertebrate or compound eyes, and these provide answers to the 
mechanisms of the evolution of a complex organ. For example, the protozoan
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Euglena has a patch of cells, called an eyespot, that allows behavioural 
changes in response to light, and this may be one of the simplest 
photoreceptive organs in an animal (Gualtieri etal. 1992).
Salvini-Plawen and Mayr (1961) suggested that photoreceptive organs 
have evolved independently at least 40 times, the first being multi-cellular 
organisms dating to -530 million years ago. This postulation was based on 
morphological criteria, for example, the profound and obvious differences 
between the compound eye of insects, and the lens cells of higher vertebrates. 
However, molecular similarities between all photoreceptive organs have 
recently been described, indicating the conservation of genetic pathways that 
determine the development of visual systems (Gehring 1996). Probably the best 
example of this involved the identification of Pax6 (discussed in more detail 
1.6.8), a gene with orthologous versions in species as diverse as vertebrates. 
Drosophila and jellyfish (Sun et al. 1997). In the naturally occurring mouse 
mutant with a null mutation in Pax6, called Small eye, heterozygotes have 
severe microphthalmia (small eyes), and homozygotes fail to develop large 
areas of the front of the head (discussed below), including the eyes (Quinn et 
al. 1996). In Drosophila, flies with a mutation in their orthologous gene, called 
eyeless, are characterised by an absence of eyes (Gehring 1996). These data 
and others indicate that these two genes, Pax6 and eyeless, both sit high up in 
a hierarchy that specifies the development of eyes, regardless of the obvious 
and substantial differences between the types of eye involved. This data was
21
compounded by the genetic rescue of the eyeless mutant fly by the introduction 
of a transgenic murine Fax6 gene (Gehring 1996).
1.2 The lens
The vertebrate eye is a highly complex organ, which has evolved to process 
visual stimuli into images within the brain. Light is initially focused by the 
cornea, and then by the lens after it has passed through the anterior chamber 
and iris. The lens is a biconvex tissue consisting of fusiform fibre cells, 
encapsulated in an elastic capsule of epithelial cells. The lens grows throughout 
life by mitosis of the outer lens. Central lens cells lose their organelles. Light 
passes through the lens and into the vitreous humour, a gel that comprises 98% 
water as well as collagenous fibrils, which on the outer surfaces of the humour 
attach it to the surrounding tissue, including the lens capsule and retina (Bron et 
al. in Wolff’s Anatomy of the Eye and Orbit, 8^  ^ Edition, 1997).
1.3 Morphology, the retina, RPE and cell types
The neural retina is a highly organised laminated three-layered tissue (see 
Figure 1.1), whose function is the capturing of photons and the subsequent 
processing of phototransduction to the brain. The outermost layer (i.e. furthest
22
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Figure 1.1. Histology of the adult retina. The mature murine retina is 
divided into three cellular strata, separated by two acellular plexiform layers, in 
which synaptic connections are made, (a) shows a cartoon schematic of the 
retina, and (b) a histological section stained with haematoxylin and eosin. The 
inner (is) and outer (os) segments of the photoreceptors are uppermost, 
connected via cilia to the photoreceptor cell bodies held within the outer 
nuclear layer (onl). The inner nuclear layer comprises three neuronal cells, 
bipolar, amacrine and horizontal cells. These in turn synapse in the inner 
plexiform layer (ipl) with cells in the ganglion cell layer (gel). Axons from 
ganglion cells project via the optic nerve to the brain.
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from the lens) of the neural retina consists of the photoreceptors, cells in which 
the process of phototransduction begins. The other cellular layers are the inner 
nuclear layer and the ganglion cell layer, which are discussed in 1.3.3 and 
1.3.4.
1.3.1 Structure and function of photoreceptors and retinal pigmented epithelium 
Photoreceptors are highly specialised light sensitive neuronal cells, capable of 
detecting individual photons (Hecht et al. 1942), comprising several cellular 
compartments (see Figure 1.2). These include the outer segment (os), which 
contains photoreceptor lamellae or discs, which resemble flattened 
membranous sacs, and these are the initial sites of the process of 
phototransduction. In broad terms, there are two types of photoreceptor, rods 
and cones. However, there are many subsets, including blue green and red 
cones. The distributions and relative proportions of the different subtypes are 
discussed below. Photoreceptors are embedded, via desmosomes and other 
anchoring junctions, in the non-neuronal layer of the retina, the retinal 
pigmented epithelium (RPE) -  a highly pigmented monolayer of epithelial cells 
that prevent photons from escaping the eye, and also provides nurturing for the 
embedded photoreceptors. On the apical, photoreceptor side of the RPE, there 
are processes that extend into the photoreceptor layer. The matrix between the 
RPE and photoreceptors is crucial for the maintenance of disc regeneration, 
which is functional in the maintenance of circadian rhythms, as this regeneration 
occurs in a roughly 24-hr period (Young 1976, Ostroy 2001).
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Figure 1.2 Diagram of generic cone (a) and rod (b) photoreceptor, showing 
how the components of the cell correspond to the layers of the retina. The outer 
segments, containing the lamellae, are embedded in the retinal pigmented 
epithelium (RPE), and connect to the inner segment via thin cilia. The nucleus 
is contained within the outer nuclear layer. Synaptic connections to 
interneurons in the inner nuclear layer are made in the outer plexiform layer.
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The outer segment is connected by a cilium to the inner segment, which 
contains the components of the subcellular organelles, including the golgi 
apparatus, and several hundred mitochondria. This connects to the nucleus 
containing cell body, which makes up the outer nuclear layer. Axonal 
projections from the innermost tip of the photoreceptor make synaptic 
connections to other retinal cells within the outer plexiform layer.
1.3.2 A simplified model of phototransduction
The membranes of the discs contained in the outer segments of photoreceptors 
harbour seven-pass membrane bound molecules, rhodopsin (Figure 1.2). The 
structure of the helical portions of this molecule encloses the chromophore 
retinal, which is a light sensitive molecule capable of several stereoisomeric 
forms. The absorption of a photon by retinal in its dark state causes the 
conversion of rhodopsin into its activated state and the subsequent activation of 
the retina-specific G protein transducin, by the conversion of GDP to GTP. This 
activated form of transducin in turn activates the multi-sub-unit enzyme cGMP 
phosphodiesterase (PDE), which catalyses the molecule cGMP to 5’GMP. The 
disruption of the cationic flow through cGMP-gated Na^ and K+channels 
caused by photonic stimulation results in the alteration of the membrane 
potential of these cells. The resultant hyperpolarisation of the photoreceptor 
initiates a decrease in the release of the molecule glutamate by vesicular 
exocytosis. The glutamate-signalling pathway allows the transduction of vistjal
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information from photoreceptors to other neurons (reviewed in Oyster, The 
Human Eye, 1999).
1.3.3 Cells within the Innernuclearlayer
The connections that photoreceptor cells make to other neurons are 
complicated. Horizontal cells of the inner nuclear layer, of which there are at 
least two distinct types, have a role in integrating input signals from multiple 
photoreceptors (Kolb 1997). Bipolar cells, of which there are a number of 
subtypes, are the prime system by which photoreceptors convey signals to the 
ganglion cells in the ganglion cell layer (GrCinert and Martin 1991, Wassle et al. 
1991). Of the subtypes that have been identified, there are cone on- and off- 
bipolar cells which have opposing sensitivities to glutamate signalling, midget 
bipolar cells, which process signals from red and green cones, blue cone 
bipolar cells, rod bipolar cells, which do not connect directly with ganglion cells, 
instead channelling through amacrine cells, and diffuse bipolar cells, which are 
non-specific. Bipolar cells are located on the outer aspect of the inner nuclear 
layer, in a similar position to horizontal celts, ^ m ^ c i^ e  cells are located on the 
opposite side of this layer, but also in the ganglion cell layer, at a frequency of 
humans. Bipolar cell terminals are located in the inner nuclear layer at 
many different functional sub-levels, and signalling to ganglion cells is 
predominantly controlled by the glutamate, glycine and GABA signalling
pathways (reviewed in Oyster, The Human Eye, 1999).
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1.3.4 The ganglion cell layer 
There are at least 20 types of ganglion cell described so far, but the majority 
can be classed as either midget or parasol ganglion cells. These are found 
throughout the ganglion cell layer of the retina, and project visual signals 
through to the primary visual-processing centres in the brain, such as the 
superior colliculus.
Müller glial cells make up the seventh cell type in the retina, but these 
are not directly involved in phototransduction and are not neurons, but rather 
have a structural supportive role in the retina. They are radial cell types, which 
span the entire depth of the retina, from the inner segments to the vitreous. The 
vitreal end-feet of these glia fasiculate the axons from ganglion cells to form the 
nerve fibre layer.
1.3.5 Spatial distribution of cells types across the human retina
The retina is not a homogeneous structure when viewed in the central to 
peripheral axes, although these variations are often species-specific. The fovea, 
although not the geometrical centre of the retina, contains the highest density of 
photoreceptors. It is located, as a depression in the retina, about 4mm 
temporally from the centre of the optic nerve head (Bron et al. in Wolff’s 
Anatomy o f the Eye and Orbit, 8^  ^ Edition, 1997). The cells in the centre of the 
fovea are almost all cones, with a complete absence of rods, and thus their 
bipolar cells have extended processes to account for that concentration. The 
density of cones across the rest of the retina is low. In the human, there are
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approximately 20 times more rods than cones. The patterns by which cones tile 
the retina are poorly understood, but are neither regular nor random. Although 
rods and cones were initially distinguished from each other by morphological 
criteria, these two cell types have distinct roles in vision: rods are primarily 
adapted to register scotopic spectral sensitivity, i.e. the phototransduction of 
dark-adaptation; photopic spectral sensitivity, i.e. colour vision, is controlled by 
cones, the precise absorbance of whose photopigments determines perception 
of different colours.
Ganglion cell density steadily declines from the fovea to the periphery of 
the retina.
1.4 Embryological origins of the eye
1.4.1 Morphological model of eye development (see Figure 1.3)
Development of the major sensory organs of the head in vertebrates involves 
the formation of epidermal thickenings, the cranial ectodermal placodes, and 
their interactions with specific regions of the neural tube (Gilbert, in 
Developmental Biology, 4^  ^ Edition 1994). In the mouse, the optic vesicles 
evaginate as bilaterally symmetrical pouches from th e ^ jo re b r^  at about 
embryonic day eight (E8). By E9, these évaginations have made contact with 
the overlying surface ectoderm, and this contact in turn causes this head 
ectoderm to thicken into the lens placode. Upon contact with the lens placode
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Figure 1.3. Early development of the murine eye. At around E8 two symmetrical 
évaginations from the forebrain emerge as the optic pits. As the optic vesicle forms, the 
évagination thins into the optic stalk. Upon contact with the surface epithelium (shown 
here in red), this tissue thickens to form the lens placode, which subsequently 
invaginates as the lens vesicle (shown here in yellow). The inner layer of the optic 
vesicle forms a pool of progenitor cells from which the neural retina develops (shown 
here in dark blue). The outer layer (shown here in light blue) differentiates into the 
retinal pigmented epithelium. By El 0.5, the neural retina in the optic cup has begun to 
differentiate, with cells in migrating to their correct position during the rest of 
development, up until P I2.
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the optic vesicle invaginates back in on itself, forming the optic cup. This 
structure at E10 defines three of the major components of the mature eye: the 
lens placode has been invaginated into the optic vesicle as the presumptive 
lens; the neuroepithelium of the optic vesicle has folded back on itself causing 
the formation of a bilayered optic cup. These two layers form pools of (at this 
stage morphologically indistinguishable) cells, which will go on to form the (non­
neuronal) RPE and neural retina respectively. Proliferation of the neural retina 
and RPE continues in the mouse until postnatal day 11 (P11). During this 
period the eye increases in size considerably, and the neural retina 
differentiates into the highly organised structure described above.
1.5 Comparative human eye development
The human retina is largely similar to that of the mouse; it is made up of the 
same sets of cells, arranged in the same three-layered strata. However, there 
are significant differences in cell distribution and development.
1.5.1 Developmental timing
Although the development of the human and mouse eyes follows the same 
overall pattern, the relative timings of development are very different, and do 
not correlate in a linear fashion (Table 1.1). These differences probably reflect 
the intrinsic differences in cellular distributions in the two retinae. The
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development of the human retina is relatively shorter compared with that of the 
mouse, given the total length of gestation. Precise timings of eye and retinal 
development have been made experimentally in the mouse (Young 1985). Of 
course, equivalent timings in humans are not known with the same testable 
accuracy.
Mitosis continues in the murine retina until postnatal day 12 (Young 
1985), and mice are bo rn^ igh tles^^ their eyelids not opening until PI 2-14 
(Kaufman, in Atlas of Mouse Development, 1995). The human retina is largely 
postmitotic by the 15th week of gestation (Hollenberg and Spira 1972, 1973), 
and babies are born sighted.
The primitive components of the adult eye have formed by the sixth week 
of gestation. These include the lens vesicle, which has invaginated from the 
surface epithelium, and the bilayered optic vesicle, whose inner layer represent 
the multipotential progenitor pool of cells from which the retina will develop, and 
the outer layer which will develop as the RPE. The presence of these 
components is roughly equivalent to that of an E9 mouse eye. Within a few 
days, the neural retina can be divided into two layers, separated by the 
transient fibre layer of Chievitz. The morphologies of the cells in these two 
layers are distinct, with the outer layer containing more elongated cells, and the 
inner layer containing more spherical cells. This may reflect the presence of 
differentiating ganglion cells in the inner layer, and mitotic cells in the outer. By 
the 8th week of gestation, the nerve fibre layer is clearly visible, indicating that 
ganglion cells have projected their axons towards the optic nerve head. The
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number of axons does not accurately represent the final number of ganglion 
cells: at 10-12 weeks about 1.9 million axons are present in the human optic 
nerve. This number rapidly increases to 3.7 million by the 16^ *^  week, reflecting 
the rapid increase in the ganglion cell pool. However, by the 33^  ^ week of 
gestation, there are only 1.1 million axons in the optic nerve. Up to 70% are 
eliminated in the foetus, relating to the number of ganglion cells that are 
undergoing apoptosis during this period (Bron et al. in Wolff’s Anatomy of the 
Eye and Orbit, 8^  ^Edition, 1997).
By the 10th week, cells displaying cone-like morphology can be detected 
in the outermost layer of the neuroblastic retina. But it is not until the 5^  ^ month 
that outer segment formation can be detected. In the mouse, this occurs from 
P3 (Sanyal et a i 1980).
By the 22nd week, the fovea is formed in the central portion of the retina, 
as an elliptical disc of about 1.5mm diameter. At this stage, cells are present in 
all layers of the foveal retina, and only by the fourth postnatal year has the 
fovea taken its mature morphology comprising only cones.
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Table 1.1 Comparative human and mouse retinal development
Developmental event Human
(weeks post coitus)
Mouse
(embryonic/postnatal day)
Evagination of optic vesicle EB
Contact with surface epithelium E9
Formation of bilayered optic cup 5 wpc E10
Formation of neural retinal progenitor cells 6 wpc E10
Formation of bilayered neural retina 7 wpc (layer of Chievitz)
Early born cells undergo terminal mitosis 8 wpc E10.5
(formation of nerve fibre layer)
Inner plexiform layer formed 9 wpc E 14-15
Tri-layered retina visible 12 wpc El 7-18
PO: birth
Onset of outer segment formation 20 PS
Cessation of retinal mitosis 15 P12
~ 40 wpc: birth
Human data adapted from Hollenberg and Spira 1973, mouse data from Kaufmann (in The Atlas of Mouse 
Development. 1995), and Chapter 5.
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Table 1.2 Glossary of terms for cellular development
Concept Definition
Birth
Cell fate
Commitment
Competence
Differentiation
Extrinsic factors 
Intrinsic factors 
Potential
Progenitor
Point of terminal mitosis, often indicating commitment or a reduction 
in potential
The cell type that an immature cell will eventually become 
State where a cell is irreversibly bound to become a specific cell type 
The ability of a cell to adopt multiple fates, via response to intrinsic 
and extrinsic cues (see below)
The process during which time a maturing cell displays specific 
characteristics
Secreted factors, e.g. signalling molecules
Cellular or nuclear factors, e.g. transcription factors
The ability of a cell to adopt cell fates. Retinal progenitors are
accepted to be multipotential
A cell with limited mitotic capability, which is capable of producing a 
range of mature cell types
Adapted from Livesey and Cepko, 2001,
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1.6 Genes involved in eye development
The migration and differentiation of proliferating cells determines the correct 
development of the eye and retina. Many of the genes involved in these 
processes are known, as are some of the conceptual ideas that shape 
development and organisation of the highly complicated retina. Definitions of 
some important concepts are outlined in Table 1.2.
1.6.1 Order o f cell birthing (Figure 1.4)
The order in which retinal cells are born, i.e. become postmitotic and migrate 
from the proliferating progenitor pool to their final destination is well 
documented, and appears to be heavily conserved across all vertebrate 
species. Cells leave the multipotential progenitor pool at specific and 
overlapping times (Young 1985). These and other data (Holt et al. 1988, Turner 
and Cepko, 1987, Turner et al. 1990) indicate that specification of retinal cell 
types is not lineage dependent, i.e. the fate of a daughter cell is not directly 
related to its mother cell. However, other evidence suggests that restricted 
potentiality of retinal progenitors exists as the retina develops, and that 
artificially altering cell fates in vitro does not necessarily permit the 
reassignment of a cell to any other retinal fate (Cepko et ai. 1996) (this is 
discussed in further detail in 1.6.2). The non-linearity of retinal fate is further 
indicated by the overlapping periods of time that spawn the various different 
types (see Figure 1.4). The important study by Young (1985) demonstrated by
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Figure 1.4. Order of cell birthing in the developing murine retina (adapted 
from Cepko et a l 1996). During the terminal mitosis by a cell, ^H-thymidine is 
taken up and subsequently not diluted (as happens with cells that are still 
dividing). The mice were sacrificed when their retinae were mature, and 
processed for incorporated ^H-thymidine. This experiment demonstrated the 
specific cells that were undergoing terminal mitoses at each specific time, with 
ganglion cells being the first cells to undergo terminal mitosis, starting 
at ~E10.5, closely followed by horizontal and amacrine cells and cones. Cells 
that differentiate late include rods, which make up the majority of cells in the 
murine retina, bipolar cells and Müller glia. The peak of the genesis of these 
cells occurs post-natally in the mouse.
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^H-thymidine incorporation the order in which cells of the retina undergo their 
terminal mitosis, and therefore are accepted to gain a specific cell fate. During 
the course of retinal development in the mouse, individual mice were injected 
with a dose of ^H-thymidine on specific days. During the terminal mitosis by a 
cell, ^H-thymidine is taken up and subsequently not diluted (as happens with 
cells that are still dividing). The mice were sacrificed when their retinae were 
mature, and processed for incorporated ^H-thymidine. This experiment 
demonstrated the specific cells that were undergoing terminal mitoses at each 
specific time.
Ganglion cells are the first cells to undergo terminal mitosis, starting 
at -E10.5, closely followed by horizontal and amacrine cells and cones. Cells 
that differentiate late include rods, which make up the majority of cells in the 
murine retina, bipolar cells and Müller glia. The peak of the genesis of these 
cells occurs post-natally in the mouse.
1.6.2 T he^om pe tenœ j^  5) ^ — -
The concept of competence of retinal neuroblasts (see Table 1.2) states that 
progenitor cells are capable of responding to molecular cues in a limited 
manner, and are thus capable of differentiating into in a subset of retinal cell 
types (Livesey and Cepko, 2001). Evidence suggests that competency is 
intrinsically determined, but for cells within a given competency, both intrinsic 
and extrinsic signals determine the cellular outcome.
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Figure 1.5. Competency model of retinal development. Muitipotential 
progenitor cells pass through different stages of competence during 
development, indicated by the different colours. During each of these 
stages they are capable of generating a subset of retinal cells, regardless 
of the lineage of that cell. The first division of the progenitor cell produces 
two cells, one that is capable of differentiating into an early-born cell 
(such as a ganglion cell), and one that progresses to the next 
competency, and so on. The number of competencies is unknown, but 
here has been divided for convenience into early, middle and late. 
Adapted from Livesey and Cepko,(2001).
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Central to the competency model of retinal development is the notion that 
progenitor cells are competent to generate different sets of retinal cells during 
the course of retinal development. This is in contrast to previous models that 
state that cells become progressively restricted in their potential, reflecting that 
late-stage progenitors give rise primarily to rods. Although a straightforward 
lineage-dependent relationship does not exist in the retina between progenitor 
cells and their progeny, some studies have shown that cellular determination is 
largely lineage independent (Turner, et al. 1990, Turner and Cepko, 1987, Holt 
at ai. 1988).
1.6.3 Retinal development
The increasing limitations of a progenitor cell’s potency as it progresses through 
development are determined by expression, or repression, of specific proteins, 
as regulated by the combination of intrinsic factors (cell autonomous factors), 
and extrinsic cues derived from long- or short-distance signalling from other 
cells. These events combine to reduce the potency of a cell until it is committed 
to a specific type, at which stage a differentiation pathway can be initiated and 
completed. As described in section 1.6, the retina contains many different cell 
types, which can be characterised by specific gene expression patterns, and 
are born and differentiate in very tightly regulated spatio-temporal patterns.
Several transcription factor genes have been identified that are involved 
in this process (Hanson and Van Heyningen 1995, Freund etal. 1996), and 
some significant ones for the intents of this thesis are discussed below, and
40
summarised in Table 1.3. Amongst the approaches used to identify key genes 
have been the analysis of a number of animal models. These include naturally 
occurring mouse mutations, such as Small-eye (discussed in 1.6.4), gene 
targeting involving retinal-specific genes, such as for Crx, (discussed in 1.6.11 
and Chapter 5). In addition, the identification of mammalian homologues of 
genes involved in invertebrate eye development has provided a source of eye 
development genes, such as the Six family (Kawakami et al. 1996, Lopez-Rios 
etal. 1999).
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Table 1.3 Transcription factors involved In retinal development
Protein Species Expression Function References
ChxIO M, Oh, H Retinal neuroblasts. Promotes proliferation and Liu efa/.(1994).
bipolar cells bipolar cell fate Burmeister et at. (1996), 
Belecky-Adams et ai. 
(1998)
Mash-1 M,X Differentiating cells Promotes differentiation of late- 
born cells
Guillemot and Joyner 
(1993)
MITF M RPE RPE survival Hodgkinson etal. (1998)
NeuroD M,X Neuronal
differentiation
Neuron specification Lee etal. (1995)
Otx2 M RPE Unknown Bovolenta etal. (1997)
Pax6 M, H, X, Neural retina. Early optic field determination Macdonald and Wilson,
z,c amacrine cells, GCL (1997)
Rax/rx M,X Neural retina Early optic field determination, 
Müller glia specification
Furukawa etal. (1997)
Brn3b M,C GCL Ganglion cell differentiation Gan etal. (1999) 
Liu etal. (2000)
Hesi M Retinal progenitors Prevents premature 
differentiation
Tomita etal. (1996)
Six-2, -3, -5 M GCL, INL, Unknown Kawakami etal. (1996)
Crx M, H Photoreceptors Promote photoreceptor 
differentiation
Livesey et al. (2000)
Abbreviations: C, chicken; GCL, ganglion cell layer; H, human; INL, inner nuclear layer; M, mouse; RPE, 
retinal pigmented epithelium; X, Xenopus] Z, zebrafish.
Adapted from Jean etal. (1998)
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1.6.4 Specification of retinal fate
Expression of the homeo- and pa/red-domain containing transcription factor 
Pax6 is widespread through the developing brain (Grindley et al. 1995). In 
terms of eye development, its expression pattern within the developing 
telencephalon defines the regions that evaginate to form the optic vesicles, and 
for this reason is thought to be one of several genes at the top of the genetic 
hierarchy that regulates vertebrate eye development. Pax6 expression 
continues throughout eye development, and becomes restricted to particular 
cell types later on (discussed in 1.6.8) (Hitchcock et al. 1996). The expression 
pattern of Pax6 is largely indistinguishable in both humans and mice (Nishina et 
al. 1999). Dosage of Pax6 is critical for ocular organogenesis. The Small eye 
mouse is caused by mutations in the Pax6 gene; heterozygous mice develop 
smaller eyes by mid-gestation (Hill et al. 1991), and humans suffer from eye 
malformations in the disease aniridia (discussed below), both as a result of 
haplo-insufficiency. Homozygous mice largely fail to develop forebrains and 
thus optic cups, and are neonatally fatal owing to CNS defects (Grindley et al. 
1997). However, as the defects that occur as a result of mutations in PaxS 
occur predominantly before retinal neurogenesis, it renders further analysis of 
Pax6 function in later development difficult without the generation of conditional 
knockout mice. Recently, a Cre-mediated conditional Pax6 knockout mouse 
was generated (Marquardt et al. 2001), and is discussed in detail in the Chapter 
7, Discussion.
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Several other genes appear to be involved as well as Pax6 in the 
specification of the different cell types of the eye.
A number of proteins (particularly transcription factors) have been 
identified that are expressed in retinal progenitor cells. However the precise 
roles that these molecules play in specifying a retinal fate is poorly understood. 
Mash1, Maths and 5, and NeuroD are all expressed in retinal progenitor cells, 
but are not detectable before the onset of ganglion cell differentiation (Brown et 
al. 1998). Targeted deletion of Mash1 does not, however, result in a retinal 
phenotype. Hesi appears to be essential for retinal development, as targeted 
deletion of the gene encoding it results in reduced optic cup size by E l0.5. 
Maths and Hes1 are targets of Pax6 (whether this interaction is direct or not is 
unknown) (Brown et al. 1998), again indicating Pax6’s role high up in the ocular 
organogenesis hierarchy.
Perron et al. (1998) use the Xenopus ciliary marginal zone (CMZ) as a 
model for the genes expressed during the course of retinal development. Unlike 
in higher vertebrates, the retina of the frog continues to grow throughout its life, 
in a periphero-central gradient, i.e. cells in most peripheral retina are most 
multipotent, expressing Pax6, Rxl and Six3. Similarly, in the mouse, retinal 
progenitor cells express Pax6, Rx, Six3 and 81x6 (Jean et at. 1999, Marquardt 
et al. 2001). The subsequent steps in Xenopus towards specific retinal cell fate 
include the onset of neurogenic gene expression (Notch, Delta), before the 
onset of expression of specific cell markers, such as ChxIO [bipolar cells, (Liu et 
al. 1994)], Brn3b [ganglion cells (Gan et al. 1996)], and so on. The use of
44
Xenopus as a model for retinal development is profound, as the CMZ provides a 
“snapshot” of gene expression for the various stages of potential and 
commitment (Perron et al. 1998).
1.6.5 Genetic specification of the neural retina and RPE
The RPE and neural retina are both derived from neuroepithelial cells, and both 
are initially bipotential. Genes involved in the distinction between neural and 
non-neural retina are known to include the leucine-zipper transcription factor 
mitf (Nguyen and Arnheiter, 2000). Expression of mitf ls maintained in the RPE, 
but down regulated in response to expression of the ChxIO transcription factor. 
Furthermore, m/ff mutant mice continue to express neuroretinal markers in RPE 
progenitor cells. Conversely, removal of the surface ectoderm results in a 
maintenance of mitf expression in the neuroretinal progenitor pool, loss of 
ChxIO expression, and subsequent conversion of this pool into a pigmented 
monolayer. These data indicate that the maintained expression of mitf, and 
repression of Chxl 0 (and vice versa) is critical for the formation of the RPE and 
neural retina, respectively. Interestingly, mutations in the mitf gene cause 
microphthalmia in mice, although the onset of expression in mice does not 
occur until around E l 3.5 (Freund et ai. 1996) (see Table 1.4).
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1.6.6 Cell-specifying genes
Recently, several genes have been identified that appear to be essential for the 
differentiation of specific cell types in the retina. It seems that the expression 
profile of specific combinations of genes during precise windows of time can 
determine the fate of a cell. Many of the genes identified are transcription 
factors, and thus are capable of regulating downstream targets. This class of 
protein is particularly interesting in terms of questions of fate-specification, as it 
is an attractive idea to suggest that the complex process of differentiation, which 
involves cascades of different genes, has a controlling factor at the top of the 
hierarchy. Some of the genes that make good candidates for this type of protein 
are discussed below.
1.6.7 Brn3b
Brn3b (also referred to in different species as Pou4F) is a POU-domain 
transcription factor that is expressed in the retina in a subset of ganglion cells. It 
is also expressed in regions of the superior colliculus that are known to be 
involved in the processing of sensorimotor inputs to control eye movement, and 
receives afferent fibres from ganglion cells (Xiang 1998). The fact that BrnSb is 
only expressed in a subset of cells reflects the diversity of ganglion cells that 
have been identified morphologically. So far, few other genes have been 
identified that have such potential as ganglion cell differentiation molecules. 
Targeted deletion of Brn3b results a loss of most (70%) of these cells in 
homozygous mice (Gan et al. 1996). Furthermore, ganglion cells in knockout
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mice fail to project their axons at the correct time and place (Gan et al. 1999). 
However, it remains one of the earliest genetic markers of ganglion cells 
development.
1.6.8 Amacrine cells
Belliveau and Cepko (1999) investigated the mechanisms by which an 
amacrine fate is determined in vitro. By co-culturing postnatal rat retinal cells 
with embryonic retinal cells, they found that inhibition of amacrine cell genesis 
was derived from postnatal amacrine cells, suggesting that amacrine cell 
number is controlled by feedback inhibition. However, the molecules involved in 
this inhibition remain elusive.
1.6.9 Müller glia
Müller glial cells are the only non-neuronal cell-type located within the neural 
retina. Their function includes providing structural support for the retina, and 
fasciculation of the ganglionic axons with their end-feet. Furukawa et al. (2000) 
demonstrated by retroviral transduction of retinal progenitor cells in culture that 
the homeobox gene rax, the basic helix-loop-helix gene Hesi, and notchi, a 
transmembrane receptor gene were all capable of inducing Müller cell genesis. 
These genes are all expressed in retinal progenitor cells, indicating that 
expression of these genes is necessary but not sufficient for Müller glia 
differentiation. Evidence also suggests that the cyclin-dependent kinase (CDK) 
and Notch signalling pathways are involved in gliogenesis in the retina and
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other parts of the central nervous system (Vetter and Moore, 2001) (see Figure 
1.6 ).
1.6.10 Horizontal cells
In experiments to determine genes involved in cell fate, Alexiades and Cepko 
(1997) demonstrated that the expression in a subset of retinal progenitor cells 
of the epitope VG1.1, a marker of horizontal and amacrine cells, coincided with 
the birthday of horizontal cells. VC1.1-positive cells in cultures of early 
progenitor cells generated a high percentage of horizontal (and amacrine) cells, 
at the expense of cones. However, VC1.1-positive cells in late progentior cell 
cultures (late embryonic and early post-natal) resulted in an increase in 
amacrine cells and rods, but not horizontal cells. This indicates that VC1.1- 
positive cells have a temporally regulated and distinct set of biases in the fates 
of their progeny, and highlights the significance of the cellular milieu that 
dictates the strict temporal regulation and order for cell birthing in the retina (see 
Figure 1.6).
1.6.11 Crx
Crx is a pa/red-type homeobox gene, which is photoreceptor specific, and is the 
earliest known marker for photoreceptor differentiation (Furukawa at al. 1997). 
In humans, mutations in CRX result in a spectrum of retinal degenerations 
including cone-rod dystrophy and Lebers congenital amaurosis (Freund et al. 
1997, Freund et al. 1998, Traboulsi 1998). Crx is first detected in the murine
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retina at E12.5, roughly the onset of cone differentiation, but earlier than rod 
generation. Targeted deletion of this gene in mice, however, does not result in 
the absence of photoreceptors. Rather photoreceptors are present but 
morphologically abnormal, in that their inner and outer segments are severely 
truncated or absent. Identification of the putative preferred binding site of Crx in 
the upstream regions of a number of photoreceptor-specific genes suggests a 
regulatory role for Crx in the expression of these genes. Indeed, using 
microarray analysis on the Crx~^ ~ knockout mouse, expression of several of 
these genes was reduced or absent, confirming their (at least partial) regulation 
by Crx (Livesey eta l. 2000). These data indicate that Crx, although not required 
for the genesis of photoreceptors, is certainly necessary for the correct 
differentiation of photoreceptors, particularly the inner and outer segments.
1.6.12 ChxIO
The cell-specifying capabilities of the homeobox gene ChxIO are discussed in 
detail in 1.9 and Chapter 5, and are the central theme of this thesis.
1.7 Extrinsic factors involved in retinal fate decisions
The complexities of the factors involved in retinal fate specification are 
exemplified in experiments in which fate can be altered in vitro. The majority of 
these experiments focus on the fates of photoreceptor cells, in particular on
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rods (possibly because these are by far the most abundant cell type in the 
retinae of most model organisms, but also because these are the primary cells 
lost in retinal degenerations). Watanabe and Raff (1992) demonstrated that rat 
retinal embryonic cells cultured in the presence of postnatal retinal cells resulted 
in a 40-fold increase in the numbers of (opsin-positive) photoreceptors 
generated, and that the cue from the postnatal cells was a short-range 
signalling molecule. Levine et al. (2000) formalised this into an analysis of fate- 
altering molecules. Retinoic acid (RA), which is known to regulate many aspects 
of development (Ross et al. 2000), is ^ m d u c e d ^ is la i^ Z ^ u a ^ ^  
developing vertebrate retina, although its role is poorly understood (Drager et 
al. 2001). Kelley et al. (1994) showed that in concentration-dependent manner, 
addition of RA to retinal progenitor cells resulted in an increase in rod 
photoreceptors, mostly at the expense of amacrine cell, which are born in vivo 
at roughly the same time (Young 1985), and that the action of RA was on 
progenitor cells. These data were corroborated by in vivo experimentation on 
zebrafish, in which RA injection during development caused precocious rod 
development, this time at the expense of cone maturation (Hyatt et al. 1996). 
Furthermore, targeted deletion in mice of two of the RA receptor genes, RARp 
and RARy, leads to the absence of rhodopsin in areas of the retina (Grondona 
et ai. 1996).
Taurine, which is critical for photoreceptor survival (Lombardini et ai. 
1991), has also been shown to promote rod development in the retina (Altshuler 
et al. 1992). Specific blockage of the fibroblast growth factor receptor (FGFR)
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using a dominant negative form in Xenopus leads to a 50% reduction in 
photoreceptors and amacrine cells, but a concurrent increase in Müller glia. 
Conversely, use of a receptor that blocks non-FGF ligand binding to FGFR 
leads to the opposite effect, with a 50% increase in photoreceptors, and a 67% 
decrease in Müller glia. These data suggest that photoreceptor and Müller glia 
generation are finely balanced using a FGFR signalling pathway that is 
determined by FGF and non-FGF ligands (McFarlane etal. 1998).
Inhibition of photoreceptor differentiation has also been demonstrated, 
for example with transforming growth factor (IG F) a, which was shown to have 
an inhibitory effect on rod genesis (Lillien and Cepko, 1992), possibly with a 
mitogenic effect.
The cytokine ciliary neurotrophic factor (ONTF) has a profound effect on 
retinal development in vitro. ONTF has a regulatory role on the regulation of 
photoreceptors, but confoundingly, this role appears to be opposite in rat and 
chicks. Ezzedine eta l. (1997) showed that addition of ONTF to retinal explanted 
cultures dramatically reduced the numbers of (rhodopsin-positive) rods being 
formed, and a corresponding increase in the numbers of bipolar cells. These 
data suggest a bipotentiality to the precursors of these cell types that can be 
regulated by ONTF. Furthermore, despite the evidence that suggests that retinal 
neurons (and indeed all neurons) became committed to a specific fate during or 
after the terminal mitosis (Young 1985), cells putatively fated to become rods 
that were postmitotic could also be respecified into bipolar cells. Resistance to 
the respecification of postmitotic rods by CNTF coincided with the expression of
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rhodopsin, a period of several days in many species, emphasising the 
difference between the birth of rod progenitors (marked by the terminal mitosis) 
and commitment to a rod fate (marked by rhodopsin expression). Levine et al. 
(2000) suggests that this is a mechanism to delay rod maturation until other 
retinal components have reached an apposite functional state.
The issue of rod genesis is further complicated by the discovery of two 
phases of rod genesis (Morrow et al. 1998), which may support Levine et a/.’s 
(2000) suggestion. Again using the rat as a model animal, studies 
demonstrated that rods born after E19 experienced a 5.5-6.5 day delay before 
the onset of rhodopsin expression. Rods born before this time experienced an 
8.5-12.5 day delay before expression of rhodopsin, and this did not correlate 
with terminal mitosis. Therefore, expression of rhodopsin was synchronised 
between the two phases of rod genesis. Co-culture of early-born cells with late- 
born cells did not affect their fate, indicating that the early-born cells were 
intrinsically programmed.
1.8 Schematic diagram of genes involved in cell fate determination 
(Figure 1.6)
The current information about some of the genetic signals that specify cell types 
and differentiation from the multipotential pool of retinal neuroblasts is 
summarised schematically in Figure 1.6, incorporating the data discussed
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Figure 1.6. Schematic representation of some of the genes involved in retinal fate determination and differentiation. See text for details. References: 1. Morrow E M. et al
(1999), 2. Morrow E.M. etal. (1998), 3. Ezzeddlne Z.D. etal. H997), 4. Belliveau M.J. and Cepko C.L (1999) 5. Alexiades M.R. and Cepko C.L. (1998), 6. Vetter and Moore, 
(2001 ).
above. The scheme indicates the genes that characterise mature retinal cells, 
as well as those involved during their development from multipotential 
progenitor cells.
1.9 The role of ChxIO in retinal development
Chx10 is a homeodomain-containing transcription factor, first identified by Liu et 
al. (1994) in a human retinal-specific library screen. Liu et al. (1994) focused on 
analysis of the murine homologue of this novel gene, which encodes a 361 
amino acid, 39-kDa protein. Sequence analysis of a 1089bp transcript indicated 
that it was a homeobox containing gene, defined by the possession of 
sequence encoding a 60 amino acid highly conserved DNA binding motif, called 
the homeodomain. Further analysis indicated that ChxW  was a member of the 
sub-family, paired-type homeobox genes, named after the first discovered in 
this family, the Drosophila gene, paired (prd) (see Figure 1.7). ChxW  was 
named on the grounds that its homeodomain shared the highest amino acid 
sequence identity with that of the Caenorhabditis eiegans gene, CehW  
(Hawkins et ai. 1990), and hence Ceh 10-like HomeoboX. Members of this 
subfamily include the Pax proteins. Orthodenticle-like proteins. The homeobox 
is typically encoded by 3 exons in prd-type genes, and consists of a helix-loop- 
helix tertiary structure (Latchman, in Eukaryotic Transcription Factors, 1998).
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Figure 1.8. Structure of the C hxW cD U A . Chx10 is encoded by a 1089bp coding sequence, consisting 
of several conserved domains.
Sequence comparison with other homeobox genes indicates that Chx10 
has several other conserved domains, which therefore may be functionally 
significant (Liu et al. 1994). Immediately 3’ to the homeobox there is a 180bp 
region that appears to be highly evolutionarily conserved between Chx10-\\ke 
genes in several different species, including goldfish, zebrafish, and chicken 
(see below). This region is termed the CVC domain [after the genes in the 
species in which it was initially identified, QehW  (C. eiegans), Vsx1/2 (goldfish), 
and Qhx10 (mouse)]. However, no function has yet been associated with this 
motif.
1.9.1 Structure of ChxIO (Figure 1.6)
The structure of ChxIO is given in the schematic diagram Figure 1.8. The 
coding sequence spans 1089bp and features several putative functional 
domains. These include the homeobox (442-622), the CVC domain (623-784), 
the function of which is yet unknown.
1.10 Expression of ChxIO in mouse
Liu et al. (1994) reported the developmental expression pattern of ChxIO in the 
mouse and rabbit. Retinal expression is discussed in section 1.10.1 and 
Chapter 5 in more detail. Expression is found in the ventral posterior neural 
tube, more specifically the developing rhombencephalon, spinal cord and
56
thalamus from E10.5. In the adult, extra-ocular expression of ChxIO appears to 
be limited to a subset of motor neurons in the spinal cord, specifically the V2 
interneurons. No functional significance of extra-ocular ChxIO expression has 
been described (Burmeister etal. 1996).
1.10.1 ChxIO expression in the murine retina
Northern blot analysis shows that transcripts are abundant in the retina,
and faintly detectable in the pons, medulla and spinal cord as discussed in 
section 1.10, but in no other tissue examined (Liu et al. 1994). In situ 
hybridisation data suggests the importance of ChxIO in the developing and 
adult retina, and are further discussed in Chapter 5.
1.11 Microphthalmia, and the microphthalmic mouse, ocular retardation
The human condition known broadly as microphthalmia [which is now accepted 
to reflect a spectrum of conditions, including anophthalmia and nanophthalmia 
(Ferda-Percin et al. 2000)], and the congenital blindness that accompanies it, is 
a clinically and genetically heterogeneous developmental disorder that is 
characterised by a small eye and other ocular abnormalities. To date, five loci 
have been identified in the human genome that co-segregate with 
microphthalmia (Bessant etal. 1998, Ferda-Percin et al. 2000).
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There are a number of animal models, in which a small eye or 
microphthalmia is a central phenotype. Details of some of these models are 
summarised in Table 1.4.
Truslove (1962) identified a spontaneous natural mutation in a colony of 
mice that were severely microphthalmic and blind. This mutation was named 
ocular retardation {oi), and displayed fully recessive Mendelian inheritance 
patterns, with no phenotype in heterozygotes. The phenotype of this mouse has 
subsequently been shown to be restricted to the eye, and is characterised by 
microphthalmia, a thin hypocellular retina, an absent optic nerve, 
morphologically abnormal photoreceptors, cataracte us lens, and an absence of 
bipolar interneurons (Burmeister et ai. 1996). Developmental analysis of this 
mutant revealed that by E l2 or/or embryos had smaller eyes than normal. 
Truslove noted that the choroid fissure prematurely closed in the or/or mice 
during development, and erroneously attributed the reduction in size of the eye 
to the reduction in blood flow through the hyaloid vessels.
Because the microphthalmia was deemed to be similar, Konyukhov and 
Sazhina (1964) investigated the interactions between or and microphthalmia 
{mi), a recessive microphthalmic mouse mutation with a similar microphthalmic 
phenotype to or. orlorlmilmi mice displayed a phenotype that was less severe 
than either of the single mutants, showing a smaller degree of microphthalmia 
(Rod Mclnnes, personal communication). The gene causing the mi phenotype 
was subsequently shown to be mitf, and interactions between mitf and ChxIO
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are critical for the definition of the RPE and the neural retina, as discussed in 
section 1.6.5.
In 1976 a new mutation on the inbred mouse strain 129/Sv-SX was 
identified in the Jackson laboratories that was shown to be allelic to or, and was 
named o /  (Theiler et al. 1976). The or allele was subsequently lost, and all 
further work on this mutant has been carried out on o /.  Theiler et ai. (1976) 
also focused on the apparent constriction of the blood vessels that flow through 
the choroid fissure during development, but more specifically identified a 
reduction in morphogenetic cell death, (described as “necrosis” there, in fact 
this cell death was almost certainly apoptotic, as it was not caused by injury) on 
the lateral edges of the choroid fissure, causing it to thicken and prematurely 
close. Silver and Robb (1979) expanded on this by noting that the edges of the 
choroid fissure abut squarely in normal mice during development, but in the o /, 
due to the reduced apoptosis, the edges overlap, and cause the premature and 
total fusion of this fissure. Analysis by Robb et ai. (1978) re-interpreted this 
phenomenon, as well as the observed absence of optic nerves and cataractous 
lens, as being a secondary to an underlying cellular defect, which manifests 
itself as a “failure of retinal precursors to differentiate beyond a rudimentary 
level”. This study noted that the developing o /  eye was in fact heavily 
vascularised, despite the constriction of the hyaloid artery. The absence of the 
optic nerve had been noted in many of these studies. Silver and Robb (1979) 
performed detailed microscopic analysis and observed that ganglion cells were 
present in the retina, and indeed projected axons. These axons fail to exit the
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globe, and instead form whorls in between the retina and the RPE, and this 
causes or adds to the observed retinal detachment. The suggested explanation 
for this is that axons face a mechanical barrier in the fused choroid fissure, 
rather than the possibility of an inherent biochemical defect within the ganglion 
cells.
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Table 1.4 Animal models with small eye or microphthalmia phenotypes
Model Species Gene Description References
Ocular retardation M ChxW Point mutation causing premature stop 
codon causes reduction of retinal 
proliferation from El 0.5
Burmeister etal. 1996
Small eye M Pax6 Homozygotes fail to form forebrain 
structures (neonatally lethal); heterozygotes 
have small eyes and are blind.
G raw 1996
Aphakia M PitxS Bilateral microphthalmia due to a failure of 
lens morphogenesis: caused by large gene 
deletion
Rieger et al. 2001
Microphthalmia (mi) M Mitf Microphthalmia in rats and mice. Freund et al. 1996
Mib R Opdecamp et al. 1998
Cyclin D1 M Gy 1-1 Homozygous targeted deleted animals 
display severe retinopathy caused by 
impaired development of all layers of the 
retina
FantI et al. 1995
Rx M Rx Homozygous targeted deleted animals fail to 
develop eyes
Zhang et al. 2000
Abbreviations: M, mouse, R, rat.
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1.12 A mutation in ChxIO causes o /
Following the identification of homeodomain transcription factor ChxIO (Liu et 
al. 1994), Burmeister at al. (1996) demonstrated that the o /  phenotype was 
caused by a mutation in ChxW, resulting in a null allele. Owing to the accepted 
terms of genetic nomenclature, the identification of the gene causing a mutation 
in a mouse requires the renaming of that mouse. The mutant mouse that 
harbours the o /  allele therefore is now officially known as . For the
purpose of this thesis, I shall continue to refer to this mouse as o /.
Sequence analysis of ChxW  in o /  revealed a C ->A  transversion that 
encodes a premature stop codon (tyrosine176stop) in the homeodomain. 
Electromobility shift assays have demonstrated that this reduces the DNA 
binding ability of ChxIO by up to 90%, and therefore this mutation can truly be 
considered a null (Rod Mclnnes, personal communication). This was confirmed 
by the absence of any detectable ChxIO protein when using an antibody raised 
to recognise the N-terminal 139 amino acids of the predicted protein. By 
contrast, ChxIO protein could readily be detected in the wild-type murine retina 
at E10.5 and E14.5.
Liu et al. (1994) and Burmeister et al. (1996) investigated the expression 
pattern of ChxW  during development by in situ hybridisation. This is described 
in detail in Chapter 4. Broadly, initial ocular expression coincided at E9.5 with 
the morphological formation of the inner layer of the optic vesicle and continues 
to be expressed throughout development in dividing retinal neuroblasts. As cells
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leave this pool and become postmitotic, ChxIO  expression is downregulated, 
apart from bipolar cells, in which expression is maintained throughout life.
Given this expression pattern of ChxIO during eye development, 
Burmeister et al. (1996) chose to focus on analysis of the retinal phenotype. 
The absence of expression of ChxIO in the choroid fissure or optic stalk, but the 
presence of a phenotype here (as discussed in the earlier work) suggests an 
interaction between ChxIO and downstream targets that have a longer range 
effect. This however, has not been investigated further.
Cell proliferation was assayed in the development of the mutant retina by 
bromodeoxyuridine (BrdU) incorporation at E11.5, which was reduced by up to 
83% in the peripheral retina (though not significantly different in the central 
retina). However, by this stage the mutant retina contains 30-50% fewer less 
cells than the wildtype. Reduced proliferation in the peripheral retina continued 
until at least E l8.5. Given ChxW s  expression pattern throughout the 
undifferentiated neuroblastic retina during early development, and this reduced 
cell proliferation phenotype, Burmeister et al. suggest that ChxIO plays a major 
role in promoting cell proliferation in the developing neural retina.
1.13 ChxIO interacts with pRB family members
Further evidence that ChxIO is involved in cellular proliferation came from 
Wiggan et al. (1998). Their study reported that members of the family of
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proteins termed pRB [(some of which cause the human ocular condition 
retinoblastoma, (Friend et al. 1986)] are capable of directly interacting with 
transcription factors that contain a prd-type homeodomain, including ChxIO. 
Members of this family are known to act as negative regulators of cell cycle 
progression. Wiggan et ai. (1998) demonstrated that the pRB family members 
p i30, p i07 and pRB itself bind in vitro to the homeodomain of ChxIO. This may 
indicate a regulator of ChxIO whose expression may influence cell fate 
decisions. The authors speculate that the binding of ChxIO by its functional 
domain to a negative regulator of cell cycle progression might repress its 
function, indicating that ChxIO may support proliferation via this pathway. These 
data give biochemical credence to ChxIO’s putative role in the promotion of 
proliferation.
1.14 ChxIO is crucial for bipolar cell fate decisions
Liu et ai. (1994) showed that expression of ChxIO in the adult retina was 
restricted to a band of cells within the inner nuclear layer. This band was 
restricted to cells in the outer aspect of the inner nuclear layer, which includes 
the location of bipolar cells. However, the band of expression appears wider 
than the bipolar layer, indicating that cells other than bipolar cells may weakly 
express ChxIO. ChxIO expression in bipolar cells was confirmed by Burmeister 
et ai. with immunocolocalisation of ChxIO and protein kinase C (PKC) proteins.
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PKC being a bipolar-cell marker (Greferath et al. 1990). This expression pattern 
suggests a role for ChxIO in the maintenance of bipolar-cell function, but also in 
function of other inner nuclear layer cell-types.
Burmeister etal. also performed immunohistochemistry, using antibodies 
to cell specific antigens, to determine whether all retinal cell types were present 
in the o /  retina. Staining for the axon specific cell adhesion molecule L1 
demonstrated the presence of ganglion cells at E l4.5, indicating this cell type 
was present and differentiated, and confirmed that the axons formed whorls, or 
neuromas in the inter-neural retinal-RPE space. Ganglion cells are amongst the 
first cell type to become postmitotic and differentiate in the vertebrate retina 
(Young 1985), and these data indicates that their birthing is little affected by the 
absence of functional ChxIO. Similarly, at P I4 (when the retina is fully 
postmitotic and can be considered mature), cell types were identified by the 
positive observation of cell specific mature markers; Müller cells (vimentin- 
positive), amacrine cells (syntaxin-positive), horizontal cells (neurofilament- 
positive), and rod photoreceptors (rhodopsin-positive at PI 8) were all shown to 
be present in the mutant retina. Furthermore, all of these cell types appeared to 
be in strata that were approximately equivalent to that of the wild type, despite 
the absence of obvious lamination or stratification in the mutant retina. LI 
positive cells were invariably seen in a layer closest to the lens, inner nuclear 
layer cells were seen in the single nuclear layer, and rod photoreceptor cells 
were seen mostly on the outer aspect of the neural retina, abutting (when not 
detached) the RPE.
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By stark contrast, no immunoreactivity was detected for the bipolar cell 
markers PKC or RetB1, indicating that bipolar cells are absent in the adult o /  
retina. Bipolar cells are amongst the last cell type born in the retina (Young, 
1985). Two arguments present themselves here to address this phenotype. 
One is that as bipolar cells are born late, and there is a great reduction in 
proliferation and hence cell number in the mutant retina, that there are no cells 
remaining in the neuroblastic progenitor pool that can differentiate as bipolar 
cells. This would be supported by the reduced level of proliferation observed 
with BrdU labelling at later stages of retinal development (Burmeister et al. 
1996). This argument is refuted however by the presence of Müller cells, which 
are born similarly late in retinal development. The second possibility is that 
ChxIO has a role in the specification and differentiation of bipolar cells, and that 
absence of a functional ChxIO results in the failure of these cell to develop 
normally or at all. This is reinforced by the high levels of expression of ChxIO in 
bipolar cells seen in the adult retina, which indicates that, at least, ChxIO has a 
role on the maintenance of bipolar cell function.
Expression of ChxIO, analysis of the phenotype of the o /  retina and 
biochemical analysis of Chx10-p130 interaction indicates that ChxIO has a 
number of distinct roles in the retina:
1. ChxIO is essential for correct levels of cellular proliferation of the 
neuroblastic retina, possibly by repressing the activity of a negative regulator 
of the cell cycle.
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2. ChxIO is necessary for specification and differentiation of bipolar cells from 
the neuroblastic pool of retinal progenitor cells.
3. Continued expression of ChxIO in differentiated bipolar cells may indicate a 
role in the maintenance of these non-diving neurons, or at least as a 
regulator of bipolar-cell-specific function.
1.15 Other ocular phenotypes in the o /  mouse
There are several phenotypes in the o /  retina that are not addressed by these 
putative roles of ChxIO. One is the absence of an optic nerve. Ganglion cells 
are present in the mutant, and they do project their axons, but these fail to leave 
the globe and fasiculate into a cohesive optic nerve. The optic stalk 
degenerates into a residual line of cells that are morphologically distinct from 
the surrounding mesenchyme (see Figure 1, Chapter 4). ChxIO is not 
expressed in postmitotic ganglion cells (Burmeister et al. 1996), leaving a 
number of possibilities to explain this phenotype. One is that the premature 
closure of the choroid fissure presents a physical barrier through which the 
axons cannot advance, and their guidance cues cause axons to form the 
observed whorls. Another is that, owing to the reduction in cell numbers during 
early development, there is a disruption in the microenvironment, which 
prevents ganglion cells from differentiating correctly. A third possibility is that 
the absence of ChxIO in mitotic cells that are fated to become ganglion cells
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results in a ganglion cell phenotype upon differentiation. The failure of ganglion 
cells to aggregate into a nerve fibre layer, or to form an optic nerve head, 
suggests that the notion of a simple mechanistic physical barrier to axonal 
growth is not sufficient to explain this phenotype. If it were, then one might 
expect the formation of a fasiculated optic nerve head, which was then unable 
to leave the globe. As it is in the o /  retina, axons migrate away from ganglion 
cells through the retina.
As ChxIO is expressed only in the neural retina during development, it is 
perhaps surprising that the o /  phenotype displays such severe microphthalmia. 
One might speculate that as the reduction in proliferation in the neural retina is 
notable when the eye is at a very early stage of development, that this has a 
profound effect on total eye size rather than just on the retina itself. This 
phenotype indicates that signalling occurs between the retina and other areas 
of the eye to convey information about growth, and that these signals are 
inhibited or lost in the o /  retina owing to reduced proliferation, or inherent 
disruption of a relevant signalling pathway.
Lens development in the o /  eye is relatively normal (although the lens is 
proportionally smaller than in the wild type), but the lens invariably becomes 
cataractous in adulthood (Burmeister et al. 1996). The reduction in the size of 
the lens again may be attributable to disturbances in signalling between the 
retina and the lens, which have been shown to be essential for lens 
development (Grainger, 1992). Burmeister et ai. (1996) suggest that the 
formation of cataracts in the o /  eye may be a secondary phenomenon, bearing
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in mind the fact that ChxIO does not appear to be expressed in the lens at any 
stage.
Similarly, Burmeister et al. suggest that the morphologically abnormal 
photoreceptors seen in the mutant may be secondary effect, as ChxIO is not 
reported to be expressed in differentiated photoreceptors. The photoreceptors 
have reduced or absent inner and outer segments, shown by the juxtaposition 
of the outer nuclear layer (i.e. the cell bodies of the photoreceptors) to the RPE. 
In the normal retina, these layers are clearly separated by the inner and outer 
segments. This is investigated in depth in Chapters 4 and 5.
It is interesting that given strong ChxIO expression in V2 interneurons in 
the spine during development and adulthopd^Sander at al. 2000) that no spinal 
phenotype has ever been associated with the o /  mouse. This has not been 
investigated yet, but it may be that other factors are capable of compensating 
for the loss of ChxIO in these cells, or that loss of these cells themselves result 
in a subtle phenotype that is not severe enough to be notable.
1.15.1 ChxIO interacts with R0R-/3
Interactions with a member of the nuclear receptor family of transcription factors 
have been suggested (Chow et al. 1998). Co-localisation of ChxIO  and RORp 
and a dramatic reduction in RORp expression observed in the o /  mouse 
suggest a role for this protein in retinal proliferation, possibly by via ChxIO.
1.15.2 Amelioration of the oi^ phenotype by genetic modifiers
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Bone-Larson et al. (2000) examined the offspring of back-crossed inbred o /  
mice of the strain 129/Sv-SX and sub-species Mus musculus castaneus. The 
ocular phenotype was ameliorated, although the eyes were not of normal size. 
Furthermore, the bipolar cell marker RetB1 was identified by 
immunohistochemistry, although the marker PKC was not. Optic nerves were 
present bilaterally, and electroretinograms indicated partial visual function. 
These data suggest that the presence of genetic modifiers, as found in a 
different genetic background, interact strongly with ChxIO during development, 
and have a profound effect on its function.
1.15.3 Identification of retinal stem ceils
Recently, stem cells have been identified in various vertebrate organs and 
tissue types, including the liver and mesenchyme (Shafritz 2000). Tropepe et al. 
(2000) and Ahmad et ai. (2000) both independently demonstrated the existence 
of neural progenitor cells from the adult mouse eye that display stem cell 
properties in vitro. These cells were capable of proliferation in culture, and 
showed subsequent differentiation into some of the cells of the retina including 
bipolar cells, rods and Müller glia. This finding opposes the dogma that the 
mature retina lacks regenerative capability, and contains no mitotic neurons. 
The putative stem cells expressed ChxIO, reflecting their multipotentiality as 
neuro- retinal precursors.
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1.16 ChxIO orthologous family members in other vertebrates
The gene with the highest sequence identity to ChxIO  in Drosophila is 
aristaless, which is predominantly involved in the establishment of the proximo- 
distal axis in leg and antennal imaginai discs (Pueyo et al. 2000). No evidence 
exists that suggests a role for this gene in ocular development, in the same way 
that Pax6 and eyeless share genetic hierarchies. However, several orthologues 
of ChxIO have been identified in various species, in which it appears to have a 
similar role to that in the mouse.
Interestingly, the 0. eiegans gene, Ceh10, (Hawkins et al. 1990) with 
which ChxIO shares sequence identity is expressed in an interneuron that may 
connect to a photosensitive cell, perhaps suggesting an evolutionary history for 
this gene family.
Levine et al. (1994) and Passini et al. (1998) report the cloning of two 
Chx10-\\ke genes, named Vsx-1 and -2, in the goldfish {Aurelius). Both are 
expressed in the adult retina, in overlapping expression patterns that indicate 
bipolar cells. Vsx-2 is expressed at high levels in the retina during 
embryogenesis, but also in areas of the metacephalon-myencephalon border 
that suggest a role for Vsx-2 in specification and maintenance of specific 
neurons.
The goldfish retina is capable of limited regeneration following injury, and 
ablation studies (Levine et al. 1994) note an upregulation in Vsx-1 expression in 
cell in the inner nuclear layer, and de novo in cells outside this layer. The
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authors speculate that this may reflect the stabilisation of differentiated cells, 
and the multipotentiality of new cells that are contributing to the regeneration. 
These functions are in accordance with the putative roles of ChxIO in the 
murine retina, if the regenerating retina is considered to be similar to the 
developing retina.
Orthologues of ChxIO have also been identified in chickens {Gallus 
domesticus), ChxIO and Chx10-1 (Chen and Cepko 2000). Their sequences 
are most closely related to Vsx-1 and -2, respectively. The embryological 
expression pattern of ChxIO is similar to that of the mouse, that is, in all 
retinoblasts in early development, and restricted to presumptive bipolar cells 
later, but Chx10-1 is expressed in a novel pattern on the naso-temporal border. 
Expression of both genes is maintained at low levels in mature bipolar cells. 
The function of Chx10-1 during development as delineated by the novel pattern 
of expression is unknown.
So far, no second highly related Chx10-like gene has been identified in 
mice or humans, as shown in chickens and goldfish. The separate functions of 
the two variants have not been fully explored, but may, at least in the goldfish, 
be specific to its regenerative retinal capabilities. The presence of a variant that 
is highly-related to goldfish Vsx-2 in the chicken (which has extremely limited 
regenerative properties in the retina) suggests that this function has been lost in 
higher vertebrates (i.e. mice and humans, at least).
A Chx10-like orthologue has also been reported in the zebrafish, named 
Alx (Barabino et al. 1997). The expression pattern of this gene mirrors that of
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ChxIO in the mouse, in that it is expressed throughout the neural retina during 
early eye development, and later and in the adult becomes restricted to the 
inner nuclear layer, presumably in bipolar cells. Inhibition of /A/x using antisense 
oligonucleotides produced a phenotype that resembled o /  in its microphthalmia 
and retinal hypocellularity.
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1.17 Aims of this thesis
Previous studies have shown that ChxIO is essential for eye development, and 
formation of bipolar cells in the inner nuclear layer.
In this thesis, I have attempted to address the following questions with 
regard to the current knowledge concerning the genes involved in human and 
murine retinal development:
1. What are the expression patterns of orthologues of ChxIO and other 
transcription factor genes that are known to be essential for murine retinal 
development in the developing human eye?
2. How does the absence of ChxIO in the o /  retina affect the expression of 
other transcription factors that are known to be essential for retinal 
development?
3. How do interactions between ChxIO and other retinal genes confer the 
phenotype of the o /  mouse?
4. What factors are capable of altering the o /  phenotype, and thus may be 
viewed as having an involvement in the genetic cascade determined by 
ChxIO?
5. Given the existence of multiple ChxIO orthologues in other vertebrate 
species, are there other Chx10-\\ke genes that have a role in mammalian 
retinal development?
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C h a p t e r  2
M e t h o d s  a n d  m a t e r ia l s
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C h a p te r  2
M e th o d s  a n d  m a te r ia ls
2.1 General reagents
All reagents apart from those listed below were supplied by either BDH Ltd 
(Poole, UK) or Promega (Promega Corp, Madison, Wl, USA). Sigma-Aldrich 
Company Ltd (Poole, UK) supplied: p-glycerophosphate, bovine serum albumin 
(BSA), 5-bromo-4-chloro-3-indolyl-p-D-galactosidase (X-gal), bromophenol- 
blue, diethylprocarbonate (DEPO), dithiothreitol (DTT), ethidium bromide, 
formamide, hydrogen peroxide (H2 O2 ), p-mercaptoethanol, orange G, 
paraformaldehyde (PFA), sodium dodecyl sulphate (SDS), Tri Reagent and 
Trizma base.
Restriction enzymes were also supplied by Promega, as were T3, T7 and 
SP6 RNA polymerases, RNase I and RNase-free DNase I.
2.1.1 Bacterial growth media
Lennox L Broth (LB Broth), Lennox L Agar (LB Agar) and ampicillin were from 
Gibco (Gibco BRL, UK).
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2.2 General molecular biology solutions
Solutions were made in following methods described in Sambrook et al. 
Molecular cloning: A Laboratory Manual, 2"^ Edition. (1989):
Phosphate buffered saline (PBS)
137mM NaCI, 2.7mM KCI, 4.3mM Na2 HP0 4 .7 H2 0 , 
1.4mM KH2PO4
2M Tris-HCI pH adjusted to 7.6, 8.0 and 9. For RNA work, this 
was made up with DEPC-treated H2 O.
0.5M EDTA pH adjusted to 7.5 and 8.0 with NaOH.
Tris-EDTA lOmM Tris-HCI, ImM EDTA. For RNA work, this 
was made up with DEPC-treated H2 O.
3M Na Acetate pH adjusted to 5.2 with glacial acetic acid.
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10% SDS (Sodium dodecyl sulphate)
100 g SDS dissolved at 68°C in 900 ml H2 O, pH 
adjusted to 7.2 with MCI, volume adjusted to II with 
H2O
TSS 10% PEG (MW 3500-8000), 5% DMSO, 50 mM
MgCl2 , in LB
2.2.1 Electrophoresis buffers
10x TAB 0.8M Tris, 40mM EDTA
Ethidium bromide lOmgml  ^ in TE
2.3 Animals used in this study
Ocular retardation mice (on the inbred strain 129/Sv-SI) were kindly provided by 
Ray Lund (Institute of Ophthalmology, UCL, London). Wild-type mice used were 
either C57BI-6^oM I^9/^^ kept in a 12hr light-dark cycle. Female
mice were mated overnight with males, and the presence of copulation plugs 
was detected at 9am the following morning. Midday on this day was considered 
to be embryonic day (E) 0.5.
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2.4 Micro-dissection and microscopy
Micro-dissection was carried out on a Zeiss SV6 stereomicroscope (Zeiss, 
Welwyn Garden City, UK), using fine-tipped watchmaker’s forceps, numbers 3 -  
5, and microscissors (Raymond Lamb, UK).
Brightfield, phase and fluorescence microscopy was generally performed 
on an Olympus BH2 microscope (Olympus, Southall, UK), using x4, x10 and 
x20 magnification objective lenses. Digital imaging was performed with a Seiss 
Kontron ProgRes 3012 digital camera (Imaging Associates, Oxford, UK), using 
version 2.0 of their software. Images were processed using PhotoShop 3.1 or 
5.0 (Adobe Systems Europe, Edinburgh, UK), and assembled and formatted in 
Microsoft PowerPoint 97.
2.5 Standard molecular biology techniques
2.5.1 Restriction digests
Diagnostic restriction digests were generally carried out in a volume of 10 jiil 
using the appropriate buffer supplied by the manufacturer (Promega or Roche). 
For double digests, the volume was doubled to accommodate for the increased 
volume of glycerol in which the enzymes are stored.
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2.5.2 Agarose gels
Gel electrophoresis for DNA separation was carried out using horizontal 
agarose gels of an appropriate concentration (0.8-2%), and run at an 
appropriate voltage (40-150v). Gels were made up in TAE with O.SpgmP^ 
ethidium bromide, and run out in the same buffer. Gels were visualised by 
transillumination with ultra-violet light, and either photographed with Kodak 
Polaroid film, or digitally processed with Alphalmager 1200 (Alpha Innotech 
Corporation) software (version 3.3b). Fragment sizes were determined with 
standard DNA markers of known molecular weight, generally Promega Ikb 
ladder.
2.5.3 DNA extraction from agarose gels
Extraction of DNA fragments for further subcloning, manipulation or sequence 
analysis was carried out by electrophoresis on low percentage gels. The 
desired band was excised from the gel with a clean scalpel, being careful to 
expose the gel to the UV light for a minimum amount of time to avoid DNA 
degradation. The band was processed using the Qiagen Gel Extraction kit 
according to the manufacturer's instructions (Qiagen, West Sussex, UK), and 
eluted from their DNA clean-up column using an appropriate volume of either 
water or TE, usually 30 or 50 \i\.
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2.5.4 Maxi preps and mini preps
Recombinant plasmid DNA was generally recovered from its host bacteria by 
maxi- and mini-prep (depending on quantity of DNA required), using column kits 
from Qiagen (West Sussex, UK). For a maxiprep, 200 ml LB ampicillin culture, 
grown shaking overnight at 37°C, was spun at 2000 rpm for 15 min at 4°C in a 
Sorvall 88-34 rotor. The bacterial pellet was resuspended in 40 ml of 
resuspension buffer by vortexing. To lyse the cells, 40 ml of lysis buffer was 
added and mixed by inversion so as not to shear the DNA. The solution was 
neutralised by adding 40 ml of neutralising buffer and mixed by inverting the 
tube. Cellular debris and precipitated chromosomal DNA were removed by 
centrifugation at 10,000 rpm for 15 min at 4°C. The supernatant was then 
filtered through a Qiagen column, cleaned with ethanol and subsequently eluted 
from the resin into a clean tube. Plasmid DNA was recovered by precipitation 
with isopropanol. The mixture was centrifuged at 10000 rpm for 15 min at 4°C. 
The DNA pellet was dissolved in an appropriate volume of either TE or water 
(based on visibility of the pellet, normally ~200|il).
For minipreps, 5ml of LB ampicillin culture was inoculated with single­
picked colonies and grown overnight at 37°C. The Qiagen 8pin Miniprep 
protocol was followed, and recovered, eluted DNA was resuspended in 50^1 of 
either TE or water.
To quantify the plasmid DNA, the preparation was diluted (xlOO) and 
light absorption at 260 nm was measured using a spectrophotometer. A reading 
of one unit at 260 nm corresponds to 50 pgmM of double stranded DNA, while
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the A2 6 0 /A 2 8 0  ratio is a measure of protein contamination of the DNA 
preparation. A ratio of 1.8 or more was accepted as sufficiently pure.
2.6 Cloning of gene fragments
2.6.1 Polymerase chain reaction (PCR)
Genes to be used for in situ hybridisation with digoxygenin labelled riboprobes 
were cloned from an E15.5 mouse retinal cDNA library (constructed by Adrian 
Hardy and Jane Sowden). Mass excision of the pBk-CMV phagemid vector from 
ÀZAP Express library phage stock (Stratagene) was used to generate a 
phagemid library. Brn3b cDNA plasmid was a generous gift from David 
Latchman (Institute of Child Health, UCL, London). Table 2.1 below shows the 
primer sequences used. 50|liI PCR reactions were used containing PCR buffer, 
1.5mM Mg^^, one unit of Thermus aquaticus polymerase (Promega), 40|iM 
combined dNTPs (all from Promega), SOpMjiiM of each primer, and Ipg of 
cDNA library as template. PCR cycling was based on the following:
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1. 5 min @ 94°C
2. 30 sec @ 94°C
3. 1min @Ta
4. 1min @ 72°C
5. repeat steps 2 -4  29 times
6. 10m in@ 72°C
where Ta is the annealing temperature for a primer pair, as calculated by the 
formula: Ta = [69.3 + (0.41 x GC%) -  (650-î-n)] -  2. [where n = length of oligo 
primer, and GC% is the percentage of G and 0  content in the oligo, typically 
55% (11/20)].
Oligonucleotides were designed using the Pubmed nucleotide enquiry 
facility (www.ncbi.nim.nih.gov/entrez/query.fgci?db=Nucleotide), and Amplify
1.2 software (William Engels, University of Wisconsin, Wl, USA). 
Oligonucleotides were custom synthesised by Genosys (Cambridge, UK).
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Table 2.1. Sequence of gene specific primers
Gene Oligonucleotide sequence Predicted 
length (bp)
Arrestin antisense 5' AAGACCTGGATGTACTGGGC 3’ 523
Arrestin sense 5’ ACTTGTACTGCGGGGTGCTA 3’
ChxfO antisense 5' ATGACGGGGAAAGCGGGGGAAG 3’ 343
ChxW sense 5' GGGTCTGCCTAGTGGGTGCAAG 3’
Crx antisense 5’ TGGTTGAAGAATGGTAGGGG 3’ 636
Crx sense 5’ TGAAAGTTGGAGGGAGTGTG 3’
Brn3b antisense 5’ ATGGTGTGGGAGAGGAAGAG 3’ 184
Brn3b sense 5' GAGAGTGTGAGGGAGTGGAAA 3’
IRBP antisense 5’ GGTGAGAGTAAGTGTGGGTG 3’ 576
IRBP sense 5’ GTGGGAGGGAGGAI 1 1 IGTG 3'
PGM1 antisense 5' GAAAAATGAAAGGGATTGGTGGG 3' 417
PGM1 sense 5' GGGAGGGAGTTGTTGAGAGAGGAT 3'
Peripherin antisense 5' GAGATAGGGGGGGGTAGATT 3’ 644
Peripherin sense 5' GGTTGTTGGGAGAGGAGTTG 3’
Pde-/3 antisense 5’ GGGAAGAAGTTGAGGGGTGA 3’ 512
Pde-^ sense 5’ TGAGTGGGATGATGAGAGGG 3'
Rhodopsin antisense 5 ' GI  1 1AGGTAAGGGGGTGGAG 3’ 490
Rhodopsin sense 5' GGAGGTTGTTGTGGTGTAGG 3’
Primers were all designed to have a Ta of ~57°C, and therefore generally have a GC content of 
55%.
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Variations on this basic PCR reaction were performed according to 
annealing temperature, quantity of template and so on, as described below.
PORs were run out on an appropriate percentage agarose gel (0.8-2%) 
(see above), and the product was cut out using a scalpel and extracted using 
the Qiagen Gel Extraction kit. Purified PCR product was ligated into pGemT or 
T-easy vector (Promega) (both of which contain the gene encoding the LacZ 
protein within their multiple cloning sites, thus allowing blue/white selection for 
recombinant plasmids) overnight at 14°C, using T4 DNA ligase and ligase 
buffer (Promega). Approximately 50ng of ligated plasmid was transformed into 
either JM109 (Promega) or DH5a competent E. coli cells and grown on 
ampicillin/X-Gal/IPTG-containing agar plates overnight at 37°C. Individual white 
colonies were picked and used to inoculate 5ml cultures of LB broth containing 
SOjLigmr^ ampicillin overnight at 37°C, and plasmid extracted and purified using 
the Qiagen Miniprep kit (see above).
2.6.2 Colony PCR
Plasmids were checked to see if they contained the desired cDNA using 
diagnostic restriction enzyme digestions (see above) or colony PCR, with gene- 
specific primers. This process allows large-scale screening without having to 
prepare plasmids from large numbers of cultures. It involves inoculation of a 5ml 
culture with the same pipette tip used to inoculate a PCR mix. The PCR is 
performed, while the cultures are grown overnight, and recombinant colonies.
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as identified by PCR, are prepared as normal, and non-recombinant cultures 
can be discarded.
The cycling for this PCR method is somewhat different from the cycle 
described above, and is modified to optimise amplification from whole bacteria, 
rather than naked DNA, by the inclusion of an extended dénaturation step that 
also disrupts bacterial cells.
(Cycle 1)
• 90 sec at 94°C
• 30 sec at 50°C
• 3 min at 72°C 
(Cycles 2-10)
• 20 sec at 94°C
• 20 sec at Ta
• 2 min at 72°C 
(Cycles 11-30)
• 20 sec at 94°C
• 20 sec at Ta
• 3 min at 72°C
where Ta is the primer-specific annealing temperature.
2.6.3 Semi-quantitative RT-PCRs
A number of PCRs were performed to test whether the amount of product 
generated was within the linear range of the PCR reaction, and thus could be
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deemed semi-quantitative. This involved doing a series of PCRs with increasing 
number of cycles ranging from 25 to 35 cycles for the analysis of a given gene. 
The samples were run on an agarose gel and the intensity of the bands were 
measured using spot densitometry with AlphaEase 3.3b software. The 
relationship between the number of cycles and the intensity of the bands was 
established by graphically representing the data so that the chosen number of 
cycles to be used for quantification could be determined within the linear range. 
The samples to be compared were run on the same agarose gel and the 
intensities of the bands were determined. Standardisation was carried out by 
comparison of band intensities for a ubiquitously expressed gene {Pgm1).
2.6.4 Somatic cell hybrid PCR
PCR was performed on somatic cell hybrid DNA, obtained from the Human 
Genome Mapping Project (Cambridge, UK). cDNA-specific primers were used 
in the same standard PCR mixture (as described above), and 1pl of template 
from each of 25 pools of DNA species. These contained individual human 
chromosomes together with complete hamster genomes, plus control genomes 
of hamster and mouse alone.
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2.7 World-Wide Web-based sequence analysis
Novel sequences were identified and analysed using freeware available on the 
world-wide web. Initial identification of sequences used the nucleotide-, protein- 
and genome-specific databases of the Entrez search tool 
(http://www.ncbi.nlm.nih.gov/entrez/query.fcgi). Sequence comparison and 
alignment was performed using the basic local alignment search tool (BLAST) 
algorithm software (Altshul etal. 1990) (http://www.ncbi.nlm.nih.gov/BLAST/) 
and its variants. These include BLASTX (translated sequence), BLASTN 
(standard nucleotide-nucleotide comparisons), BLASTP (standard protein- 
protein comparisons) and MEGABLAST (graphical output of various other 
BLAST algorithms) (all available at the same URL).
More c o rn p lic a ^  ^ q uence analysis was performed using software 
ava ilab le laK the  UK Human Genome Mapping Project Resource Centre 
(http://www.hgmp.mrc.ac.uk/). These are included in the NIX package ( 
(http://www.hgmp.mrc.ac.uk/Registered/Webapp/nix/), and include GAP and 
Bestfit (alignment tools). Translate and MAP (DNA-protein manipulation tools) 
and Seqed (sequence editing).
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2.8 Bacterial transformation
Transformation is the process of inserting a plasmid into a bacterium. Methods 
to do this include electroporation, in which a pulse of a high voltage is applied to 
a suspension of bacteria causing their membranes to become permeable to 
exogenous DNA, or chemical transformation. In the latter case, cells become 
competent (permeable to DNA) in the presence of cations and dimethyl 
sulfoxide (DMSO).
2.8.1 Competent cells
E. coli XL1-Blue cells were grown overnight in 5 ml of LB with the appropriate 
antibiotic (usually 50 pg/ml kanamycin). One millilitre of this culture was added 
to 100 ml of pre warmed LB containing kanamycin and incubated at 37°C until 
the OD reached 0.3 -  0.4. The cells were centrifuged at 1500 rpm for 20 min at 
4°C and resuspended in 10 ml of cold TSS. The competent cells were then 
either used immediately or aliquoted on dry ice, stored at -70°C, and thawed on 
ice when required.
2.8.2 Transformation
Generally, 3 |il of ligation reaction were put into a chilled microfuge tube on ice 
and 50 pi of competent bacterial cells was added. The contents were gently 
mixed by tapping the tube, to avoid shearing the DNA and lysing the cells. The 
tube was placed on ice for 15 min, then heat-shocked in a 42°C waterbath for
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90 seconds and placed immediately on ice for 2 min. One millilitre of LB without 
antibiotic was added and incubation was continued at 37°C for an hour to allow 
the cells to recover. The cells were spun at 2000 rpm for 3 min, most of the 
supernatant was removed and the pellet resuspended in the rest. Using a 
sterile spreader, transformed bacteria were plated onto warm LB-ampicillin-agar 
plates, and incubated inverted at 37°C overnight.
2.8.3 Screening for recombinant bacteria
Screening for recombinant bacteria was based on various methods and levels 
of screening. A first round of selection was generally assessed based on the 
presence of an antibiotic resistance gene in the vector, so that only transformed 
bacteria could grow on the ampicillin-containing medium. Presence of a DNA 
insert in the vector was confirmed using either of the following two methods. If 
the DNA fragment was long enough to be able to see a size shift on an agarose 
gel, the following method was frequently used. Colonies were inoculated into 1 
ml of LB ampicillin and incubated for 5 h at 37°C. Half of the suspension was 
spun and bacteria were resuspended in 50 pi TE. DNA was extracted first with 
phenol then with chloroform. The samples were run together with the vector on 
agarose gels as described previously.
If the insert was too short to be detected in this way, standard minipreps 
were performed, followed by the appropriate digestions with restriction enzymes 
as described above.
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2.9 Tissue preparation
2.9.1 Mouse sacrifices
Mice were paired in the evening, and when vaginal plugs were observed the 
following morning 12.00 p.m. was taken to be E0.5. Pregnant mothers were 
sacrificed at 12.00 p.m. on the appropriate day by cervical dislocation. Embryos 
were removed and dissected using watchmakers forceps (size 3-5, Raymond 
Lam, UK) in cold PBS before being fixed in 4% w/v paraformaldehyde in PBS 
overnight at 4°C. E l8.5 embryos were decapitated, and postnatal eyes were 
enucleated before fixation, and the lens was removed.
2.9.2 Human tissue
Human tissue was received in dissection medium and washed in PBS before 
fixation. Adult human eyes were sometimes calloted to allow better penetration 
of fixative into the globe; this involves the removal of a lateral pole of the globe 
by sectioning through a plain parallel with the vertical axis of the eye. Large 
foetal eyes (e.g. 15 weeks post conception) were pierced with a hypodermic 
needle through the lens for the same reason. Foetal age was determined by 
anatomical measurements (foot or crown-rump length). Human tissue was 
obtained after informed consent from the MRC Tissue Bank, Royal 
Postgraduate Medical School Hammersmith Hospital, Imperial College, 
London).
2.9.3 Tissue embedding
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Tissue was washed post fixation in PBS, dehydrated through a graded ethanol 
series with water (30% ethanol, 50%, 70%, 85%, 95%, 100%, 100%, and 
cleared in xylene. Tissue was then carefully placed in an appropriately sized 
mould, and submerged in molten parafin. Whilst still hot, the tissue was 
orientated to achieve the desired plain of section. Paraffin embedded tissue 
was sectioned, using a Sigma microtome into 6-8|Lim transverse sections on 3- 
aminopropyltriethoxy-silane (APES) (Sigma) coated microscope slides. These 
create a surface on the microscope slide to which the sections stick well, and 
were prepared by initially submerging slides in acid-alcohol (70% ethanol, 10 
HCI), and then 100% ethanol. Slides were then left to dry, and when dry, 
submerged in 4% APES in acetone, and washed in acetone twice. Slides were 
then left to dry overnight at 37°C.
2.9.4 Histological staining
Glass staining troughs and racks, storage containers and all histological stains 
were obtained from BDH. Glass microscope slides, covers lips and paraffin wax, 
(Lambwax - melting point 57-58°C) were obtained from Raymond Lamb (UK). 
HistoClear was purchased from National Diagnostics (Atlanta, GA, USA). 
Dehydrated samples on slides were mounted in dextropropoxyphene (DPX, 
BDH). Citifluor aqueous mount and clear nail varnish was used to mount 
aqueous samples (Citifluor Scientific, Cambridge).
Section integrity and histology was assessed by staining with the nuclear 
and cytosolic stains (respectively) haemotoxylin and eosin, using the following
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protocol. Sections were placed in a polythene rack and rehydrated and 
dewaxed by sequentially passing through HistoClear twice, for 10 minutes each 
and a graded alcohol series of 100% (x2), 95%, 85%, 70%, 50% and 30% each 
for 5 minutes. The slides were then washed in filtered water for 5 minutes to 
equilibrate the tissue. Nuclei were stained by immersing the slides in Erhlich’s 
or Mayer’s haematoxylin for 5 minutes followed by running tap water for 5 
minutes to develop the blue coloration. The sections were dehydrated to 95% 
ethanol, (5 minutes in each grade), and dipped in 1% eosin in 95% ethanol for 5 
minutes followed by a wash in 95% and 100% ethanol. Finally, the slides were 
immersed in HistoClear twice, for 10 minutes each before mounting in DPX and 
drying overnight in a fume hood.
2.10 In situ detection of mRNA
2.10.1 Synthesis of digoxygenin (dig)-iabelied riboprobe 
The plasmid to be transcribed was linearised with an appropriate restriction 
enzyme (see table 2.2), in a volume sufficient to yield -Im gm M  after the digest 
and purification. Linearised plasmid was purified and washed using phenol 
extraction (as described above). Transcription of labelled RNA was carried out 
as described in the Boehringer-Mannheim protocol for the labelling of 
riboprobes. In brief, nucleotide mix (containing Dig-UTP), 0.001 DTT, Ipg 
linearised plasmid, RNase-inhibitor and the appropriate RNA polymerase (T3,
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T7 or SP6) and DEPC water were mixed to a volume of 20|ii. This was 
incubated for one hour at 37°C, and 1|liI removed. Then, 2|xl of RNase-free 
DNase I was added and the mixture incubated for a further 15 minutes at 37°C. 
Pre-DNase-treatment and post-DNase-treatment samples were compared on a 
native gel, to assess the success of the RNA synthesis and the success of the 
DNA degradation. Labelled RNA was then precipitated by overnight suspension 
in 70% ethanol with 3M NaOAc at -20°C, and harvested by centrifugation for 15 
minutes at 4°C. The consequent pellet was washed in 70% ethanol, allowed to 
air-dry for a few minutes (typically 5-10), and resuspended in 100|il of TE. This 
was stored at -20°C, until resuspension in hybridisation buffer (see below) for 
use in situ.
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Table 2.2. Riboprobe synthesis conditions
cDNA Plasmid vector Linearised with: RNA polymerase
Chx 10 anWsense pBS KS A/ofI T3
Chx10 sense pBS KS EcoRI T7
Crx antisense pGEM T-easy A/ofI T7
Crx sense pGEM T-easy A/col SP6
Brn3b antisense pGEM T-easy A/ofI T7
Brn3b sense pGEM T-easy A/col SP6
Pax6 antisense pBS KS A/ofI 13
Pax6 sense pBS KS EcoRI T7
Novel human cDNA Modified pBS KS EcoRI T7
antisense
Novel human cDNA Modified pBS KS A/ofI 13
sense
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2.10.2 RNA in situ hybridisation
In situ hybridisation was performed using a protocol modified from Breitschopf 
et al. (1992). Most steps were performed in 400ml glass troughs, containing 250 
ml of liquid. Sections were dewaxed in two changes of xylene and rehydrated 
through graded ethanol (100% (x2), 95%, 85%, 70%, 50% and 30% each for 2 
minutes). Sections were then postfixed in 4% paraformaldehyde in PBS for ten 
minutes, washed for 15 minutes in three changes of Tris-buffered saline (pH7.5) 
(TBS), then partially denatured in 0.2M HCI for ten minutes, and washed as 
before in TBS. Sections were acetylated for ten minutes in 0.5% acetic 
anhydride in 0.1 M Tris (pHB), by drizzling acetic anhydride over the sections in 
a glass rack, while the trough was being gently stirred by a magnetic stirrer. 
Following this, the slides were washed as before in TBS. The tissue was 
partially digested at 37°C with Proteinase-K for ten minutes at a concentration 
of 50 |Ligmr^ in a 30ml solution of TBS in a plastic Coplin jar (BDH) with 2mM 
CaClz, and again washed in two changes of TBS. Tissue was dehydrated again 
through graded alcohols, and left to dry for up to 2 hours. A ring was drawn 
around the sections using an hydrophobic wax pen (DAKO Ltd, High Wycombe, 
Bucks, UK) for later in the protocol.
Antisense and sense riboprobe was diluted in hybridisation buffer 
consisting of 2x SSC, 10% dextran sulphate (Sigma), 100|igmM sheared 
salmon sperm (Gibco) and 50% formamide (Sigma), and lOOpI (approximately 
equivalent to 40pg of RNA, dilution of 1:20) was applied to sections overnight at 
65°G underneath a glass coverslip. Unhybridised probe was washed off with
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1xSSC 50% formamide at 60°C for 1 hr, then 20 minutes in 1xSSC and 10 min 
in O.SxSSC at room temperature. Sections were then washed in 0.1M maleic 
acid buffer (pH7.5) with 0.3% Tween 20 for ten minutes, and blocked in 1% 
Blocking reagent (Boehringer, Germany) in maleic acid buffer for 30 minutes. 
Slides were incubated for 1 hr with 400|il of anti-digoxigenin alkaline- 
phosphatase-conjugated Fab fragments (Boehringer-Mannheim) at a 1 in 500 
dilution in 1% blocking solution, and washed for 1 hr in maleic acid buffer. 
Probes were visualised by incubating in a 1:1 molar ratio of BCIP and NBT in 
Tris pH9.5 (the alkaline pH is critical for the colour reaction to proceed). The 
reaction was incubated for lOmins in the dark, and then closely observed until 
staining was visible. This could range from 10 mins to 24 hours for different 
probe preparations. The reaction was terminated by submerging the slides in 
tap water. Slides were dehydrated as described in section 2.9.4, and mounted 
in DPX (Sigma) or Citifluor. Images were digitally captured and processed using 
Adobe Photoshop 3.1, or 5.0
2.11 Immunohistochemistry on paraffin embedded sections
Immunohistochemistry was performed on paraformaldehyde fixed, paraffin 
embedded tissue cut into 6-8|im  sections. Several methods were tested to 
establish the best results for the antibodies against ChxIO (kindly provided by T. 
Jessell, Howard Hughes Medical Institute, Columbia University, New York), and
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Crx (kindly provided by 0. Gregory-Evans, Imperial College London). Sections 
were dewaxed and antigens unmasked by microwaving in Declere (Cell 
Marque, USA) at 60% power for 10 minutes. Endogenous peroxidase was 
blocked by treatment in 0.6% H2O2 ; this step prevents false signal, as the colour 
reaction for the tertiary detection of the antigen relies on exogenous H2 O2 . 
Tissue was permeabilised by incubation in 0.5% Triton xlOO in 0.05M Tris-HCI, 
and blocked for 1 hour in 10% foetal calf serum. Antibody at a range of dilutions 
(1/250-1/4000 were tested, and 1/1000 was found to generate the best results) 
in 1% foetal calf serum was applied to sections overnight at 4°C. Biotinylated 
goat anti-rabbit (Sigma) at a 1/600 dilution was applied to the sections for 1 
hour at room temperature, and the signal amplified by incubation in ABC 
biotin/streptavidin amplification kit according to the manufacturers instructions 
(Vector Laboratories, USA). This process amplifies the immunolocalised signal 
by binding further biotinylated streptavidin complexes, thus providing more 
colour-reactive H2 O2 molecules to interact with 3,3’-Diaminobenzidine (DAB) 
(Sigma/Vector Laboratories), which is a substrate for horseradish peroxidase 
and produce a brown water-insoluble precipitate. The colour reaction was 
sometimes modified to produce a darker signal by the addition of nickel to the 
DAB buffer.
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2.12 Gene expression by RNA analysis
2 .72.7 RNA extraction
All solutions for RNA work were made, where possible, from solids that were 
kept separate from the general chemicals in the laboratory, and using DEPC 
treated water. DEPC is a potent inhibitor of ribonuclease (RNase) and is broken 
down to ethanol and carbon dioxide by autoclaving. RNAse-free pipette tips 
were used throughout the procedure.
Total RNA was extracted from tissues and cultured cells using TRI- 
Reagent (Sigma) (or RNAzol) promotes the formation of RNA complexes with 
guanidinium and water molecules and inhibits hydrophilic interactions of DNA 
and proteins. As a consequence, DNA and proteins are excluded from the 
aqueous phase, leaving the RNA, which can then be purified. The RNA 
contains the whole range of cellular RNA molecules.
Tissues for RNA extraction were freshly dissected and were 
homogenised in 1 ml TRI-Reagent per 100 mg of tissue. Homogenates were 
transferred into a 1.5 ml microfuge tube and left at room temperature for 5 min 
to allow the complete dissociation of nucleoprotein complexes. The 
homogenate was supplemented with 0.2 ml of chloroform per ml of TRI- 
Reagent. It was then vortexed, and left to stand at room temperature for 10 min. 
The samples were centrifuged at 12,000 rpm at room temperature for 15 min. 
The homogenate separated into an upper clear aqueous phase containing the 
RNA, and a lower red coloured phase containing the DNA and protein.
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separated by a thick interface of cellular debris and protein. The upper aqueous 
phase was carefully transferred to a new tube and 0.5 ml of isopropanol was 
added as well as 10 |llI of a carrier, linearised polyacrylamide, if necessary. 
Samples were mixed, left to stand at room temperature for 10 min to precipitate 
the RNA and centrifuged at 12,000 rpm for 10 min. The white RNA pellet 
formed at the bottom of the tube was washed with 75% ethanol and 
resuspended in an appropriate amount of DEPC water depending on the size of 
the pellet. RNA was quantified by spectrophotometry and visualised on a 
denaturing gel (1% agarose, 1x MOPS, 5% v/v formaldehyde), and stored at 
-70°C  until used.
2 .12.2 RT-PCR
~1|ig of RNA template was used in a 25|il reaction, using Promega reagents of 
2pl oligo-dT, 5pl MMLV 5x buffer, 1.25p.l lOmM dNTP, 0 .75 |liI RNase-out, or 
other RNase inhibitor, and up to 15|llI of DEPC dH20. This reaction was 
incubated at 65°C for 10 minutes, then quenched on ice. Ip l of Reverse 
Transcriptase was added, and the mix incubated at 42°C for 90 minutes. This 
cDNA was stored at -20°C indefinitely.
Equivalent amounts of cDNA were used in RT-PCR reactions, with 30 
cycles for ChxIO, PGM1, and Crx, and 34 cycles for Brn3b. A list of primers 
used in all experiments is given in Table 2.1.
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2.13 Western blotting
2.13.1 Tissue lysis
Tissue was dissected in ice cold PBS, added to solubilisation buffer and kept on 
ice for 15 mins. Tissue was then triturated using a series (19-21-23 gauge) of 
needles attached to a syringe (Becton Dickinson). Retina was solubilised in either 
ice-cold PBS or ice-cold RIPA buffer (ISOmM NaCI, 1% Tergitol, 0.5% Sodium 
Deoxycholate, 0.1% SDS, 50mM Tris-HCL pH 8.0) containing protease inhibitor 
cocktail (Sigma) The lysed tissue was then centrifuged at 14,000 rpm for 2 mins 
and the supernatant mixed 1:1 with laemmli sample buffer.
2.13.2 Electrophoresis and labelling of proteins: Sodium Dodecyl Sulphate- 
polyacrylamide gel electrophoresis (SDS-PAGE)
SDS-PAGE was performed using 12cm x 10cm glass plates assembled 
according to manufacturers protocols (Biorad). The appropriate percentage 
separating gel was prepared (see Table 2.3 for constituents) and pipetted 
between the plates taking care to avoid air bubbles. The gel was pipetted to a 
height that left enough room for the stacking comb plus 1cm of stacking gel, and 
subsequently overlaid with distilled H2 O. The gel was left for 45mins to 
polymerise, the overlaying H2 O poured off and the stacking gel prepared (see 
Table 2.4 for constituents). The stacking gel was then pipetted on top of the 
separating gel and the comb inserted, again taking care not to trap air bubbles. 
The gel was again left for 45 mins to polymerise, at which point the comb was
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removed and any unpolymerised acrylamide removed from the wells by rinsing 
with distilled H2 O and the resulting gel was mounted using a vertical slab gel unit 
and bathed in Laemmli running buffer (25mM Tris, 192mM glycine, 0.1% SDS). 
Protein samples were denatured by heating in a 100°C heat-block for 5 mins in 
Laemmli sample buffer (125mM Tris, 4% SDS, 20% glycerol, 5% 
P-mercaptoethanol). Samples were loaded into each well using a gel loading 
pipette tips (Biorad) and electrophoresis applied at 10mA (Amersham Pharmacia 
Biotech EPS-300 powerpack).
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Table 2.3. Separating gel constituents for SDS-PAGE (18 ml)
4% 6% 8% 10% 12% 15%
Monomers (ml) 2.4 3.6 4.8 6.0 7.2 9.0
1.5M tris-HCL pH 8.8 (ml) 4.5 4.5 4.5 4.5 4.5 4.5
10% SDS (pi) 180 180 180 180 180 180
Distilled H2 O (ml) 10.8 9.6 8.4 7.2 6.0 4.2
APS (pi) 110 100 100 90 90 80
TEMED (pi) 11 11 10 8 8 7
Table 2.4. Stacking gel constituents for SDS-PAGE (5 ml)
4%
Monomers (vl) 651
0.5M tris-HCL pH 6.8 (ml) 1.25
10% SDS (pi) 50
Distilled H2 O (ml) 3.0
APS (pi) 25
TEMED (pi) 5
2.13.3 Semi-dry and wet transfer western blotting
For semi-dry transfer the following sandwich was assembled on the anode. Three 
layers of absorbent paper (Whattman 3 MM) were wetted in transfer buffer
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(48mM Tris, 39mM glycine, 0.037% (v/v) SDS, 20% (v/v) methanol) followed by 
the nitrocellulose membrane (Schleicher & Schuell) soaked in distilled H2 O. The 
polyacrylamide gel was laid on top followed by a further three layers of absorbent 
paper wetted in transfer buffer. Air bubbles were removed by rolling the sandwich 
with a pipette, the cathode plate was placed on top and a current of 0.8 mA cm'^ 
of gel was applied for a period of 1.5 hours.
Following electrophoretic transfer the nitrocellulose membrane was 
removed from the sandwich and washed twice in PBS for 5 mins. To check for 
efficient transfer of proteins the membrane was stained with a 1 in 10 dilution of 
Ponceau S solution (Sigma) (20% Ponceau S dissolved in 30% trichloroacetic 
acid, 30% sulfosalicyclic acid) which was added to the nitrocellulose membrane 
for 3 mins before being rinsed off with distilled H2 O and the molecular weight 
ladder bands marked with pencil. The membrane was rinsed several times in 
PBS to remove all Ponceau S before being processed for either immunological 
detection of proteins or blot-overlays.
2.13.4 Immunological detection of immobilised proteins
Non-specific sites on the membrane were blocked by incubation of the 
membrane in 5% Marvell in PBS at 4°C overnight. The membrane was then 
removed from the blocking solution and washed once for 10 mins in PBS, 0.1% 
(v/v) Tween-20. The primary antibody was diluted to the appropriate 
concentration in 5% Marvell, 0.1% Tween-20 and incubation was performed in a 
heat-sealed bag for 1 hour with agitation at RT. The blot was subsequently
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washed three times for 10 mins in PBS, 0.1% (v/v) Tween-20. The HRP- 
conjugated secondary antibody was diluted in 5% Marvell, 0.1% Tween-20 in 
PBS and again incubated with the membrane in a heat-sealed bag for 1 hour with 
agitation at RT. The blot was then washed three times for 10 mins in PBS, 0.1% 
(v/v) Tween-20, once in PBS for 5 mins and then processed using the enhanced 
chemiluminescence (ECL) (Amersham Pharmacia Biotech) method. ECL was 
achieved by performing the oxidation of luminol by HRP in the presence of 
chemical enhancers. The membrane was covered in detection buffer, a 50:50 mix 
of solution 1 [solution 2 for exactly 1 min, subsequently drained, wrapped in 
SaranWrap and placed in a film cassette. The membrane was then exposed to 
blue-light sensitive autoradiography film (Kodak) and mechanically developed.
2.14 Primary cell cultures
Various forms of primary retinal cultures were investigated to test a number of 
different gene expression criteria.
Dulbecco’s modified essential medium (HEPES buffered DMEM), FI 2 
modification of Eagle's minimal essential medium with ribosides and 
deoxyribonucleosides (a-MEM), Leibovitz’s medium (L-15 code number 11415) 
and Dulbecco’s calcium-, magnesium- and sodium bicarbonate- free phosphate 
buffered saline, were all supplied by Gibco BRL (UK). Foetal calf serum (FCS) 
was purchased from Sigma-Aldrich (UK). Penicillin/streptomycin solution
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(100,000 units per ml) was purchased from Sigma-Aldrich. Tissue culture grade 
petri-dishes and other plastics were supplied by Philip Harris (UK), Nunc Inc (IL, 
USA) and Helena Bioscience (UK).
PO (new-born) pups were killed by cervical dislocation (typically by 
decapitation with a scalpel) and their heads transported from the animal 
laboratory to the procedures laboratory in ice cold LI 5 medium (typically 20 
minutes), a minimal medium that does not promote cellular differentiation or 
proliferation. Eyes, and subsequently retina were carefully micro-dissected and 
placed in FI 2 medium, being mindful to remove lens, RPE and any other extra- 
retinal tissue. Typically, up to 30 individual eyes were used per experiment, and 
divided into 8 wells. However, this was variable, given the unpredictable 
fecundity of the o /  mouse.
A similar procedure was used for embryonic mice, although embryos 
were transported undissected and in utero before retinal dissection.
Retinal tissue was partially mechanically dissociated by titration through 
a fine-bore glass pipette up to 10 times, and then enzymatically dissociated by 
incubation in 0.025% Trypsin-EDTA for 4 minutes at 37°C. This reaction was 
halted by the addition foetal calf serum (FCS) to a final concentration of 10%. 
After gentle spinning down on a bench centrifuge (500 rpm for 5 minutes), cells 
were resuspended in a volume of F I2 (containing 25mM HEPES, 100 units ml'^ 
penicillin, lOOpgml'^ streptomycin, and 10% FCS) estimated to give a 
concentration in the culture wells of -200-300 cells per pi, as calculated by cell- 
counting using a haemocytomter. Typically this volume was -2ml. Adjustments
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of volume were made by either adding medium, or gentle centrifugation (as 
above) and resuspension.
In order to aid adhesion of cells in culture, glass coverslips were placed 
in 24 well cell culture plates with a diameter of 102 mm, a 10% mixture of 
laminin and poly-L lysine used to coat them for up to 30 minutes. Coverslips 
were allowed to dry before application of cell-containing medium. Up to 200pl of 
culture was used per well, and this volume was adjusted according to the 
requirements of the experiment (see below).
Variations on several conditions of the culture medium were tried in order 
to optimise these settings.
After 6 hours the medium was changed to remove any dead cells and 
any cell debris. Cells were typically incubated in culture for up to 72 hours, and 
were checked regularly for vitality, before performing immunocytochemistry.
2.15 Immunocytochemistry
These experiments on cultured retinal cells were designed to investigate gene 
expression, and whether it could be altered in both the wild-type and o /  
cultures. Therefore, immunocytochemistry was performed on cultured cells after 
a period in culture to assess the expression of specific epitopes. Medium was 
removed from cell cultures wells and wells were washed 3 times with PBS. 
Cells were then fixed with ice cold methanol for 20 minutes (which was found to
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retain morphology better than PFA fixation), and again washed 3 times in PBS. 
Primary antibody was applied in goat serum in PBS at a concentration of 1/500 
(Crx, ChxIO), 1/1000 (H3 and PCNA). H3 rabbit polyclonal IgG was obtained 
from Upstate Biotechnology (New York, USA). The immunogen used for the 
antibody production was a KLH-conjugated peptide corresponding to amino 
acids 7-20 of the human histone H3. Anti-PCNA (PC10) (cell division marker) 
mouse monoclonal lgG2a antibody was obtained from Santa Cruz 
Biotechnology, Inc (California, USA). This antibody was derived by the fusion of 
BALB/c mouse spleen cells with recombinant PCNA, with Sp2/0-Ag14 myeloma 
cells. After one hour, wells were washed with 3 changes of PBS, and secondary 
antibody was applied as required.
Double labelling experiments were attempted, but owing to the fact that 
both ChxIO and Crx antibodies were raised in the same animal (rabbit), an 
alternative detection system was investigated.
2.15.1 Biotinylation of Crx antibodies
Crx antibodies were biotinylated using the following technique. Anti-Crx was 
diluted to 2.0 mg mM in 1 ml of 0.1 M NaCOa pH9.5, and then dialysed against 2 
litres of 0.1 M NaCOa pH9.5 overnight at 4°C, at which point the solution had an 
optical density of 2 at 280nm. Biotin ss-NHS (Biotin 3-sulfo-N-hydroxy- 
succinimide ester [Sigma-Aldrich, UK], 20 mg mM in DMSO) was added to a 
ratio of 0.2 m gm g'\ and this was incubated for 2hrs rotating at room 
temperature, and further dialysed against 4 litres of Tyrode’s solution (plus
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10mM Hepes, pH7.2, without IVIg^ )^. Biotinylation allowed for the simultaneous 
detection of ChxIO (with a fluorescent secondary antibody), and Crx using HRP 
and DAB, as described above. However, results were disappointing (see 
Chapter 4), and non-specific staining was observed. Therefore, this strategy 
was not pursued.
2.15.2 Fluorescent immunocytochemistry
Secondary antibodies used for immunocytochemistry were either goat anti­
rabbit (TRITC) or rabbit ant-goat (FITC) (depending on the animal in which the 
primary antibody was raised), combined with a 1/500 dilution of Hoescht stain 
(which is a vital sub-nuclear marker) for 20 minutes in the dark (cells were kept 
in the dark from this point onwards). In double-labelling experiments, secondary 
antibodies were mixed and applied simultaneously. Wells were washed again 
three times in PBS, medium was removed without allowing the cells to dry, and 
then the coverslips were removed from the culture dishes using a bent 
hypodermic needle, and mounted inverted on microscope slides in a non- 
fluorescent aqueous mountant (either Aquamount, Citifluor, or 50% glycerol in 
water). Coverslips were sealed with nail varnish, and viewed on a fluorescent 
microscope with the appropriate filters. Photographs were either taken using 
FujichromelOO Pro via film, or using the digital imaging AlphaEase 3.3 software. 
Images were processed, and composite, superimposed images created in 
Adobe Photoshop 5.0.
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2.15.3 Culture conditions for altering gene expression
Experiments described in Chapter 4 aim to alter gene expression by various 
culture conditions. A co-culture system was used, in which o /  cells were 
exposed to secreted factors from wild-type cells. Transwells with a membrane 
pore size of 0.4 |im were purchased from Corning Costar (New York, USA). 
Mutant cells were placed on the membrane and wild-type cells in the well and 
cultured for 24 hrs. However, mutant cells did not survive longer than 24 hours 
in two experiments, and this technique was not pursued.
A second technique used was to expose o /  cells to medium that had 
itself been exposed to wild-type cells for 48 hours, and thereby contained all of 
the factors secreted by the wild-type cells during that period (conditioned 
medium). Wild-type E12.5 retinal cells were cultured as described above in F12 
medium, which was removed after 48 hours, and this medium was diluted by 
half with fresh F12 (in order that there was a ready supply of fresh nutrients), 
and o /  cells were cultured for a further 48 hours.
Cultured o /  cells were also exposed to retinoic acid (RA) as a means of 
inducing photoreceptor gene expression (see Chapter 4). All-trans RA was 
resuspended in DMSO as a 50mM stock, and added to F12 culture at a 
concentration of lOOnM. Control experiments containing equivalent amounts of 
DMSO without RA were also cultured. When culturing for 48 hours medium was 
replaced with fresh medium with lOOnM RA after 24, in order to ensure a ready
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supply of RA. As before, after 48 hours these cells were harvested for 
immunocytochemistry (as described above).
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3.1 Introduction
Over 25% of the conditions listed in the Online Mendelian Inheritance in Man 
(OMIM) database feature an ocular phenotype (Gregory-Evans and 
Bhattacharya 1998, Ferda-Percin et al. 2000). This statistic indicates the high 
number of disease causing genes that are involved in development and 
maintenance of the eye.
Mutations in 14 transcription factor genes to date have been shown to 
cause human ocular diseases, thus indicating the significance of this class of 
protein in human retinal development (Freund et al. 1996). As in the mouse 
however, very few retinal cell fate-specifying genes have been identified. 
Although histological analysis is well established (Hollenberg and Spira 1972), 
few studies have been performed analysing transcription factor gene 
expression in the human retina.
I analysed the developmental expression patterns of three transcription 
factors in human retinal development, using tissue obtained with informed 
consent from terminated pregnancies. The transcription factors analysed are 
known to be essential for normal retinal development in the mouse, and two of 
them (CHXIO and PAX6) are ocular disease causing genes in humans (Ferda- 
Percin et al. 2000, Glaser et al. 1992, Wehr and Gruss 1996). These genes are 
all thought to mark specific cell types at early stages of their differentiation. This
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study aims to compare the timing of retinal development in humans and mice. 
The period of time during which the retina develops in humans is condensed 
relative to total gestation time compared with the mouse. No mitotic cells are 
present in the human retina after 16 weeks post-conception (wpc) (Hollenberg 
and Spira 1972), whereas murine retina development continues until 12 days 
after birth (Young 1985). Although the order of cell birthing in the retina is 
thought to be conserved, the relative numbers of the various cell types differ 
considerably between human and other species, so analysis of patterns of cell 
specification will provide information about human retinal development as 
compared to murine eye development.
3.2 CHX70 expression In the developing human retina
The human homologue of the mouse gene ChxIO has recently been cloned and 
characterised. Mutations in CHX10 have been shown to cause isolated 
microphthalmia, a condition that is very similar to the phenotype of the o /  
mouse (Ferda-Percin etal. 2000, Burmeister etal. 1996).
I investigated the developmental expression pattern of CHX10 in human 
foetal eyes as a means of establishing its function in human development. This 
was achieved by performing in situ hybridisation on wax embedded human 
tissue from 8 wpc up to 15 wpc, and in the adult retina. The protocol was 
performed as described in Chapter 2.10, Methods.
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A 3kb plasmid containing the entire CHX10 cDNA was kindly given by 
Rod Mclnnes (Hospital for Sick Children, Toronto, Canada), from which 
antisense and sense riboprobes were generated. These riboprobes contained 
the C/-/X70 coding sequence (1.089kb), and a 1.9kb 3’UTR.
The earliest human tissue available was at 8 wpc. At this stage eye 
development is well under way, as shown in Figure 3.1, which is a transverse 
section through a foetal face. The section runs through the central retina on the 
right eye, shown by the presence of the optic nerve and optic nerve head on 
adjacent sections. On the left eye, the plain of section is dorsal retina, shown in 
Figure 3.1a, and does not cut through the vitreous.
The developing lens and cornea are present, as is the retinal pigmented 
epithelium, and neural retina. The retina is divided into two layers, inner and 
outer, separated by the layer of Chievitz, which is a transient acellular layer 
derived from the migration of cells into the inner layer (Hollenberg and Spira 
1972). A nerve fibre layer (nfl) is visible, and forms the optic nerve head (onh) in 
the central retina. These observations indicate that the human retina is at a 
stage of development that is (in some aspects) approximately equivalent to 
E l 3.5 in the murine retina (Kaufman 1995 in The Atlas of Mouse Development). 
The presence of a nerve fibre layer, optic nerve head and an optic nerve 
indicates that post-mitotic ganglion cells are projecting axons.
CHX10 expression in the 8wpc foetal head was only detected in the 
neural retina and not in surrounding tissue, shown in blue/purple from the 
NBT/BCIP precipitate generated from the detection of digoxygenin labelled
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Figure 3.1. Transcription factor gene expression in the 8 wpc 
human retina by in situ hybridisation. In the Bwpc human retina (a), 
CHX10 expression by in situ hybridisation (b). At this stage the retina is 
dived into two layers, and while CHX70 expression can be readily 
detected in both, it is certainly expressed at lower levels in the inner 
layer. This may reflect the presence of differentiating ganglion cells in 
the inner layer, which do not express CHXIO. Abbreviations: nc, nasal 
cavities; I, lens; nr, neural retina; onh, optic nerve head. Scale bar: 
1mm.
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riboprobe (Figure 3.1b). Figure 3.1b shows a low magnification image of this 
expression pattern. Although expression is detected throughout the retina, it is 
clearly more concentrated in the outer layer. This corresponds with the 
hypothesis that CHXIO is expressed in retinal neuroblasts, but not in postmitotic 
ganglion cells. The inner layer is the site of developing ganglion cells, (see 
below), and lower levels of CHXIO expression are detected here. CHXIO 
expression is most concentrated in the outer retina, but is certainly detectable in 
the inner, either in fewer cells, or at lower levels. This indicates one of two 
possibilities;
(1) The inner layer consists of dividing cells expressing CHXIO, as well 
as postmitotic ganglion cells;
(2) Ganglion cells express CHXIO at low levels during this phase of 
development.
Data shown below indicates that ganglion cell markers and CHXIO do not co- 
localise at later stages in development, and certainly not in the adult retina. 
Therefore it seems more likely that this inner layer consists of ganglion cells, 
and mitotic cells that are expressing CHXIO. The more concentrated expression 
in the outer layer indicates that this layer is predominantly neuroblastic, and 
fewer postmitotic cells are present.
At lOwpc (Figure 3.2c), the inner and outer layers are morphologically 
distinct, and the layer of Chievitz is no longer present (Hollenberg and Spira 
1972). Cells within the inner layer are round compared with the more elongated 
and densely packed cells in the outer layer, possibly indicating that these cells
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Figure 3.2. CHXTO expression in the developing human retina by in  s itu  hybridisation, (a)
shows a high magnification image of Fig. 3.1, an 8 week post conception (pc) human retina. 
Two distinct cellular layers can be resolved, and CHX70 expression (b), although present in 
both, is reduced in the inner layer (il). By 10 weeks (c), the inner layer has expanded 
considerably, and the outer layer remains densely packed. CHXIO is by this stage only 
significantly expressed in the outer layer, reflecting both the mitotic nature of cells within this 
layer, and the presence of postmitotic ganglion cells in the inner. Abbreviations; 0, layer of 
Chievitz; nf, nerve fibre layer. Scale bars lOOjim.
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are migratory. The nerve fibre layer is clearly present (nf). The expression 
domain of CHX10 is now restricted to the outer layer, and a very few individual 
cells in the inner layer. This is consistent with the evidence that CHX10 is not 
expressed in ganglion cells (Burmeister et al 1996). The concentration of 
CHX10 expression in the outer layer suggests that the majority of cells are 
dividing progenitor cells.
The ganglion cell layer is the first to form, and is largely postmitotic by 10 
wpc (Hollenberg and Spira 1972, Oyster, The Human Eye, 1999). However, 
other discrete retinal layers have not yet been formed, indicating that many cells 
divisions and cell differentiation has to take place in order for the rest of the 
cells and layers of the retina to develop.
By 13wpc, lamination is well under way in the retina (Figure 3.3a). The 
ganglion cell layer has become separated from the rest of the retina by the 
presumptive inner plexiform layer. Cells in the neuroblastic layer are 
morphologically indistinguishable, indicating that the human retina is roughly 
equivalent to the E18.5-P2 murine retina (Kaufman 1995 in The Atlas o f Mouse 
Development). The expression domain of CHX10 is restricted entirely to the 
neuroblastic layer (Figure 3.3b), and no ChxIO expressing cells can be 
detected in the ganglion cell layer. However, CHX10 expression is restricted to 
the inner aspect of the neuroblastic layer, and cells in the outer-most aspect are 
not expressing CHX10.
Foetal tissue is obtained with informed consent from terminated 
pregnancies, ethical approval was not granted for tissue older than 13 weeks.
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and was not available for analysis. Figure 3.3c shows the histology of the adult 
human retina. The characteristic three cellular layers are clearly visible 
(ganglion cell, inner nuclear, and outer nuclear), separated by the two plexiform 
layers (inner and outer), and the inner and outer segments of the 
photoreceptors are fully developed and embedded in the retinal pigmented 
epithelium. In the adult retina, CHX70 expression is restricted to cells within the 
inner nuclear layer. Furthermore, these cells are located on the outer aspect of 
the inner nuclear layer. The location of CHX10-positive cells corresponds with 
the location of bipolar cells, although as in the murine retina, the band of 
CHX10 expressing cells is probably wider than just the bipolar cell layer, 
indicating that CHX10 expression may persist in other cells within the inner 
nuclear layer, particularly horizontal cells, whose location is similarly in the outer 
aspect of the inner nuclear layer. Due to their location on the inner aspect of the 
inner nuclear layer these cells are unlikely to include amacrine cells (see 
below).
These data suggest that the postulated functions of ChxIO in the murine 
retina are indistinguishable to those of its human orthologue from in the human 
retina, i.e., CHX10 is expressed in retinal neuroblasts during early development, 
but later its expression is restricted predominantly to bipolar cells (but possibly 
to other cells within the inner nuclear layer).
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Figure 3.3. CHX70 expression in the developing and adult human retina by in situ 
hybridisation. At 13 weeks, the retina is partially stratified, with a clear ganglion cell layer (gel) 
and inner plexiform layer (ipl). CHX70 expression is restricted to the neuroblastic layer (nbl), but 
a sharp demarcation of expression exists in the outer aspect of this layer. This may reflect the 
presence of cells differentiating as photoreceptors, which do not express ChxIO. In the adult 
retina ChxIO expression is restricted top cells within the outer aspect of the inner nuclear layer 
(ini). Abbreviations: rpe, retinal pigmented epithelium; os, outer segments; is, inner segments; 
onl, outer nuclear layer; opi, outer plexiform layer. Scale bars = 100pm.
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3.3 Expression of BRN3b and PAX6 in the developing retina
Plasmid containing a 200bp fragment of the mouse Brn3b gene was kindly 
donated by David Latchman (Institute of Child Health, UGL, London). Over the 
length of this fragment, the sequence conservation between mouse and human 
is high enough to make a useful human riboprobe (Liu et al. 2000). In the 
mouse, Brn3b is expressed in the retina exclusively in a proportion of 
postmitotic ganglion cells, and is the first known marker of a ganglion cell fate 
(Xiang, 1998). Evidence from expression studies and analysis of mice 
containing targeted deletion of Brn3b indicate that it is not required for ganglion 
cell fate specification, but is required for correct differentiation and maintenance 
of this cell type (Gan etal. 1999).
PAX6 is involved in the earliest stages of eye development, but in the 
adult retina in both humans and mice expression is maintained in a proportion 
(-30% ) of ganglion cells (Graw 1996, Nishini et al. 1999), and in amacrine cells 
of the inner nuclear layer. Expression patterns for BRN3B and PAX6 were 
generated by in situ hybridisation as described above and in Chapter 2, 
Methods.
At Bwpc, expression of BRN3B expression (Figure 3.4b) can be seen 
throughout the neural retina, but is more concentrated in the inner layer. This 
expression pattern may reflect the developing ganglion cell layer; the punctate 
and lower levels of BRN3B expression in the outer retina may reflect the 
migration of postmitotic ganglion cells into the presumptive ganglion cell layer.
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Figure 3.4. Transcription factor 
gene expression in the 8 wpc 
human retina by in situ 
hybridisation. At this stage the 
retina is dived into two layers (a), and 
while BRN3b expression can be 
readily detected in both (b), it is 
certainly expressed at lower levels in 
the outer layer. This is in contrast to 
to the expression pattern of CHX10  
at the same stage (Fig. 3.2), but 
again reflects the presence of 
postmitotic ganglion cells within this 
layer. PAX6 expression (c) is uniform 
throughout both layers, possibly 
reflecting both the presence of diving 
cells and ganglion cells.
Abbreviation; rpe, retinal pigmented 
epithelium. Scale bar = 100pm.
PAX6
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The expression gradient observed is complementary to that observed for 
CHX70 (Figure 3.2).
In contrast to the gradients of expression seen at 8wpc for both CHX10 
and BRN3B, PAX6 expression (Figure 3.4c) is seen uniformly throughout the 
retina. As Pax6 in mice is expressed in retinal neuroblasts and ganglion and 
amacrine cells, it is difficult to dissect this expression pattern at this stage of 
development with reference to specific cell types. Judging from intensity of 
staining, cells are either expressing PAX6 at lower levels, or not every cell is 
PAX6-positive. However, single-cell resolution is not visible. Given that PAX6 is 
only expressed in a relatively small proportion of ganglion cells, the lower levels 
of expression seen in the inner layer may reflect PAX6 expression in ganglion 
cells.
In the 10wpc retina, the morphological distinction between the inner and 
outer retina is far clearer (Figure 3.5a), and as discussed above, CHX10 
expression is maintained only within the outer (neuroblastic) layer (Figure 3.2d). 
Expression of BRN3B (Figure 3.5b), by contrast, is almost entirely restricted to 
the inner layer. This suggests that by 10wpc the majority of ganglion cells are 
found within a single layer of the retina. There are a very few BF?A/3B-positive 
cells within the outer layer, which may reflect late born ganglion cells within this 
layer as they migrate towards the putative ganglion cell layer.
PAX6 expression at this time (Figure 3.5c) is similarly restricted to the 
inner layer, with a few individual cells expressing in the outer layer. The 
intensity of PAX6 expression is higher than that of BRN3B within this inner
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Figure 3.5. Transcription factor gene expression 
in the 10 week human retina by in  s itu  
hybridisation. By this stage (c), the inner layer has 
expanded considerably, and the outer layer remains 
densely packed. expression is limited to the
inner layer, the putative ganglion cell layer. PAX6 
expression is also largely restricted to the inner 
layer, and its higher expression levels may reflect 
both ganglion and amacrine cells. Abbreviation; rpe, 
retinal pigmented epithelium. Scale bar = 100pm.
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layer. Although PAX6 is expressed in proportionally fewer ganglion cells than 
BRN3B, this increased intensity of staining may reflect development of 
amacrine cells within the inner retina at 10wpc.
In the adult retina, BRN3B expression (Figure 3.6b) is weakly detected in 
the ganglion cell layer, suggesting that this gene has a role in the maintenance 
of this cell type. Expression appears to be in the majority of cells within this 
layer, consistent with the expression pattern seen in the mouse, and the loss of 
70% of ganglion cells within the Brn3b targeted deletion mouse (Gan et al. 
1996, 1999).
PAX6 expression in the adult human retina (Figure 3.6c) is seen in the 
ganglion cell layer in the majority of cells. This is in contrast to the 30% of Pax6 
expressing cells within the ganglion cell layer observed in the mouse. Although 
the differential gene expression patterns for the many different classes of 
ganglion cells has not been established, this may reflect differences in the 
relative proportions of distinct ganglion cell classes between mouse and human.
Expression of PAX6 is also readily detected in the inner nuclear layer, in 
a discreet band on the inner aspect. This position is consistent with the location 
of amacrine cells (Hollenberg and Spira 1972). In comparison to the expression 
of CHX10 in the inner nuclear layer there is no overlap between CHX10 and 
PAX6 expression domains, indicating that the cells expressing CHX10 are 
certainly not amacrine cells.
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Figure 3.6. Transcription factor gene ^  
expression in the adult human / /
retina by in situ hybridisation.
BRN3b expression is limited entirely to 4.%'
the ganglion cell layer (gel), although is 
not expressing in all cells in this layer.
PAX6 expression is restricted to a 
proportion of cells within both the inner 
nuclear layer (ini), and the gel. These 
are presumed to be amacrine cells in 
the ini (their position on the inner •
aspect of the ini supports this), and
ganglion and displaced amacrine cells '  ■ ' <. ' " .
in the gel. Abbreviations; ipl, inner
plexiform layer: opi, outer plexiform
layer: onl, outer nuclear layer: is, inner
segments: os, outer segments: rpe, ^
retinal pigmented epithelium. Scale
bar, 100pm.
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3.4 Discussion
The data presented here suggest that the expression patterns, and possibly the 
functions of Chx10 in the murine retina are indistinguishable to those of its 
human orthologue from in the human retina. CHX10 is expressed in retinal 
neuroblasts during early development, but later its expression is restricted 
predominantly to cells within the inner nuclear layer, predominantly bipolar cells.
The reduction in levels of CHX10 expression in the inner retina at 8wpc 
corresponds with ganglion cell differentiation, which is marked by an 
upregulation in BRN3B expression at the same developmental stage. 
Expression of PAX6 at 8wpc is uniformly throughout the retina. These last two 
pieces of data reflect the same expression patterns seen in the mouse at E13.5 
(see Figure 4.3).
The restriction of CHX70 expression at 13wpc may be an indication that 
photoreceptor genesis has begun, and these CHX10-negative cells are in fact 
postmitotic photoreceptors. This supports the evidence that CHX10 is not 
expressed in postmitotic photoreceptors (Furukawa et al. 1997). This 
expression restriction has not been reported in any other species, including the 
mouse, chick and goldfish (Liu et al. 1994, Burmeister et al. 1996, Chen and 
Cepko 2000, Passini etal. 1998).
Expression patterns of BRN3B is largely the same as in the mouse, and 
this suggests that they are functional as well as structural homologues.
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MOUSE
4.1 Introduction
The recessive mouse mutant ocular retardation (o /) has a C->A transversion, 
which causes a tyrosines stop mutation at amino acid position 176 (Y176Stop) 
within the homeodomain of the transcription factor gene Chx10 (Burmeister et 
al. 1996). The phenotype resulting from this mutation includes microphthalmia, 
blindness, an absent optic nerve, short, truncated photoreceptors and an 
absence of bipolar interneurons. Expression patterns of Chx10, coupled with 
analysis of the phenotype of the o /  retina suggests that ChxIO has a number of 
distinct roles in the developing eye, including as a promoter of proliferation in 
retinal neuroblasts, and also as a gene involved in establishing a bipolar cell 
fate.
Of the seven cell types found in the retina, immunohistochemical 
markers for all, bar bipolar cells, were found in the mature post-natal (P)14, PI 8 
(or in the case of ganglion cells E l4.5) o /  retina (Burmeister et al. 1996). This 
indicates that all cell types apart from bipolar cells are capable of differentiating 
in the absence of ChxIO. Although the cellular composition of the mature o /  
retina has been investigated, no studies have attempted to establish how 
development of distinct cell types differs in o /  from the wild type retina. Here, I
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aimed to investigate how the timing of birthing and onset of differentiation of the 
various cell types of the retina was affected by the absence of ChxIO, and 
whether alterations in differentiation patterns explains the disorganisation of the 
o /  retina.
The precise order and times at which the cell types leave the 
multipotential progenitor pool in the wild-type retina is well established through 
^H-thymidine incorporation studies (Young 1985). I chose to analyse the 
expression of cell specific markers (for the times investigated), which are known 
to be involved in cell specification at the earliest stages of cellular 
differentiation. All the genes analysed initially were transcription factor genes, 
and are the earliest known markers for each specific cell type. Homeodomain 
transcription factors, through their DMA binding and homo-/hetero-dimer forming 
capacity, are capable of regulating the expression of cascades of downstream 
target genes (Wilson et al. 1993), and therefore can play significant roles in 
cellular differentiation.
Gene expression was initially investigated using in situ hybridisation on 
paraformaldehyde fixed, paraffin wax embedded tissues, using a protocol 
modified from Breitschopf at ai. 1992 (see Chapter 2 for details), looking at the 
transcription factors Pax6, ChxIO, BrnSb and Crx. Expression patterns were 
examined at several stages during development; E l2.5 and E l3.5, when the 
retina is predominantly neuroblastic); E l 8.5, when lamination is well under way, 
and several strata can be observed, including the ganglion cell layer (gel) and
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the inner plexiform layer (ini); and P12, when all cells are postmitotic, and the 
retina can be considered mature.
4.2 Histological analysis of the o /  retina during retinal development
At E13.5, the wild-type murine retina comprises two layers, and a distinctive 
optic nerve (Figure 4.1a). The cells within these two layers are morphologically 
distinct from each other. The inner layer consists of presumptive ganglion cells, 
which project axons to the optic nerve head and nerve, and fasciculate to form 
the nerve fibre layer. In the o /  mouse at E l3.5 the eye is noticeably 
microphthalmic, with all aspects of the eye being considerably smaller than the 
wild-type mouse (Figure 4.1b). The retina is hypocellular, comprising only one 
discernible layer. The nerve fibre layer is apparently absent, and sectioning 
throughout the eye reveals that the optic nerve head and nerve are completely 
absent (b shows a section through the central retina). Figure 4.1c shows a high 
magnification image of the tissue behind the retina in the region of the optic 
tract. A thin line of cells can be seen (arrow) in several sections around the 
central retina, which corresponds to the position of the now-degenerated optic 
stalk. In sections from several embryos (n=3), nerve fibres were never seen in 
this remnant optic stalk, indicating that either the o /  retina fails to develop an 
optic nerve, or it rapidly degenerates, such that by E l3.5 no axons are present.
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Figure 4.1. Histological analysis of the or^ and eye retina. At El 3.5, the wild-type (+/+) retina 
(a) comprises the outer (ol) and inner (il) layers. The nerve fibre layer (nfl) is developed, indicating 
the presence of differentiated ganglion cells. These aggregate at the optic nerve head (onh). The 
o r' eye (b) at the same stage is considerably smaller, and the retina comprises only one 
discernible nuclear layer (nl). There is no nfl and no onh. (c) shows a high magnification view of 
the midline of the ot^ eye. The optic nerve is absent; instead there is a thin line of cells indicated 
with an arrow. At El 8.5 the wild-type eye (d) is notably larger than the o/^ eye (e). The lens in the 
wild type is connected at the ciliary margins, and is flush with the front of the eye. In the mutant, 
the lens appears to be free floating within the vitreous. The E l 8.5 wild-type retina (f) is developing 
into a stratified tissue, comprising a neuroblastic layer (nb), an incomplete inner nuclear layer (ini), 
an inner plexiform layer (ipl) and a ganglion cell layer. By contrast, the or^ retina (g) is thin and 
unstratified, with no discernible plexiform layers, rpe, retinal pigmented epithelium; ch, choroid. 
Scale bars; 100pm, except (c): 300 pm.
PI 2
Figure 4.2. Histological analysis of the adult or^ and eye retina. At
PI 2, the wild-type retina is mature (a), and consists of the characteristic 
three cellular layers: outer nuclear layer (onl) with inner (is) and outer 
segments (os); inner nuclear layer (ini); and ganglion cell layer (gel). 
These are separated by the inner (ipl) and outer plexiform layers (opI) The 
01^ retina is now severely hypocellular and partially stratified with two 
discernible layers (b), a gel and a nuclear layer (nl) separated by an 
interrupted plexiform layer (pi), rpe, retinal pigmented epithelium; ch, 
choroid. Scale bar: 100pm.
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By E18.5, the wild-type retina is developing into a stratified tissue, with a 
neuroblastic layer, an incomplete inner nuclear layer, and a ganglion cell layer, 
separated from the rest of the retina by a presumptive inner plexiform layer 
(Figure 4.1 d). By contrast, (Figure 4.1e) the mutant retina is hypocellular and 
unstratified, comprising only 10-15 cells at its thickest point (-lOOpm, as 
compared with ~200pm in the wild-type retina). These cells are morphologically 
indistinguishable from each other, and the retina is clearly lacking organisation.
The wild-type retina at PI 2 (Figure 4.2a) is fully postmitotic and can be 
considered effectively mature (Young 1985). It is well organised into its 
characteristic three cellular and two plexiform layers, and cell types are 
morphologically distinct, for example with photoreceptors possessing inner and 
outer segments. The o /  retina is by this stage irregularly stratified, with one 
inconsistent plexiform layer, and at best two cellular layers (Figure 4.2b). No 
photoreceptor inner or outer segments are visible adjacent to the RPE, and 
cells in the ganglion cell layer at the inner aspect appear to be prolapsing 
through the inner limiting membrane, which itself is inconsistent. The thickness 
of the retina is consistently <20 cells deep at its thickest point. Compared with 
the o /  retina at E l 8.5, in which all of the cells appear to be homogeneous, the 
P I2 o /  retina contains cells that have different morphologies to each other, 
implying that some differentiation has occurred.
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4.3 Transcription factor gene expression analysis by in situ hybridisation
4.3.1 Pax6
The paired-\ype homeodomain transcription factor Pax6 is known to play roles 
in many aspects of eye development (Graw 1996, Freund et al. 1996). For the CL 
purpose of this study, I was interested in using Pax6 expression as a marker of 
the development of ganglion and amacrine cells. Early in development, Pax6 is 
expressed throughout the neural retina, but in the mature retina, its expression 
is limited to amacrine cells and a subset of ganglion cells (Hitchcock eta l. 1996, 
Belecky-Adams etal. 1997, Nishini et al. 1999). Antisense and sense riboprobe 
were synthesised from a plasmid containing a 1.6kb fragment of Pax6 cDNA.
At E l2.5 the wild-type neural retina is largely undifferentiated [although 
early-born cell types have become postmitotic, such as ganglion cells, (Young, 
1985)]. Figure 4.3 shows expression of Pax6 throughout the retina, as well as in 
the anterior lens, and the overlying surface ectoderm. The distribution of Pax6 
mRNA within the neural retina appears to follow a centro-peripheral gradient, 
where there is a higher concentration of expression in the peripheral retina.
The expression pattern of Pax6 in the o /  retina at E l 2.5 (Figure 4.3) is 
largely similar to that of the wild-type retina, despite the overall microphthalmia. 
Expression can be seen throughout the neural retina, in the lens and in the 
surface ectoderm. However, the gradient of expression seen in the wildtype is 
not apparent in the mutant retina.
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Figure 4.3. Pax6 expression at E12.5. (a) and (b) show Pax6 expression by in situ 
hybridisation in the wild-type (+/-i-) retina and surface epithelium, (c) and (d) show 
expression in the oP retina. Although the eye is noticeably smaller, the expression 
pattern is similar, suggesting that Pax6 expression is unaffected by the absence of 
ChxIO. (b) and (d) are magnifications of (a) and (c). Abbreviations: ne, nasal 
epithelium; nr, neural retina. Scale bars: (a) and (c) 200 pm; (b) and (d) 100pm.
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Pax6 expression at E13.5 (Figure 4.4c and d, pages 148-149) in both 
the wild-type and 0 /  retinae is still widespread, although the intensity of staining 
appears reduced, possibly indicating that Pax6 expression is becoming 
restricted to specific cell types. In the wild type, lowest levels of mRNA were 
detected in the outer retina. In the mutant retina, signal is noticeably more 
intense in the inner retina (despite the absence of any histological strata. The 
highest levels of mRNA correspond to cells expressing Brn3b (see below) and 
therefore are likely to be ganglion cells.
By E l 8.5, wild-type expression of Pax6 (Figure 4.5e, pages 150-151) is 
abundant within cells of the developing inner nuclear layer and in the ganglion 
cell layer. These are presumed to be amacrine and ganglion cells, respectively. 
Expression has become downregulated in the majority of retinal cells. In the 0 /  
retina at E l8.5, Pax6 (Figure 4.5f) expression has also become downregulated 
in approximately half of the retinal cells; however, these cells are distributed 
apparently randomly throughout the unstratified retina. This suggests that 
regulation of Fax6 expression is maintained in the absence of ChxIO, although 
these cells have thus far failed to migrate to an appropriate position across the 
laminae.
At P I2 (Figure 4.6, pages 152-153) Pax6 expression is limited to cells 
within the ganglion cell layer and to cells within the inner aspect of the inner 
nuclear layer. These are presumed to be ganglion and amacrine cells 
respectively, as previously reported. In the 0 /  retina at P I2, Pax6 expression is 
restricted to a layer of cells in the inner aspect of the neural layer. Based on
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their location and Pax6 expression, these are presumed to be ganglion and 
amacrine cells (Hitchcock et al. 1996). The presence of both of these cell types 
has been demonstrated previously in the o /  mouse using other cell specific 
markers (Burmeister et al. 1996). The contrast between the distribution of Pax6 
expressing cells at E l8.5 and P I2 is notable. Cells that were randomly 
distributed at E l8.5 have migrated by P I2 into a tight stratum corresponding to 
the position of the inner nuclear layer and the ganglion cell layer.
Several conclusions can be inferred from these expression data.
1) Early Pax6 expression patterns are not significantly affected in the absence 
of ChxIO. During early development expression patterns are similar (despite 
the microphthalmia). This almost certainly indicates that Pax6 is upstream 
from ChxIO in the hierarchy of genes involved in eye development. This is 
perhaps unsurprising given that Pax6 expression precedes ChxW  
expression. Moreover, it also indicates that onset of ChxIO within the neural 
retina is not needed for the continued expression of Pax6 in this tissue.
2) Amacrine and Pax6 expressing ganglion cell genesis is relatively unaffected 
by the ChxW  mutation. It appears that at E l8.5, developing amacrine and 
ganglion cells are expressing Pax6 as in the wild type, but these cells are 
not organised into a layer. However, in the mature retina, these cells have 
migrated to a stratum that approximates that of the wild type.
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4.3.2 Brn3b
A 200bp riboprobe was synthesised from a plasmid containing a fragment of the 
cDNA sequence for BrnSb, which was a kind gift from David Latchman (Institute 
of Child Health, UGL, London). BrnSb is a POU domain transcription factor 
whose retinal expression is restricted to post mitotic ganglion cells, and is the 
earliest known marker for this cell type (Gan 1996). In situ hybridisation with a 
BrnSb riboprobe at E l 3.5 (Figure 4.4e, pages 148-149) showed weak 
expression in cells in the inner layer of the neural retina indicating the presence 
of newly forming ganglion cells. Ganglion cell birthing spans from E l 0.5 until P3 
(Young 1985), and by E l3.5, the optic nerve is clearly visible on different 
sections of the same specimen. At E l3.5 in the o /,  expression of BrnSb was 
detected in the otherwise unstratified retina (Figure 4.4e) in a thin band of cells 
in the innermost aspect of the retina. This expression pattern appears to 
overlap with that of a high concentration of Pax6 (see above). These data 
indicate the presence of ganglion cells in the mutant retina although the optic 
nerve is apparently absent in any specimen analysed (see Figure 4.1). Although 
the neural retina is disorganised at this stage and later, this result suggests that 
ganglion cell birthing is relatively unaffected by the absence of ChxIO, and also 
that these cells migrate to their appropriate location, as is observed in the wild- 
type retina. However, the absence of an optic nerve or a nerve fibre layer in the 
o /  retina indicates that these cells are not projecting their axons correctly.
Expression of BrnSb at E l8.5 (Figure 4.5g, pages 150-151) in the wild- 
type retina is restricted to the forming ganglion cell layer. The cells expressing
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Brn3b are no longer as densely packed as in the earlier retina, and axonal 
projections can be seen, as in the mature ganglion cell layer. Weak expression 
in the mutant retina is restricted to a thin layer of cells on the innermost aspect 
of the still apparently disorganised and unstratified retina (Figure 4.5h). Upon 
close inspection of histological stains of the o /  retina this layer of Brn3b- 
positive cells are not morphologically distinguishable from cells in the rest of the 
retina, perhaps indicating that these ganglion cells are not undergoing normal 
differentiation. This is a possibility that reflects the inability of these cells to 
project their axons to form an optic nerve.
^Dpspite repeated independent experiments (n=3), expression of Brn3b 
was not deteetetrS~pr^'1fMh_a-'€rr^^^ by^n''s/ftrhybridisation. This may 
reflect a retinal degeneration where 8m3b-positive ganglion cells have died.
The observed Brn3b expression pattern during development indicates 
that ganglion cell birthing is relatively unaffected by the absence of functional 
ChxIO, as is the capacity of these cells to migrate to an appropriate location in 
the mutant retina. However, ganglion cell differentiation is abnormal, as 
demonstrated by the absence of an optic nerve.
4.3.3 ChxIO
A 1.6Kb length of ChxW  cDNA was amplified from a wild-type E l5.5 mouse 
retinal library using primers that flank the position of the C -> A  mutation 
(Burmeister et al. 1996). A riboprobe was generated from this clone and was 
used in in situ hybridisation experiments on both wild-type and o /  retinae. The
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aims of these experiments were to examine the d istribution^^ 
the defective mRNA during development. Expression was analysed in the wild 
type at E18.5 and P12.
At E18.5, expression of ChxW  in the wild type is restricted to the 
neuroblastic retina (Figure 4.5c, pages 150-151), and appears to be present in 
all of the cells within this layer. This is similar to the expression patterns seen in 
the human at 10 wpc (see Figure 3.2). By this stage, the presumptive inner 
nuclear layer is apparent but incomplete, separated from the ganglion cell layer 
by the developing inner plexiform layer. Bipolar cells are amongst the last 
neuronal cells in the retina to be born, in a period that spans from E l4.5 until 
P11 (Young 1985). At E l8.5, ChxIO mRNA was detected in the neuroblastic 
layer and within the presumptive inner nuclear layer.
By P I2 expression of ChxW  (Figure 4.6c, pages 152-153), is restricted 
exclusively to cells within the inner nuclear layer, with a higher concentration on 
the outer aspect of this layer, corresponding to the location of bipolar cells. This 
is consistent with the role of ChxIO in bipolar cell specification and 
maintenance. The band of expression may be wider than just the bipolar cell 
layer, indicating that ChxW  may be expressed at low levels in other cells of the 
inner nuclear layer. Liu et al. (1996) reported co-localisation of ChxIO and the 
bipolar marker PKC, indicating that ChxIO is expressed in bipolar cells. 
However, the co-expression of ChxW  with other cell specific markers has not 
been investigated, either during development or in the mature retina.
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Expression of mutant ChxIO transcripts (here denoted Chx10r^~) was 
investigated in the o /  retina by in situ hybridisation. At E18.5 mutant mRNA 
transcripts were readily detectable (Figure 4.5d), whereas hybridisation with a 
sense probe resulted in no discernible signal. This indicates that the mutant 
mRNA transcript is stable, and that the riboprobe used to investigate ChxIO 
expression hybridises successfully with the Chx10~^~ mutated transcript. It has 
been reported previously that mRNA transcripts containing mutations are often 
unstable and are degraded. By contrast, other reports (Carlson et ai. 2000) 
indicate that point mutations do not affect the quantity of mRNA transcribed.
This analysis allowed the monitoring of levels of C/?x7 transcription in 
the absence of functional ChxIO protein, where any autoregulatory mechanism 
would be absent. Chx10~^~ transcripts were strongly detected at E18.5 
throughout the disorganised retina, except, on closer inspection, in a very thin 
band of cells on the inner most aspect of the retina. These correspond to the 
layer of cells expressing Brn3b (Figure 4.5h) and are presumed to be 
postmitotic ganglion cells. This, again, reinforces the notion that ChxIO is not 
required for the differentiation of ganglion cells, and that developing ganglion 
cells are capable of downregulating ChxIO  expression in the absence of 
functional ChxIO protein. However, at this stage of development, when in the 
wild type many cells in the inner retina have downregulated ChxW  expression, 
the vast majority of cells in the mutant retina are expressing ChxW  at higher 
levels. This may indicate a number of possible explanations:
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(1) the mutant retina is immature compared with the wild type, and there 
is consequently a much larger proportion of dividing cells that are strongly 
transcribing Chx1CT^~ mRNA]
(2) the mutant retina contains a number of cell types which are incapable 
of downregulating Chx1CT^~ expression in the absence of a ChxIO protein. 
These possibilities are investigated below.
In contrast to its expression pattern at E18.5, ChxW  mRNA has become 
restricted by P12 to a layer of cells on the inner aspect of the 0 /  retina (Figure 
4.6d). This indicates that the cells on the outer aspect are capable of 
downregulating Chx1Cr^~ transcription independently of ChxIO. The band of 
cells expressing Chx1Cr^~ corresponds to cells in the inner aspect of the nuclear 
layer (and is distinct from the putative ganglion cell layer). The absence of PKC 
immunolocalisation in the mature 0 /  retina (Liu et a/. 1996) indicates that 
differentiated bipolar cells are absent. Chx1Cr^~ expression in the mutant at P12 
is therefore marking other cell types of the inner nuclear layer i.e. amacrine 
cells, horizontal cells or Müller glia, or labelling postmitotic bipolar cells that are 
blocked in their differentiation by the absence of ChxIO.
Here, I have shown that there is a pool of cells located in the inner 
aspect of the neural retina, but outer to the ganglion cell layer which maintain 
Chx1Cr^~ expression, despite the absence of differentiated bipolar cells.
Two important points emerge from this finding. First, the size of the 
putative photoreceptor layer in the mutant, as indicated by the downregulation 
of ChxW  mRNA, is approximately 30% of the width of the equivalent layer in
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the wild type. Second, the relative proportion of cells expressing Chx10~^~ in the 
mutant appears to be greater than in the P12 wild-type retina. This may indicate 
that several cell types in the inner nuclear layer are dependent on functional 
ChxIO protein to down regulate expression of ChxW  mRNA. Given that the 
band of cells that is expressing Chx1Cr^~ in the mutant retina is wider than, but 
fully overlaps with, the band of cells expressing Pax6 (here assumed to be 
amacrine and a proportion of ganglion cells, see above), amacrine cells may be 
the cell types incapable of downregulating ChxW  expression, and this may be 
consistent with the possibility that ChxW  is expressed at low levels in other cell 
types in the inner nuclear layer.
4.3.4 Crx
A 637bp fragment of the photoreceptor-specific transcription factor gene Crx 
was cloned from an E15.5 mouse retinal cDNA library, and this was used to 
synthesise sense and antisense riboprobes. Expression of Crx was analysed by 
in situ hybridisation (see Chapter 2, Methods for details).
At E13.5 faint Crx expression could be detected in the outer layer of the 
neural retina (Figure 4.4g, pages 148-149). This layer corresponds to the 
location of the prospective photoreceptor layer, and expression of Crx at this 
stage indicates the presence of developing cone photoreceptors (albeit in small 
numbers) (Furukawa et al. 1997), whose birthing precedes that of rods (Young 
1985). This expression pattern is complementary to that of Brn3b in adjacent
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sections, which indicates that these two genes are not co-expressed in the 
same layer of the developing retina.
In experiments with appropriate wild-type positive controls, Crx 
expression could not be detected in the o /  retina at E13.5 (Figure 4.4h). The 
lack of signal was comparable to incubation with a sense riboprobe (data not 
shown). This result suggests that Crx mRNA transcripts are not present at this 
time in the mutant retina, indicating a delay of at least one day in the onset of 
expression of this gene. This result was reproduced in separate independent 
experiments (n=4).
Expression of Crx in the wild-type E18.5 retina is restricted to the 
neuroblastic layer, and is punctate (Figure 4.5i, pages 150-151). This pattern 
reflects the presence of developing rods and cones (Young 1985). There is 
more concentrated expression signal in the outer most aspect of the 
neuroblastic layer, and this corresponds to the zone in which photoreceptor 
differentiation is underway. The apparently punctate pattern of expression 
reflects the nature of the neuroblastic retina, which contains many newly-born 
photoreceptors and dividing cells (see section 4.3) that will contribute to the 
other non-photoreceptor late born cell types in the mature retina, e.g. bipolar 
cells (born during the period E 14.5-P12).
Again, mirroring the situation at E l 3.5, Crx expression could not be 
detected in repeated experiments by in situ hybridisation at E l 8.5 in the o /  
retina (Figure 4.5j). Positive controls within these experiments (i.e. other 
riboprobes on adjacent sections, Crx antisense riboprobe on different
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specimens) demonstrated the robustness of the protocol and the integrity of the 
mRNA in the tissue. These results lead to the conclusion that Crx expression is 
delayed by at least six days in the o /  retina.
Crx expression is not detectable by in situ hybridisation at either E13.5 or 
18.5 in the o /  retina (Figures 4.4h and 4.5j). However, by P I2 expression is 
readily detectable in a layer of cells on the outer aspect of the retina (Figure 
4.6h, pages 152-153). The band of Crx-positive cells seen here are presumed 
to be photoreceptors. Previous work has reported the presence of rod 
photoreceptors at PIS, based on detection of rhodopsin using antibody staining 
(Liu et al. 1994). Normal length inner and outer segments are not detectable in 
the o /  retina by light microscopy, suggesting that photoreceptor differentiation 
is disrupted. The expression pattern of Crx at P I2 is complementary to that of 
ChxIO  on adjacent sections. This indicates that these cells that are capable of 
downregulating C/?x7C? expression in the absence of a functional ChxIO protein 
are in fact photoreceptor cells. Furthermore, these data suggest that the 
downregulation mechanism is specific to photoreceptors.
147
148
Figure 4.4. Transcription factor gene expression by in situ hybridisation at El 3.5. Pax6 expression is distributed 
throughout the wild-type (+/+) and oP retinae (c and d) at E13.5, as well as on the overlying surface epithelium. BrnSb, which 
is ganglion cell-specific, is expressed only in the il of the wild-type retina (e), and in a layer of cells in the inner aspect of the 
unstratified o/^retina (f). This indicates that ganglion cells are present in the absence of ChxIO, and localise to the correct 
tissue aspect. By contrast, the photoreceptor transcription factor gene Crx is expressed in the ol of the +/+ retina (g), 
corresponding to the future photoreceptor layer. However, Crx could not be detected by in situ hybridisation in the or  ^retina at 
E13.5 (h). Scale bar; 100 p,m
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Figure 4.5. Transcription factor gene expression by in situ hybridisation at E18.5. The characteristic stratified retina is 
beginning to form In the wild-type (+/+) retina (a), but is notably retarded in the mutant retina (b). Mutant ChxfO expression 
is readily detectable throughout the oi^ retina (d) at this stage, implying that there may be an autoregulatory mechanism 
that downregulates expression into a subpopulation of cells in the wild-type (c). Expression of Pax6 (f) is in a proportion of 
cells in the oH retina, indicating that it has been downregulated as in the wild-type retina (e), but organisation of these Pax6- 
positive cells is absent. Brn3b expression is detected in the oP and wild-type retinae (g and h). Crx expression is restricted 
to the outer, neuroblastic layer in the wild-type (i), but remains undetectable in the absence of ChxIO (j). Scale bar: 100pm.
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Figure 4.6. Transcription factor gene expression by In situ hybridisation at P12. (a) shows the characteristic 
mature retina, with its three cellular and two plexiform layers, (b) The mutant retina is hypocellular and disorganised. 
ChxtO expression in the wild-type {+/+) (c) is restricted to cells within the inner nuclear layer (ini), presumed to be bipolar 
cells. ChxW  expression in the mutant (d) is restricted to cells within the inner aspect, in contrast to its global expression 
at E18.5, suggesting that cells within the outer aspect have a Chx10-independent mechanism for the downregulation of 
Chx10. Pax6 expression is restricted in both the wild-type (e) and mutant retina (f) to cells within the inner layers, 
presumed to be amacrine and ganglion cells. C/x expression, while absent at E18.5, is present in cells within the outer 
aspect of the mutant (h), indicating a delay in onset of expression in the absence of Chx10. Wild-type expression (g) is 
within the outer nuclear layer (onl). Scale bar: 100pm.
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4.4 Transcription factor gene expression analysis by RT-PCR
Reverse transcriptase polymerase chain reaction (RT-PCR) was used as an 
alternative and more sensitive method of detecting gene expression in the o /  
retina. The aim was to compare expression of the genes examined by in situ 
hybridisation using a different and independent technique. Moreover, RT-PCR 
is a very sensitive technique that would provide closer analysis of the apparent 
absence of Crx transcripts in the o /  retina.
Eyes (or separate dissected retinae from P12 eyes) from whole litters at 
the same stages as used in the in situ hybridisation experiments were dissected 
and total RNA extracted as described in Chapter 2, Methods. This RNA was 
quantified both by spectrophotometry and on denaturing ethidium bromide- 
stained agarose gels. Equivalent amounts were used as templates to 
synthesise cDNA pools, and these were used as templates for gene-specific 
PCR.
Primers were designed to amplify multiple exon spanning fragments from 
Brn3b, Chx10, Crx and phosphogluco-mutasel {Pgm1) (Figure 4.7). This was 
to avoid any possible contamination of PCR product by amplification of genomic 
DNA. Pgm1 is a ubiquitously expressed gene, whose expression was used as a 
positive control to demonstrate the integrity of the RNA extracted and cDNA 
quality (Putt et al. 1993). PCR was performed for each of these genes at each 
time point, using 30 amplification cycles (35 in the case of Brn3b). 
Quantification of PCR products amplified from mRNA for Pgm1 and Crx at 24,
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Figure 4.7. Transcription factor gene expression in the oH retina during development was assessed by RT-PCR at the 
same developmental stages as had been investigated for in situ hybridisation (see Figs 4.3, 4.4 and 4.5). In situ  data were 
confirmed, in that both Brn3b and ChxIO vjere readily expressed in the wild-type (-i-/+) and oi^ retina at all stages investigated, 
as was the ubiquitously expressed gene PGM1, but Crx was not detected at El 2.5 and El 8.5 in one litter, and was only faintly 
detected at E l 8.5 in a second (suggesting recent onset of expression). This indicates that expression of Crx is delayed in the 
absence of ChxIO.
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Fig. 4.8. Quantitative analysis of RT-PCR for Crx and Pgml demonstrates 
that 30 PCR cycles is within the linear range of the reaction.
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26, 28, 30 and 32 cycles demonstrated that 30 cycles was within the linear 
range of the PCR, and thus these data could be considered semi-quantitative 
(Figure 4.8).
Figure 4.7 shows gene expression of these genes, comparing wild-type 
samples at E13.5, E18.5 and P12 with o /  at the same stages. Expression of 
Pgm1 at approximately equal levels in all samples demonstrates that RNA was 
successfully extracted. Negative controls (no mRNA template) show that 
amplification was not caused by cDNA contamination.
Expression of Brn3b was detected at all time points analysed, with a 
531 bp band clearly visible. This suggests that Brn3b expression is little affected 
at the time points analysed by the absence of ChxIO, and is consistent with the 
in situ hybridisation data.
Expression of ChxW  similarly was readily detectable at all times 
analysed. Primers used in this reaction did not flank the mutation site. This 
result demonstrates that the ChxW  mRNA transcripts are stable, and this 
confirms the result of the in situ hybridisation. Furthermore, these results 
suggest that transcription occurs independently of ChxIO protein, and
thus rules out a model of ChxW  expression that is dependent on a self- 
regulatory feedback loop for continued expression at later stages.
Crx expression was analysed by the same methods, and was readily 
detectable at E l3.5, E18.5 and P I2 in the wild-type eye, in accordance with the 
in situ hybridisation and published data (Furukawa et al. 1997). In the o /  eye
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Crx transcripts were undetectable at E13.5, although other cDNA species were 
readily amplified, confirming the in situ hybridisation result.
At E18.5 o /  Crx expression was investigated in two litters. In Litter 1, no 
Crx expression could be detected. However, a faint band at the corresponding 
size was detected in Litter 2. Equivalent amounts of RNA were used in the 
synthesis of wild-type and mutant cDNA, and equivalent amounts of cDNA were 
used in each PCR. The intensity of the band showing Crx expression in Litter 2 
is significantly less intense than that of the wildtype. This can be interpreted as 
showing very low levels of expression, indicating onset of expression at around 
E18.5 (see below). This suggests a six-day delay in Crx expression in the o /  
mouse retina.
Crx expression was readily detectable at P12 in the o /  retina. The 
intensity of the band is equivalent to that of the wild type, and this suggests that 
levels of expression per milligram of total RNA are comparable with that of the 
wild-type retina. These data indicate that the low levels of expression detected 
in Litter 2 at E18.5 reflect the onset of Crx expression being around E18.5, 
rather than generally lower levels than the wild type.
4.4.1 Onset o f Crx expression
RT-PCR was performed on RNA extracted from o /  retinae from newborn pups 
at P1, 2, 3, 4 and 5, Tissue was dissected from both eyes of single mice on 
each of these days. Pgm l expression was again used as a positive control to 
ensure the integrity of the RNA extracted, and this is shown in Figure 4.9. Crx
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Figure 4.9. Onset of expression of Crx in the oW retina was investigated, 
and was shown by RT-PCR to be readily detected at postnatal day (P) 1. 
Onset of rhodopsin expression, a putative downstream target of Crx, was 
shown to begin at P2, thus reinforcing the notion that it may be regulated by 
Crx.
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expression was detected using the same primers as in Figure 4.7 at all times 
from P1-5. Mice are born (PO) at approximately 19.5 days post coitum (dpc). 
These combined data suggest that in the retina of the o /  mouse Crx mRNA 
transcripts are first detectable within a 48-hour period between E18.5 and P1. In 
the wild-type mouse Crx expression begins at E l 2.5 (Freund et al. 1997). 
Therefore, in the absence of ChxIO, Crx expression is delayed by 
approximately seven days.
4.5 Cell proliferation in the developing oW retina
The observed delay in C/x expression in the o /  retina might be the result of one 
of a number of causes. As Crx is expressed only in developing and mature 
photoreceptor cells (Furukawa et al. 1997), one possibility might be that a 
Chxl 0-dependent disruption of cell cycling in the mutant retina might be 
preventing the birth of photoreceptor cells. One of the most striking phenotypes 
of the o /  retina is its extremely hypocellular nature. Burmeister et ai. (1996) 
reported a dramatic reduction (up to 85% in the dorsal peripheral retina) in cell 
proliferation of retinal neuroblasts at E l 1.5 by BrdU incorporation. This is 
described as the cause of the hypocellular retina, although cell proliferation in 
the central retina was comparable to that of the wild-type retina. The assay 
performed in their experiments does not take into account the length of time 
during which retinal proliferation is taking place, only that there is an absolute
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reduction in the amount. Significantly, the number of cells in the mutant retina is 
already 30-50%  lower than the wild-type retina by E11.5.
The immunolocalisation of a marker of mitosis was investigated at E13.5, 
E18.5 and at P12 in the wild-type and o /  retinae. Proliferation cell nuclear 
intigen (PCNA) is a protein involved in DNA replication, and is only expressed 
in mitotic cells (Hall et al. 1990). At E l3.5 many mitotic cells are detected 
throughout the embryo (Figure 4.10c). Within the neural retina many PCNA- 
positive cells were observed in the outer, proliferative, layer, and only a very few 
cells within the inner layer. This reflects the early differentiation of ganglion cells 
relative to other cell types in the retina. Many of the cells that are PCNA-positive 
have the morphology of migrating cells. Within the o /  retina (Figure 4.10d) 
there are similar proportions of PCNA-positive cells. However the retina is much 
thinner, and there is no distinction between the two layers seen in the wild type 
retina.
At E l8.5, many proliferative cells (PCNA-positive) can be observed 
throughout the wild-type retina (Figure 4.11b). By contrast, in independent 
repeatable experiments (n=4), no PCNA-positive cells could be seen in the o /
retina (Figure 4.1 Id). Extra-ocular tissue on the same sections showed
immunoreactivity to the PCNA antibody, indicating a robust positive control 
(Figure 4.11e). Liu et ai. (1996) suggested that the hypocellular retina observed 
in the o /  mouse is the result of a reduction in proliferation, shown by reduced
BrdU labelling indices. This reduction was observed from E l0.5 until E l8.5,
after which it was not recorded. The data presented here suggest that by E l 8.5,
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Figure 4.10. PCNA immunolocalisation in the or^ retina at El 3.5. (a) and (b) show H and E stained wild-type and or> retinae at E13.5. (c) and 
(d) show staining of cells that are positive for the mitotic cell marker PCNA. The majority of cells that are positive in the wild-type (-r-/+) are located 
within the outer layer (ol), but are distributed throughout the single layer of the mutant retina, (e) and (f) show high magnification images of (c) and 
(d). Abbreviations: il, inner layer; rpe, retinal pigmented epithelium. Scale bar: 100pm
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Figure 4.11. PCNA 
immunolocalisation at El 8.5 in the 
o/^ retina, (b) The majority of retinal 
dividing cells in the wild-type (-t-/-f-) are 
located within the outer, neuroblastic 
layer (nb). However, PCNA-positive 
cells were not detected within the 
retina of the oW retina at E l 8.5 (d). 
These data suggest that the 
hypocellular retinal phenotype is at 
least in part caused by an early 
cessation of mitosis, (e) shows a 
positive staining of extra-ocular tissue 
on the same mutant section as (d). 
Scale bars: 100pm
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no proliferating cells could be detected. Therefore, the hypocellular retina may 
be the result of a reduced period of proliferation, which stops approximately 12 
days early, as well reduced proliferation per se. By PI 2 no PCNA-positive cells 
could be detected in either the wild-type or the o /  retinae (data not shown).
These data also suggest that as there are no dividing cells at E l8.5 in 
the o /  retinae, all of the cells that are present in the mature retina are already 
postmitotic. The observed delay in Crx expression therefore cannot be caused 
by a failure of photoreceptor birthing, and suggests that differentiation of 
photoreceptors is disrupted. This is investigated in the following section, 4.6.
4.6 Photoreceptor-specific gene expression by RT-PCR
Expression of the photoreceptor specific transcription factor Crx is delayed by 
approximately seven days in the o /  retina. This is perhaps a surprising result, 
as ChxIO has not been reported to be expressed in photoreceptors, although 
the o /  mouse does have a photoreceptor phenotype, with an absence of 
normal sized inner and outer segments (Burmeister et al. 1996). The preferred 
binding site for Crx has been described, and during the course of this thesis, 
many photoreceptor genes have been shown to posses this motif in their 5’ 
promoter regions (Livesey et ai. 2000). These data indicate that Crx is (at least 
partially) responsible for the expression of several photoreceptor specific 
downstream targets.
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Given this information, one prediction might be that expression of 
downstream targets of Crx would be similarly or further delayed in the o /  retina, 
and that disruption of this hierarchy is responsible for the observed 
photoreceptor phenotype. This prediction was addressed by examining the 
expression of a number of photoreceptor genes using RT-PCR on the same 
stages as before, E l3.5, E18.5 and P12. Primers were designed to amplify 
short fragments of photoreceptor-specific genes.
The common factor for the choice of these genes was the presence of a 
Crx binding site in their 5’ promoter regions (Livesey et al. 2000). Therefore, the 
prediction was that expression of these genes would be delayed in a similar 
manner to that of Crx in the o /  retina. Rhodopsin is a seven-pass membrane 
bound protein whose location is restricted to the outer segments of 
photoreceptors (Pepe 1999). Phosphodiesterase-p (Pde-p) is a sub-unit of the 
rod cGMP phosphodiesterase enzyme, and is part of the photo-transduction 
pathway. Mutations in Pde-p are known to cause autosomal recessive retinitis 
pigmentosa, and autosomal dominant stationary night blindness (Gal et ai. 
1994). Arrestin is a protein whose function contributes to the regulation of G- 
protein-mediated photo-transduction (Dolph et ai. 1993). Peripherin (rds) plays 
an essential role in the maintenance of photoreceptor rod cell disk membrane 
structure. Mutations in peripherin in mice cause the retinal degeneration slow 
{rds) phenotype, and retinitis pigmentosa in humans (Kajiwara et al. 1991).
Interphotoreceptor retinoid binding protein (IRBP) is a secreted 
glycolipoprotein that is localised to the interphotoreceptor matrix surrounding
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the inner and outer segments (Liou et al. 1994). There is evidence that the 
function of IRBP is to transport vitamin A across the hydrophilic subretinal 
space. Expression is first detected as early as E11, and thus may precede 
onset of Crx expression, which is first recorded at E12.5. Furthermore, there is 
some evidence that IRBP co-localises with BrdU incorporation in dissociated 
P2/3 retinal cultures (Liou at al. 1994). This suggests that IRBP may be a pre­
terminal mitosis marker of photoreceptor fate. The 5’ promoter region of IRBP 
also contains a Crx preferred binding site (Livesey at al. 2000), suggesting that 
Crx is involved with transcription of this photoreceptor specific gene.
As in section 4.3, primers to Pgm1 were used again to test the integrity of 
the RNA. C/x expression was shown to be absent at E l3.5 and E l 8.5 in the o /  
retina (Figure 4.9), as was expression of rhodopsin (see above). Figure 4.12 
shows that expression of Pda-/3 was weakly detected at E l 3.5, and readily at 
E l8.5 and P I2 in the wild-type mouse. This may reflect the low number of 
photoreceptors present at E l3.5 (Young 1985), or photoreceptors at early 
stages of differentiation. However, no Pda-p expression by PCR could be 
detected in o /  retina in separate independent experiments at any time 
examined (n=3). This absence is likely to be an indirect result of the ChxIO 
mutation, and may reflect the absence of outer segments, as this is where Pde- 
P is located. While C/x expression is delayed rather than totally absent in the oi^ 
retina, this result indicates that mis-timing of a regulatory factor of Pde-p results 
in its complete absence.
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Figure 4.12. Photoreceptor gene expression in the oW retina. Given the observed 
delay in Crx expression in the oi^ retina, expression of other photoreceptor specific 
genes was investigated by RT-PCR at the same developmental stages. All of these 
genes have Crx consensus binding motifs in their promoter regions, and therefore are 
putative targets of Crx regulation. Comparative expression patterns fell into two 
groups: onset of expression of arrestin, peripherin and IRBP  preceded that of Crx in 
the oP  retina, whereas rhodopsin and phosphodiesterase (Pde)-f3, were similarly 
delayed to Crx. This suggests that the former set are not dependent upon Crx for their 
expression, despite their possessing a Crx binding site. Wild-type is shown on the left.
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Expression of arrestin was very faintly detected at E13.5, and readily 
detected at E18.5 and P12 in the wild-type retina. At E13.5 in the o /  retina 
arrestin transcripts were undetectable. A very faint band was present at E18.5 
and similarly low levels of expression were present at P12. The absence of 
expression at E13.5 is indicative of a delay as compared with the wild type. 
However, transcripts were detectable when Crx was absent, albeit at low levels. 
The low levels do not represent the hypocellular nature of the retina, as 
equivalent amounts of RNA were used in each cDNA synthesis reaction. This 
suggests that arrestin expression is partially regulated by Crx, as it is affected 
profoundly by the C/x delay, but is present before the onset of Crx expression.
Expression of peripherin was found to be readily detectable at all stages 
examined in the wild-type retina, although the intensity of the band at E13.5 
was lower than that at E18.5 and P12. Again, this may reflect the low numbers 
of photoreceptors present, or photoreceptors at early stages of differentiation. 
Expression is strong at E18. the o/*^  retina, although the intensity of the band is 
much less than that of the wildtype at the same stage, again suggesting a 
reduction in expression levels, but not an absence. By P12 expression of 
peripherin is reduced back to very low levels. One possible explanation for this 
is that the absence of other factors caused by the mis-timing of Crx expression 
causes the subsequent downregulation of peripherin by P12.
/R8P expression was analysed at E13.5, E18.5 and P12, and was found 
to have comparable levels of expression at all stages. Surprisingly, expression 
of IRBP in the mouse was also found to be indistinguishable from that of the
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wild type. These data indicate that expression of IRBP is neither affected by the 
mutation in ChxIO, nor by the consequent delay in the expression of Crx.
Further to the examination of the expression of these photoreceptor 
genes during development, I examined the precise onset of expression of 
rhodopsin by RT-PCR in the o /  mouse retina at P1, 2, 3, 4 and 5 (Figure 4.9). 
Expression was not detected at P1. Faint expression was detected at P2, and 
at P3, 4 and 5 transcripts were readily detectable. Although, as before, the 
amount of product amplified form these PGRs was not quantified, the absence 
of expression at P1, weak intensity at P2 and strong intensity at P3 indicates 
that the onset of rhodopsin expression in the o /  retina is on P2. This delay of at 
least one day after the onset of Crx expression certainly reinforces the 
possibility that Crx directly regulates rhodopsin expression.
4 .7  M o u s e  b ackg ro u n d  s tra in  d iffe ren ces
The o /  mutation is present on the Mus muscuius musculus strain sv129. Owing 
to ease of availability, mice of the C57Black6 x CBA were used as wild type in 
all experiments described. sv129, C57Black6 and CBA are inbred strains, i.e. 
are derived from more than 20 brother-sister matings, and are effectively 
homozygous at all genetic loci (Hogan et ai. in Manipulating the Mouse Embryo 
2"^ edition). Strain differences are fundamentally polymorphisms, which may 
affect gene expression or protein function. While the observed delay of seven
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Figure 4.13. Demonstration by RT-PCR that Crx and IR BP  
expression is equivalent at E l3.5 and El 8.5 in two different strains 
of M us m uscu lus. The o r' phenotype is on the sv129 background, and 
this demonstrates that the observed phenotype of delayed Crx 
expression in t o r ' retina is not caused by an affect of its strain.
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days in Crx expression in the o /  mouse is almost certainly above the upper 
threshold of gene expression strain differences, expression of Crx and IRBP in 
the sv129 wildtype retinae at the time points examined was tested. RNA was 
extracted from retinal tissue of E13.5 and E18.5 eyes of both the C57BI6 x CBA 
and sv129 strains.
cDNA was generated by reverse transcription of equivalent amounts of 
RNA, and this was used as template in a standard PGR reaction, with primers 
for Pgm1 as a ubiquitously expressed gene as a positive control, and Crx and 
IRBP (Figure 4.13). Using 30 PGR cycles all three genes were shown to be 
expressed at E13.5 and E l 8.5 in both mouse strains. These data demonstrate 
that the validity of the result showing a delay in Crx expression in the o /  mouse 
is intact and this observation is not caused by differences in mouse background 
strain.
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4.8 Discussion
The data presented here imply the significance of Chx10 on retinal 
development. There does not appear to be a profound effect on the genesis of 
ganglion cells and amacrine cells, which express differentiation markers 
appropriately. In terms of cellular location, ganglion cells appear least affected 
by the absence of Chx10, being in the innermost aspect of the mutant retina 
from the earliest time investigated. The complete absence of an optic nerve, 
however, suggests a defect that may reflect a disruption in the interactions 
between ganglion cells and the cellular milieu.
Amacrine cells appear to ultimately locate correctly, having previously 
been randomly distributed throughout the developing retina -  a defect not seen 
in the developing wild-type retina.
The most profound effect that the absence of Chx10 confers, apart from 
on bipolar cells, appears to be on the differentiation of photoreceptors. A delay 
in the onset of Crx expression has a knock-on effect on a set of photoreceptor- 
specific Crx target genes. However, these data indicate that the photoreceptor- 
specific genes investigated here fall into two categories with respect to their 
expression in the o /m ouse:
1) those whose expression follows that of Crx, which is delayed in the 
mutant mouse, and,
2) those whose expression is not dependent on the presence of Crx.
172
All the genes investigated here have Crx binding sites in their promoter regions, 
suggesting that they are all (at least partially) regulated by Crx. However, these 
data indicate that at least for IRBP and peripherin, and possibly arrestin, 
absence of Crx is not enough to prevent expression, suggesting that expression 
of these genes is not simply regulated by Crx. Conversely, expression of 
rhodopsin and Pde-p is not detected before the delayed onset of Crx expression 
in the o /  mouse, suggesting that expression of these genes is principally 
regulated by Crx.
Mice with homozygous targeted disruption of Crx (Furukawa et a!. 1999) 
show reductions in expression of rhodopsin, Pde-p, arrestin, and peripherin, 
indicating that Crx is required for expression of these photoreceptor specific 
genes, but is not the sole regulator. Kimura et a/. (2000) demonstrated that 
high-level photoreceptor specific gene expression required the presence of 
photoreceptor conserved element 1 (PCE1)/Rx interactions as well as OTX 
element-Crx interactions. Levels of expression of IRBP in the C rx '"  mouse are 
normal (Furukawa et al. 1999). These data indicate that IRBP expression is 
independent of Crx in vivo, despite evidence that Crx is capable of 
transactivating the IRBP promoter (Furukawa et ai. 1997). Co-transfection 
experiments show that human 0TX2 as well as Crx activates the IRBP 
promoter (Bobola et ai. 1999). The presence of IRBP mRNA in the o /  and 
mice may indicate that Otx2 is capable of compensating in the absence of 
Crx and thus directing photoreceptor specific IRBP expression. Expression of 
Otx2 has not been investigated in the o /  mouse yet.
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A requirement for expression of rhodopsin in a specific and discrete 
window of developmental time has been suggested as critical for normal retinal 
development in experiments in Drosophila rhodopsin mutants. Fly rhodopsin is 
encoded by the ninaE gene, and is expressed in the rhabdomere -  a structure 
equivalent to the vertebrate outer segment. While abnormal rhabdomere 
development caused by mutated ninaE can be rescued by transgenic 
introduction of wild-type ninaE, delaying expression of the transgene fails to 
rescue the phenotype (Kumar etal. 1997).
It seems likely that the delay in expression of Crx in the o /  retina and a 
consequent delay in expression of other photoreceptor-specific genes disrupts 
outer segment morphogenesis and leads to the abnormal outer segments seen 
in the o /  retina.
The disruption in the Crx-dependent pathway caused by the absence of 
ChxIO suggests that there is an interaction between these two genes. The fact 
that onset of Crx expression is delayed, rather than completely absent, 
indicates that ChxIO does not directly regulate Crx expression, but is a key 
factor in the temporal regulation of expression of this gene.
Both ChxIO and Crx are homeobox transcription factors. This suggests 
that they are capable of dimerizing with each other (Wilson et al. 1993), or that 
one regulates gene expression by binding to the other’s 5’ promoter as a 
possible mechanism for interaction. However, data suggest that these two 
nuclear bound proteins are not expressed in the same cell at any stage 
(Burmeister at a i 1996, Furukawa et a i 1997). Other mechanisms for potential
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interactions could involve a signalling pathway, utilising as yet unidentified 
molecules. These potential mechanisms are investigated in the following 
chapter.
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C h a p t e r  5
In v e s t ig a t io n s  in t o  in t e r a c t io n s
BETWEEN CHXIO AND CRX 
DURING RETINAL DEVELOPMENT
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5.1 Introduction
Data presented in Chapter 4 indicate that in the absence of Chx10, expression 
of the photoreceptor-specific transcription factor gene Crx is delayed by up to 
seven days. No evidence has yet been presented that suggests that these two 
genes ever co-express within the same cell, although their domains of 
expression overlap during development (Burmeister et al. 1996, Furukawa et al. 
1997, Chapter 4, Figure 4.5). Indeed, the current understanding, based 
predominantly on expression data, is that Crx is only present in developing 
photoreceptors (Furukawa et al. 1997), and limited cells within the inner nuclear 
layer (Bibb et ai. 2001), although these cells remain unidentified. By contrast, 
C hx io  is expressed in mitotic retinal cells, and postmitotic bipolar cells. 
Therefore, the data presented in this thesis is somewhat surprising, that in the 
absence of ChxIO, expression of a photoreceptor specific gene is disrupted. 
Given that both of these genes encode nuclear transcription factors there are 
two alternative possibilities as to how this delay in Crx expression could be 
explained. One is that ChxIO controls the instigation of Crx expression within 
photoreceptors indirectly through signalling pathways from nearby cells. The 
second possibility is that a direct interaction between ChxIO and Crx is involved
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in photoreceptor development. For example, if Chx10 and Crx are transiently 
coexpressed in a progenitor cell, which has not yet started to differentiate as a 
photoreceptor, one might postulate an interaction where Chx10 directly 
regulates Crx expression by binding to its promotor, or where a Chx10-Crx 
p rote in-protein interaction is required for photoreceptor development.
There is some evidence to support the existence of a cell that may co­
express C hx io  and Crx. Cepko et al, (1992) demonstrated the presence in 
culture of a postmitotic cell that was fated to express the photoreceptor marker 
rod opsin, whose fate could be altered by the addition of the secreted signalling 
molecule ciliary neurotrophic factor, (CNTF) to that of a bipolar cell, shown by 
expression of the cell specific marker PKC. In the adult retina, Chx10 is 
expressed strongly within bipolar cells, and therefore may have a role in bipolar 
cell fate and differentiation (Liu et ai. 1996). One possibility is that the re­
specified bipolar cells maintain or re-instigate Chx10 expression as a result of 
exposure to CNTF, and thus the photoreceptor differentiation pathway is 
blocked, and bipolar cell differentiation occurs. To test the hypothesis that Crx 
and C hx io  interact directly in vivo, I chose to investigate the possibility of the 
existence of a cell in which Crx and ChxIO could both be identified 
simultaneously in vitro.
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5.2 Immunolocalisation of Crx and ChxIO
The expression patterns of both Crx and Chx10 at E13.5 and E18.5 indicate 
that they are expressed within the same domain (see Chapter 4, Figures 4.3 
and 4.4). However, the re s ^ tfo n  of the in situ hybridis^qn__data is not 
sufficiently high to demonstrate co-expression within the same cell. By P2, the 
developing photoreceptors in the outer retina no longer express ChxIO (Figure 
5.1). The aim of this section was to investigate whether any cells during 
development were Crx-positive and mitotic, and by extrapolation were ChxIO- 
positive also.
In order to analyse the localisation of Crx and ChxIO in single cells, 
newborn (PO) wild-type retinae were dissected and mechanically dissociated 
into a single cell suspension in LI 5 medium, and transferred to 24 well culture 
plates, containing poly-L lysine coated coverslips (see Chapter 2, Methods for 
details). PO pups were chosen because of availability, and as this point is close 
to the peak of rod genesis (Young 1985), and therefore a maximal number of 
putative co-expressing cells would be found. When these retinal cells had 
adhered to the coverslips, cells were either fixed or not, and 
immunocytochemistry was performed, using antibodies to ChxIO, Crx, and to 
the cell proliferation markers PCNA and the phosphorylated histone H3 
(Vermuru et ai. 1992), individually and in certain combinations as double 
labelling. Two markers of proliferation were used to complement the secondary 
antibody used in double labelling experiments, i.e. PCNA was raised in mouse.
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ChxW
Figure 5.1. C/?x70 expression at P2. (a) shops H and E stained postnatal (P) 
day 2 retinal section, (b) Expression of Chx10 by in situ hybridisation shows 
that cells on the outermost layer are now no longer Chx70-positive, 
suggesting that they are differentiating as photoreceptors. Scale bar: 100pm.
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and H3 in rabbit, so H3 could not be used together with Chx10 or Crx, as these 
were both antibodies also raised in rabbit. Cell vitality and integrity was 
observed using the Hoescht nuclear stain (see Chapter 2, Methods).
Two Crx antibodies were used and these were raised to recognise part of 
the homeodomain and the N-terminus, respectively (provided by Cheryl 
Gregory-Evans, Imperial College, London). Before using for immunostaining on 
dissociated retinal cells in culture, these were tested by Western blotting using 
mouse retinal tissue, and showed binding to a protein of ~37kDa (Figure 5.2) 
(Bibb et al. 2001). Incubation with pre-immune serum did not detect this band. 
Higher affinity was observed in the homeodomain-specific antibody, and 
therefore this one was used in subsequent experiments. Immunolocalisation 
with the homeodomain-specific antibody was performed on adult paraffin 
embedded sections of mouse retina. Staining was seen in the bipolar layer 
(Chxio), and the outer nuclear layer (Crx) (Figure 5.3), both confirming 
published data (Liu at al. 1994, Furukawa ef a/. 1997).
Immunocytochemistry on dissociated PO retinal cells identified ChxIO-, H3- 
Crx- and PCNA-positive cells. Cells expressing ChxIO, H3, PCNA and Crx were 
each shown to be a proportion of the total number of cells (representative fields 
of view shown in Figures 5.4, 5.5, 5.6 and 5.7, respectively). Antibody and 
Hoescht staining have been superimposed to give a different colour. In Figure 
5.4, -50%  of the total number of cell (n=64) in this field are expressing ChxIO. 
In Figure 5.5, -36%  of the total number of cells (n=70) are expressing H3. In
181
116-
97.4-
66 .2 -
45-
37 -
31-
21.5-
14.4-
Figure 5.2. Western 
blotting to show 
antigen-specific affinity 
of antibodies raised 
against Crx 
homeodomain (hom), 
and Crx N- terminus (- 
N). Dilutions of primary 
antibody are indicated. 
The numbers indicate 
the size of each 
fragment in kOa, from a 
marker (not shown). 
Low-molecular-weight 
proteins are likely to be 
degradation products.
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Figure 5.3. Immunolocalisation of ChxIO and
Crx to the inner (ini) and outer (onl) nuclear 
layers of the adult mouse retina, respectively. 
These data, combined with immunoblotting 
(Figure 5.6) confirmed the specificity of the ChxIO 
and Crx antibodies. Scale bar: 100pm.
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Figure 5.4. Immunocytochemistry of ChxIO to PO 
retinal cells. Fluorescent staining of the vital marker 
Hoescht (blue), and ChxIO (red) shows that a proportion of 
retinal cells are expressing ChxIO at P2. The red arrow is 
indicating a cell which is both Hoescht- and ChxIO- 
positive, whereas the green arrow shows a cell which is 
Chx10-negative.
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Figure 5.5. Immunocytochemistry of H3 to PO retinal 
ceils. Fluorescent staining of the vital marker Hoescht 
(blue), and H3 (red) shows that a proportion of retinal 
cells are dividing at PO. The red arrow is indicating a cell 
which is both Hoescht- and H3-positive, whereas the 
green arrow shows a cell which is H3-negative.
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Figure 5.6. Immunocytochemistry of Crx to PO retinal cells.
Fluorescent staining of the vital marker Hoescht (blue), and Crx 
(red) shows that a proportion of retinal cells are expressing Crx 
at PO. The red arrow is indicating a cell which is both Hoescht- 
and Crx-positive, whereas the green arrow shows a cell which 
is Crx-negative.
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Figure 5.7. Co-localisatlon of ChxlO and PCNA by 
Immunocytochemistry In PO retinal cells.
Fluorescent staining of the vital marker Hoescht (blue), 
and C hxio (green) shows that a proportion of retinal 
cells are expressing ChxlO at PO. PCNA (red) 
immuno-fluorescence shows that all PCNA-positive 
cells are also Chxl 0-positive, but some Chxl 0-positive 
cells are not PCNA-positive. The red arrows indicates 
a cell which is Hoescht-, ChxlO- and PCNA-positive, 
whereas the green arrows show a cell which is ChxIO- 
positive but PCNA-negative. White arrows indicate 
cells which are positive for neither ChxlO or PCNA, 
but are Hoescht stained.
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Figure 5.6, Crx expressing cells make up -24%  of the total number (n=84). In 
Figure 5.7, PCNA immunostaining labelled -30%  of cells.
Double labelling with PCNA and ChxlO (Figure 5.7) indicated that a subset 
Chx10-positive cells expressed PCNA. This exemplifies dual roles of ChxlO in 
the developing retina, in that the Chx10-positive/PCNA-positive cells are 
dividing cells, whereas the Chx10-positive/PCNA-negative are presumed to be 
postmitotic cells. No Chx10-negative/PCNA-positive cells were observed in 
separate independent experiments (n=2). The postmitotic Chx10-positive cells 
are likely to be developing bipolar cells, as bipolar cell genesis is underway by 
PO. However, without co-labelling with a bipolar specific marker, these cells 
could represent other post-mitotic cells.
Several attempts were made to co-label cultures with antibodies to Crx 
and C hxio. Both antibodies were raised in rabbits (Bibb et al. 2001, Jessel et 
ai. 1998), ruling out the possibility of straightforward double immunolocalisation, 
as a secondary anti-rabbit antibody would not be able to distinguish between 
the two primary antibodies.
The Crx antibody was conjugated with biotin to use in double labelling 
experiments with ChxlO antibody (see Chapter 2, Methods), to enable a 
separate detecting system. However, immunolabelling proved fruitless with the 
biotinylated antibody as it resulted in non-specific background staining. (Figure 
5.8).
Double labelling was performed with Crx and PCNA, and these were 
shown to never co-localise (n=2) (Figure 5.9). Therefore, Crx is confirmed as
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Figure 5.8. Attempted Immunolocalisation of ChxlO 
(red) and blotlnylated-Crx (visualised with HRP-DAB) 
resulted in weak signal that sometimes did not colocalise 
with Hoescht staining, indicating that it was false positive. 
This technique was not pursued further.
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Hoescht/Crx/PCNA^
Figure 5.9. Crx and PCNA do not co­
localise by Immunocytochemistry In PO 
retinal cells. Fluorescent staining of the vital 
marker Hoescht (blue), and Crx (green) shows 
that a proportion of retinal cells are expressing 
Crx at PO. PCNA (red) immuno-fluorescence 
shows that no PCNA-positive cells are Crx- 
positive. The red arrows indicates cells which 
are Hoescht- and PCNA-positive, whereas the 
green arrows show cells which are Crx- 
positive. White arrows indicate cells which are 
positive for neither Crx nor PCNA. 189
not being present in cells that are dividing, at least in these culture conditions. 
These data have not found any-support for the hypothesis that ChxlO and Crx 
^ 4 d c a lis e  within the same cell. Thus any direct interaction, whether it be 
p rote in-protein or protein-DNA, seems unlikely.
One possibility that has not been ruled out here is that the cells that are 
Chx10-positive and PCNA-negative are in fact postmitotic photoreceptors, 
which were expressing Crx.
5.3 Cell-cell interactions of ChxlO and Crx
The possibility of an indirect interaction between Crx and ChxlO was 
investigated using a dissociated retinal cell culture system, based on the 
hypothesis that a secreted factor(s) causes the upregulation of Crx in 
presumptive photoreceptors, and this factor was absent in the o /  retina.
5.3 .1 Retinoic acid cultures
Kelley et ai. (1994, 1995) investigated the effect of the vitamin A derivative 
retinoic acid (RA) upon retinal cells in culture, based on the knowledge that all- 
trans RA was capable of altering cell fate decisions in the developing limb bud, 
hindbrain, and inner ear (Altaba and Jessell 1991, Kelley et al. 1994). RA has 
been shown to be important in a number of different aspects of eye 
development. All-frans RA and at least one of the RA receptors, RARa, have
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been shown to be present in the developing retina (Drager et al. 2001). 
Furthermore, double knockout mice with targeted deletions in both RARa and 
RAR/5 display retinal hypoplasia and a shortening of the ventral retina 
(Ghyselinck et a/. 1997). Kelley and colleagues (1994) added aW-trans RA at a 
concentration between 10 and 500nM to culture media that contained 
dissociated retinal cells from either E l5 or E l8 rats. In these cultures, 
disproportionately high numbers of rod photoreceptors differentiated from 
precursor cells, sometimes at the expense of bipolar cells. Their conclusions 
included that RA acted directly on a proportion of mitotic progenitor cells to 
steer their fate towards that of a rod photoreceptor, identified by 
immunocytochemistry with an antibody raised against rhodopsin.
In this study, I used a similar system to test whether aW-trans RA was a 
factor capable of inducing expression of Crx in o /  retinal cultures, at a time 
point when these cells were not expressing Crx, but wild-type cells were. Kelley 
et a/.’s (1994) use of rhodopsin as a marker for photoreceptor fate is in line with 
this test, as data presented here have already demonstrated that rhodopsin 
expression is similarly delayed to that of Crx in the o /  retina.
A culture system was used as described in Chapter 2, Methods, where 
dissociated E l4.5 o /  retinal cells were cultured with Dulbecco’s modified eagle 
medium (DMEM) for 48hrs on laminin and poly-L-lysine coated coverslips, this 
time with the medium containing lOOnM aW-trans RA. Previous studies have 
found that concentrations of SOOnM have cytotoxic side effects (Kelley et ai. 
1994). Control experiments were carried out, with o /  cells being simultaneously
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cultured without RA. Cells were checked after 6, 24 and 48 hours (Figure 5.10), 
by which stage, some cells had developed cellular processes. After 48hrs, cells 
were harvested for immunocytochemistry using an antibody for Crx.
Although cell survival was low in o /  retinal cultures, Crx expressing cells 
were detected by immunocytochemistry (Figure 5.11) in independent 
experiments (n=2), some of which displayed cellular processes, indicating that 
some level of differentiation had occurred. Untreated controls, or those with 
added DMSO but no RA showed no Crx immunoreactivity. These data suggest 
that addition of aW-trans RA to culture medium was capable of inducing Crx 
expression in o /  retinal cells. Figure 5.12 shows immunoreactivity to Crx of 
wild-type cells cultured in untreated medium
5.3.2 Co-culture of wild-type and cells
Two other approaches were used to examine induction of Crx expression, and 
to increase cell survival in o /  retinal cultures.
Based on the hypothesis that wild-type retinal neuroblasts are secreting 
RA, which is capable of inducing the expression of Crx in presumptive 
photoreceptor cells, but is absent or delayed in the mutant retina, retinal cells of 
these two genotypes were grown together in culture, under the possibility that 
RA or other signalling moleculeswas then introduced into the mutant cells. As 
these two genotypes are indistinguishable when dissociated, in vitro Corning 
Transwells were used to keep the two genotypes separate. This system allows 
the transfer, mediated by the size of the filter, of molecules between cells.
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48hrs
Figure 5.10. Morphology of El 4.5 
retinal cells after 0 and 48hrs cultured 
in medium containing lOOnM retinoic 
acid (RA). The left hand column shows 
wild-type cells after Ohrs and 48hrs. After 
48hrs in culture, cells have proliferated, 
and many cell projections can be seen. 
After 48hrs, mutant cells have not 
proliferated, although cell projections can 
also be seen, indicated with arrows.
48hrs 4 '  r" • V.V ' }
193
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Hoescht/Crx
Figure 5.11. Immunoreactivity for Crx on E l4.5 oH 
retinal cells cultured for 48 hrs In medium with lOOnM 
retinoic acid (RA). A small proportion of mutant cells 
expressed Crx, indicating that RA is capable of inducing 
Crx expression in the absence of ChxlO. Cells cultured in 
medium without RA did not express Crx (data not shown). 
The digital combination of the blue Hoescht-stained and 
red Crx-stained cells gives a mauve colour (white arrows).
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Hoescht
Hoescht/Crx
Figure 5.12. Immunoreactivity for Crx on El 4.5 wlld- 
type retinal cells cultured for 48 hrs In untreated 
medium. These data demonstrates that the Crx antibody 
immunostains a proportion of wild-type cells after 2 days 
in culture. Digital superimposition of the blue Hoescht- 
stained and red Crx-stained cells gives a mauve colour 
(white arrow).
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without actually mixing the cells. E14.5 wild-type cells were harvested as 
described in Chapter 2, Methods, and allowed to adhere to coated coverslips in 
F12 DMEM medium. E14.5 o /  cells were also dissected in the same way and 
allowed to stick down to the Transwell membrane, with a filter size of 0.4|Lim. 
Repeated attempts of this method failed to generate cells that lived for 48hrs, 
and the medium was always full of cell debris, indicating the presence of dead 
cells. Therefore, this experiment was not pursued.
5.3.3 Conditioned medium
The second method used to increase the survival of o /  cells in culture was to 
culture mutant cells in medium that had been exposed to wild-type retinal cells 
(“conditioned medium").
Wild-type retinal cells were dissected from E12.5 mouse embryos and 
cultured with DMEM and 10% foetal calf serum, as described before, at a 
density of -400 cells per Ipl. After 48hrs the medium from these cultures was 
collected, and added to an equal volume (200|il) of fresh DMEM. E l4.5 retinae 
were dissected from o /  mice, and prepared as described above, and were 
incubated in the half-conditioned, half-fresh medium for 48hrs. Cells were 
observed and photographed after 4, 24, and 48hrs (Figure 5.13) to check their 
health, and differentiation status. After 48hrs, cells were harvested for 
immunocytochemistry.
Immunocytochemistry was performed as described previously, with 
antibodies to detect Crx. Effectively, these cell cultures were o /  retinal at E l 6.5,
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48hrs
Figure 5.13. Morphology of E l4.5 or^ 
retinal cells after 0 and 48hrs culture in 
conditioned medium. A small proportion of 
mutant cells displayed cellular processes, 
which are consistent with differentiation, 
indicated with arrows.
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so, according to the data presented earlier (Chapter 4), would not be 
expressing Crx. Many of the cells displayed cellular processes (Figure 5.13), 
possibly indicating that cellular differentiation was progressing in these cultures. 
This is in agreement with the earlier data (Chapter 4.6), which showed that 
other photoreceptor genes were not delayed in their expression, and that only 
the Crx-dependent pathway was affected by the mutation in ChxW. In these 
cultures, where E l4.5 o /  retinal cells had been cultured with wild-type- 
conditioned medium, cells expressing Crx were detected (Figure 5.14). This 
indicates that a secreted factor(s) induces Crx expression, and that it is not 
present in o /  retinae. Control experiments in which o /  were grown in medium 
which had not been exposed to wild-type cells, but had been treated in the 
same way (i.e. kept at 37°C for 48hrs, and diluted by half with fresh medium) 
did not show Crx immunoreactivity after 48hrs (data not shown).
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Figure 5.14. immunoreactivity for Crx on El 4.5 oH 
retinal cells cultured for 48 hrs in conditioned medium.
A small proportion of mutant cells expressed Crx, which 
indicates that a factor (s) in the medium was capable of 
inducing its expression despite the absence of ChxIO.The 
digital superimposition of Hoescht-stained (blue) and Grx- 
stained (red) cell gives a mauve colour (white arrow).
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5.4 Discussion
In the developing o /  retina, the molecular cascade that regulates the timing of 
Crx expression is defective. This fact invites the possibility that Chx10 and Crx 
interact during development, and that this interaction is disrupted in mutant 
retina. No evidence was found to support the hypothesis that Chx10 and Crx 
interact directly. All existing data indicates that these two are not co-expressed 
in the same cell at any stage of retinal development, leaving the possibility of a 
regulatory pathway that involves extrinsic factors.
Data presented here indicate that a factor, secreted by wild-type retinal 
cells at E12.5-14.5 is indeed capable of inducing Crx expression in cells in 
which it is absent, and that factor may be aW-trans RA. The conditioned medium 
(5.3.3) itself was not examined to see whether it contained aW-trans RA or not, 
but it is attractive to conclude that the unknown factor in the conditioned 
medium was in fact aW-trans RA. Control experiments where o /  cells were 
grown in medium which neither was conditioned, nor contained RA showed that 
induction of Crx expression was not an artefact of culturing these cells in DMEM 
with PCS, and conversely, Crx immunoreactivity was detected in E l4.5 wild- 
type cells cultured without treatment (Figure 5.12).
Difficulties with these experiments included the low level of cell survival 
for o /  cells in culture, regardless of the various combinations of medium used. 
The low levels of cell survival may reflect a number of factors, including the 
intrinsic lack of ChxIO, as well as the very low numbers of cells in the o /  retina.
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and therefore difficulty in culturing these cells in densities that mirrored that of 
the wild-type cells.
The fact that control cultures of wild-type cells showed survival, 
proliferation and apparent differentiation under the same culture conditions 
indicates that fragile nature and low survival is a property of the o /  cells. It will 
be important in future experiments to try a variety of different culture conditions 
including the addition of other growth factors to try to increase survival, 
proliferation and differentiation of the o /  cells in culture. This approach may 
provide a useful strategy for identifying conditions needed to promote 
photoreceptor development and proliferation from retinal progenitor cells.
Analysis of patterns of gene expression using in situ hybridisation of 
tissue sections has provided useful insights into the impairment of 
photoreceptor development in the o /  retina. Efforts to analyse photoreceptor 
development in vitro in dissociated cell culture have been hampered by low cell 
numbers and low survival, possibly caused by the reduced proliferation of o /  
cells compared with wild-type retinal cells. An alternative strategy for future 
experiments could be the use of explanted whole o /  retinae. This approach 
would provide increased cell contact, which may allow an increased survival 
rate for o /  cells.
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C hapter 6
Identification and characterisation
OF A NOVEL CHXIO-LIKE CDNA
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C h a p t e r  6
Id e n t if ic a t io n  an d  c h a r a c te r is a t io n  o f  a  n o v e l  C h x io - l\k e  cDNA
6.1 Introduction
At the onset of this thesis, a human homologue of the murine gene Chx10 had 
not yet been identified or cloned. A search was instigated using the resources 
of the various genome databases available through the Internet for human DNA 
sequences that contained significant levels of identity to the mouse ChxW  
sequence. This involved using the programs available at the National Centre for 
Biotechnology Information (NCBI) (http://www.ncbi.nlm.nih.gov/), predominantly 
the various BLAST (basic local alignment search tool) tools (Altshul et a i 1990).
6.2 Identification of ESTs containing novel cDNA sequence
Using the 3.089kb sequence of mouse ChxIO cDNA (accession number 
L34808) as a search string in the basic BLAST program, covering all databases, 
identified several genes in different species which have been shown to be 
structural and functional homologues in diverse species. These include Vsx1 
and Vsx2 from both the goldfish Carassius auratus (Levine et a i 1994, 1997) 
and zebrafish Danio rerio (Passini et a i 1998). Restricting the database 
searches to human sequence results in the identification of a number of cDNA
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sequences that show high levels of sequence identity to mouse ChxIO over 
short fragments. These include a 30 bp stretch of 96% identity within the ChxIO 
3 ’ untranslated region (UTR) to an unidentified fragment of genomic DNA, and 
several stretches of 90^% identity over less that 30bp to the coding sequence of 
several homeobox genes including Phox1, PMX1, SHOXa and b and Nkx6.1. 
Given the high level of sequence conservation in the DNA binding domain 
between homeobox genes in general, these results are not surprising, and the 
significance of these regions of identity is not high enough to regard these 
genes as homologues of murine ChxIO. Further restricting these searches to 
the database dbEST, which only contains human expressed sequence tags 
(ESTs), produced rather more limited results. A fragment showing 92% 
sequence identity over 520bp from a Stratagene ovarian cancer cDNA library 
has highest significance, although the region on where this identity lies is
from 2135-2197bp, and therefore lies within the ChxIO 3' UTR. Therefore, this 
was not considered for further investigation. Also significant was a 94% identical 
stretch of DNA identified as being from the human gene CART1. However, like 
ChxIO, CART1 is a pa/red-type homeodomain protein (Cai 1998), and this short 
stretch of sequence identity lies within ChxW ’s homeobox, which is heavily 
evolutionarily conserved. Furthermore, this EST was generated from a colon 
cDNA library, where ChxIO is not known to be expressed. Therefore this result 
did not warrant further investigation.
An 82% stretch of sequence identity with an expected value of 3e"^ over 
a 107bp region from an EST (H87757) was identified in this BLAST result (see
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Figure 6.1), indicating a highly-related sequence. This identity ran from 433- 
545bp on ChxW. The homeobox of ChxW  runs from 442-622bp, indicating that 
this sequence identity is almost exclusively within the homeobox. This EST was 
from an adult retinal cDNA library made from the RNA of a 55-year-old 
Caucasian man. As this cDNA was expressed in the retina it was investigated 
further as a candidate for the human homologue of ChxW, or a closely related 
gene. The total length of the EST H87757 was 264bp. However, significant 
numbers of “N” nucleotides were present in the last 50bp, which are unknown 
nucleotides caused by sequencing errors. Therefore the sequence was only 
reliable for 216bp. This sequence translates into a predicted protein with an 
open reading frame (ORF) from 1-230nt, and appears to encode an incomplete 
prof-type homeodomain from 100-222nt (see Figure 6.2). However, no 
significant nucleotide or protein identity with mouse ChxW  was observed 
outside of the putative homeodomain, suggesting that this cDNA represented a 
novel prof-type homeobox gene, rather than the human CHXW  homologue.
In order to generate more sequence for this cDNA, the EST H87757 was 
used to search the dbEST database using the BLAST algorithm (Altschul et al 
1990) (“BLASTed”) (http://www.ncbi.nlm.nih.gov/BLAST/). This identified 
another (362bp) EST from the same retinal library (H87056), which showed 
90% sequence identity with H87757 over a llO bp  stretch from 252-362bp. 
Although these ESTs are directionally cloned into specialised vectors, H87056 
shared sequence identity in the reverse orientation to H87757 (see Figure 6.3). 
Because of the high level of sequence identity, the two ESTs were assumed to
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Expect = 3e'°^ , Identities = 88/107 (82%)
ChxIO 433 aagcgtaagaagcggcgacacaggacaatctttacttcctaccagctagaggagctggagaaagca 498 
EST 100 aagaggaagaagcggcggcacaggacagttttcactgctcaccagctggaagagttggagaaggca 165
ChxIO 499 ttcaatgaagcccactacccagatgtctacgcccgggagatgctggc 545 
EST 166 ttcagcgaggcccactaccctgatgtgtatgcccgagaaatgctggc 212
Figure 6.1. BLAST output following searching dbEST using the murine ChxIO sequence as a search string.
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Figure 6.2. Comparison of the predicted amino acid sequences of various prd-type homeodomalns, including the putative 
translation of the novel EST cDNA. Green shading indicates conservative changes, boxes indicate identity.
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Figure 6.3. Diagram showing the ESTs displaying regions of sequence identity to ChxIO identified by BLASTing murine 
C/urf(7 sequence through the dbEST database. EST H87757 showed a 78% sequence identity to a 164bp stretch of ChxIO, 
while EST H87056 showed a 90% sequence identity to a 1 lObp stretch of H87757. Sequence comparison indicates that these two 
ESTs represent the same cDNA species, and both are derived from the same adult retinal library. Slate-blue lines indicate the 
position of the cDNA primers (forward, F, to the left); red lines indicate the positions of the Genomic primers (forward, F, to the 
left).
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be representative of the same cDNA species. H87056 predominantly only 
shared sequence identity with ChxW  over the regions that it shared sequence 
identity with H87757. No ORF could be seen in either the forward or reverse 
orientation, and certainly no sequence identity with sequence of ChxW. 
Aligning these two ESTs and forming one sequence generated a 507bp 
fragment of putative cDNA, which encodes a putative 76 amino acid residue 
polypeptide, including a partial prof-type homeodomain (47 out of 60 residues, 
which is equivalent to -90%), but no further ORF (see Figure 6.2). These two 
EST containing clones were obtained from the Human Genome Mapping 
Project as Escherichia coli plasmids, and were amplified and prepared in the 
standard way (see Chapter 2, Methods). Sequencing both of them failed to 
generate any further sequence, as the two clones overlapped considerably. It 
did however correct some of the database sequence, but not significantly 
enough to alter the identity comparisons presented above.
Three possibilities presented themselves at this point in the analysis;
1) The cDNA sequence represents a novel gene, which encodes a truncated 
homeodomain protein. This seemed unlikely, as no truncated homeobox 
proteins have yet been reported, and the last 10 amino acid residues of the 
homeodomain are heavily evolutionarily conserved (Purugganan 1998).
2) The cDNA represented a transcribed, but untranslated, non-functional 
pseudogene.
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3) The sequence identity between the novel Chx10-like cDNA sequence and 
ChxW  diverges in the last 13 amino acid residues in the homeobox (nt 579 
in ChxW). At this point the ORF in the novel cDNA terminates. The 
equivalent point in mouse ChxW  represents the junction between exons 3 
and 4 in the genomic sequence. Therefore it was possible that the retinal 
cDNA library from which these clones originated was contaminated with 
unspliced RNA, and that this divergence represented an intron.
It is worth noting that an EST containing a fragment of a recently published 
novel gene, Vax1, was derived from the same retinal cDNA library, and certainly 
did contain intronic sequence (Jim Bellingham, personal communication, 
Hallonet et al. 1998), indicating that this library may be contaminated with 
unspliced RNA. Therefore this reinforced the notion that the cDNA represented 
a genuine homeobox gene. The insignificant levels of sequence identity outside 
the homeobox, coupled with the amino acid sequence identity within the 
homeobox being only 90% for the 47 encoded amino acids lead to the 
conclusion that this cDNA represented a novel gene, and not the human 
homologue of ChxW. This was confirmed when a plasmid containing the 
human CHXW  gene was kindly provided by Rod Mclnnes for comparison. 
Sequence analysis indicated that the amino acid identity between CHXW  and 
its murine homologue was 97% over the whole gene (Ferda-Percin et al. 2000), 
which is higher than the sequence identity of the novel cDNA sequence.
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Sequence comparison thereby confirmed that he novel cDNA was not human 
ChxIO.
6.3 The novel cDNA EST clones contain genomic sequence
A PCR based strategy was used to determine whether the non-ORF sequence 
in the E S I was in fact genomic, intronic DNA. Two sets of primers were 
designed (see Figure 6.3 and 6.4), one pair that amplified a fragment solely 
from the putative ORF (dubbed cDNA primers), and another pair that flanked 
the putative intron-exon boundary (called genomic primers). PCR amplification 
was performed using adult human retinal cDNA generated from reverse 
transcription using RNA extracted from an adult retina. The genomic primers 
failed to generate a PCR product, whereas a PCR product of the predicted size 
was generated using the cDNA primers. These data suggest that the sequence 
to which the reverse genomic primer annealed (see Figure 6.3 and 6.4) was not 
present in the adult retinal cDNA, leading to the conclusion that it was genomic 
DNA, and the non-ORF sequence from the ESTs was indeed intronic. A positive 
control, demonstrating that the genomic primers successfully amplified a 
fragment of the predicted size from genomic DNA is shown in Figure 6.8.
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Figure 6.4. Scheme (a) for and results (b) showing a demonstration by 
PCR that EST containing clone contains unspliced genomic DNA, using 
adult retinal cDNA. Primers which flanked the putative intron/exon boundary, 
known to amplify a PCR product from the E S I containing clone, would not 
amplify a product from adult retinal cDNA, indicating that this clone contained 
DNA which was not transcribed.
211
6.4 PCR-based amplification of novel cDNA
Primers were designed which were within the ORF of the novel cDNA 
sequence. These were used initially to determine whether a fragment of this 
cDNA could be amplified from various cDNA libraries, and also to determine 
using RT-PCR an expression profile for this putative novel Chx10-like gene.
Figure 6.5 shows that a 200bp fragment could be amplified from adult 
human retinal cDNA library (a generous gift from Jeremy Nathans) (this library 
was divided up into clones of length shorter than 1kb and more than 1kb, and 
the amplification was successful on both). Furthermore a band was amplified 
from an E15.5 retinal mouse cDNA library. No band was amplified from human 
adult genomic DNA. This is perhaps not surprising; the primers were designed 
to flank two intron/exon boundaries (see Figure 6.3, and 6.5) that are heavily 
conserved amongst a number of prof-type homeodomain genes. Introns 2 and 3 
in ChxW  (which is most similar in sequence to the novel cDNA) are both over 
6kb in length, and therefore amplifying a fragment of DNA from genomic 
template would not be possible with these two primers, assuming that the 
genomic structure of this novel gene was similar to that of ChxW.
Based on the assumption that this novel cDNA was represented by 
clones in the various retinal libraries available, an “anchored” PCR strategy was 
employed to generate more sequence for this cDNA (see Figure 6.6). This 
method was unsuccessful using the human and mouse cDNA libraries on many 
attempts, despite the observation of a consistent pattern of PGR products when
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Figure 6.5. Novel cDNA is a genuine transcript. Using primers designed to the 
ORF of the putative novel cDNA, fragments were amplified from an adult retinal 
cDNA library, and a mouse El 5.5 retinal library. No band was detected using 
genomic human DNA as a template.
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Figure 6.6. (a) Scheme for amplifying further sequence of novel cDNA 
from retinal cDNA library sources, using “anchored” PCR. EST specific 
primers were used in combination with vector specific primers to amplify 
fragments of the novel cDNA present in the E15.5 mouse retina cDNA library. A 
1kb PCR product was consistently amplified (b) using the F sequence primer 
and the 5’ vector primer. This product was excised from the gel and cloned into 
the plasmid vector pGEM T-easy (c) for sequencing.
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performing this on the mouse E15.5 retinal library (see Figure 6.6). Of particular 
interest was a 1 kb fragment using the F cDNA primer and the 5’ vector primer, 
but upon cloning and sequencing it using the ABI 373 sequencing kit the clone 
showed no similarity to the known sequence of the novel cDNA, other that a 
fortuitous 15/20 stretch which corresponded with the sequence of the primer 
itself. Conventional library screening attempts were not successful, and it was 
concluded that the novel Chxl 0-like cDNA was either not present or present at 
very low levels in the human retinal library. Sequence differences between the 
mouse and human Chxl 0-like cDNAs may have also hampered isolation from 
the mouse library.
6.5 Tissue specific expression profile of novel cDNA
Using the primers designed to anneal to the CRF of the EST sequences 
described above, a tissue specific expression pattern was generated by RT- 
PCR. RNA was extracted (see Chapter 2, Methods) from the following human 
tissues: adult retina, 12wpc whole eye, l lw p c  retina, embryonic brain, heart, 
kidney, limb, liver and spinal cord. RNA from these tissues was quantified and 
used as template for cDNA synthesis by reverse transcription. PCR was 
performed on cDNA from each of these tissues. Figure 6.7 shows that a strong 
PCR product was observed from the adult retina and very faint bands in the 
12wpc eye and 11 wpc retina. A PCR band was not detected in any other tissue
215
Intron/exon
boundary
cDNA F
Putative intron
------------ h
I
c D ^  r !
Known sequence
<6
I
? /
1
1 / /
I / / /
i* i-
Figure 6.7. Expression profile of novel cDNA by RT-PCR. A strong band of the predicted size was 
observed, amplified from oDNA synthesised from RNA extracted from adult retina. Faint bands were seen in 
the 12wpc eye and 11 wpc retina extracts, but not in any other tissue examined.
ro
examined. Both ESTs were from an adult retinal cDNA library, and were not 
represented in any other EST library on dbEST. These results suggest that the 
novel cDNA is an eye-specific transcription factor, which may have a role in eye 
development, but is strongly expressed in the adult retina.
6 .6  C h ro m o s o m a l m app ing
PCR primers that were specific to the genomic sequence (as described above, 
see Figure 6.4) were used to map the novel cDNA to a human chromosome 
(see Figure 6.8). A set of individual human chromosomes generated by somatic 
cell hybrid with either hamster or mouse cells was obtained from the Human 
Genome Mapping Project. These pools were used as templates for PCR. A 
PCR product was only detected from the chromosome 20 pool, and the total 
human pool, indicating that the novel cDNA is located on human chromosome 
20. No fragments were amplified from either genomic hamster or mouse DNA 
indicating that the band for human chromosome 20 was indeed amplified from 
the human DNA and not the host cell genome.
There are several eye diseases that map to chromosome 20, including 
congenital hereditary endothelial dystrophy (CHED) and posterior 
polymorphous dystrophy (PPD) (Semina et al. 2000). This novel cDNA may 
stand a candidate for one such disorder.
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Figure 6.8. Scheme (a) and results (b) of PCR 
on somatic cell hybrid screen to map novel 
cDNA to a human chromosome. A band of the 
predicted size is present in the Chromosome 20 
pool and the total human pool, indicating that the 
novel cDNA maps to human chromosome 20. F/R 
represent forward and reverse PCR primers 
respectively. Numbers represent human 
chromosome pool. Abbreviations; C, control (no 
template): Hu, total human genomic; M, total 
mouse genomic; H, total hamster genomic.
6.7 Tissue localisation by in situ hybridisation
In order to determine the location of expression of the novel cDNA within the 
adult retina, in situ hybridisation was performed on human tissues at various 
stages of development. A ~200bp riboprobe was generated using the previously 
described method (see Chapter 2, Methods), and was incubated with paraffin 
embedded, paraformaldehyde fixed human eyes, as described previously.
As predicted by the RT-PCR experiments described above, where 
fragments of the novel Chx10-like cDNA could not be amplified from 
developmental eye tissue from 9 to 15 weeks pc, no in situ hybridisation was 
observed in foetal eyes or retina (data not shown). These two results taken 
together support the hypothesis that this novel cDNA is not expressed in the 
eye during development.
However, expression was detected in the inner and outer nuclear layers 
of the adult human retina. Within the inner nuclear layer expression appeared to 
be restricted to the outer aspect, i.e. the location of bipolar and horizontal 
interneurons (Hollenberg and Spira 1972), as demonstrated by CHX10 
expression (see Figure 6.9). Expression within the outer nuclear layer, 
conversely, indicates expression within photoreceptor cells, an observation not 
seen with CHX10, but seen here with the photoreceptor marker gene CRX. 
Furthermore, expression was only observed in adult tissue (bearing in mind the 
paucity of range of human developmental tissue, which is restricted to 9-15
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Figure 6.9. In s itu  hybridisation shows expression of Chx10-like  
cDNA  is within the inner (in!) and outer nuclear (on!) layers of the 
adult human retina. By contrast, C HX10an6 CRX  are expressed 
exclusively in the inner and outer nuclear layers, respectively, rpe, 
retinal pigmented epithelium; os, outer segments; is, inner 
segments; opi, outer plexiform layer; ipl, inner plexiform layer; gel, 
ganglion cell layer. Scale bar: 100pm.
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weeks), in stark contrast to the expression of CHX10, which is strongly 
expressed in the developing retina (for comparison see Figures 3.2 and 4.5).
These data indicate that the Chx10-\\ke novel gene has a very distinct 
role from that of CHX10 in retinal biology. In the mouse, ChxIO is required for 
normal retinal development, and its developmental and maintained expression 
in bipolar cells indicates that it has a function in the development and 
maintenance neurons (Liu et aL 1994, Burmeister et al. 1996). Lack of detection 
by RT-PCR and by in situ hybridisation of the novel cDNA suggests that it is 
absent during development, and therefore is not required. Expression in the 
adult retina indicates that this gene may have a role in maintaining the function 
of the cells in which it is present, which, as observed by in situ hybridisation, 
appear to be bipolar cells and photoreceptors. As the novel cDNA almost 
certainly encodes a homeobox transcription factor, it seems likely that it 
regulates downstream targets that are involved in cellular function. Identification 
of these cell types needs to be confirmed by double labelling using known cell 
specific markers.
The identification of this putative novel transcription factor raises the 
strong possibility that it is a human retinal disease-causing gene. Of the retinal 
diseases that display Mendelian inheritance patterns, the majority involve 
degenerations of the photoreceptor layer, and these include the extensive 
group termed retinitis pigmentosa (RP) (Gregory-Evans and B h attach a rya 
1998). A transcription factor that regulates cellular function in photoreceptors is 
therefore a good candidate gene for the cause of a retinal dystrophy disorder.
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No RPs have been mapped to chromosome 20 however, so this gene is not 
immediately obvious as a specific candidate.
6.8 VSX1/RINX1
Since the discovery of the novel Chx10-\\ke cDNA reported here, two papers 
have been published which simultaneously identified the gene represented by 
this cDNA, and named it VSX1, given its similarity to the goldfish homologue of 
Chx10 (also called Vsx1) (Levine et al. 1997), The gene was cloned from a 
human embryonic craniofacial cDNA library (Semina et al. 2000) -  a tissue type 
not examined in this thesis -  and was shown to be a 1433bp cDNA, which 
encoded a predicted 365 amino acid homeobox transcription factor. The 
homeobox was demonstrated to be complete, and furthermore a complete CVC 
domain was also identified. The genomic structure was also characterised, and 
as predicted by results shown here, the intron-exon boundary within the 
homeobox was conserved with that of Chx10. These data suggest that the non­
coding sequence shown in the EST database is indeed contaminating genomic 
DMA or unspliced RNA. By contrast though, the total genomic structure of VSX1 
spanned a length of only 6.2kb, compared to over 30kb for Chx10 (Burmeister 
et al. 1996, Ferda-Percin et al. 2000). Chromosomal mapping also confirmed 
results presented here, and this region was narrowed to 20p11-q11. RT-PCR
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confirmed that expression was maintained in the adult eye, and was present in 
the developing craniofacial region.
The second study (Hayashi et al. 2000) identified the same Chx10-like 
protein by employing a yeast one-hybrid screen, using the locus control region 
(LCR) of human red and green visual pigment genes, which are exclusively 
expressed in cone photoreceptors. Hayashi et al. found VSX1 (which they 
named RINX1, for retinal inner nuclear layer homeobox) to be expressed only in 
the outer aspect of the inner nuclear layer of the adult retina (in contrast to 
results presented here, which reveal outer nuclear layer expression too). This 
study also further narrowed VSXVs chromosomal location to 20p11.2, with 
which no retinal disease has yet been associated. Interestingly though, Hayashi 
et al. showed that VSX1 encodes two splice variants, one of which lacks most 
or all of the homeodomain. How this splice variant behaves in vivo is unknown, 
and requires further investigation.
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One of the primary aims of the field of developmental biology, especially with 
the relatively recent integration of embryological, molecular biological and 
genetic techniques, has been the identification of the molecular determinants of 
cellular fate.
In recent years, much research has been devoted to the identification of 
determinants of cellular fate of the cells in the retina, a large proportion of which 
has come out of the laboratory of Connie Cepko (Harvard Medical School, MA 
USA) (Livesey and Cepko 2000). This research has revealed that there are 
inscrutable complex networks of genes that play crucial roles in the 
determination of specific cellular fates. Pax6 was thought to stand at the top of 
the hierarchy of factors that controlled the development of an eye, and was 
labelled a “master control gene” (Gehring 1996, Gehring and Ikeo 1999). The 
degree of evolutionary conservation in the regulation and function of Pax6 is 
profound, with the 5’ regulatory regions being conserved, as well as the coding 
sequence between Drosophila and mice (Xu et al. 1999). Recent evidence 
suggests that the picture is more complicated. Members of vertebrate 
homologue families of the Drosophila sine oculis, eyes absent and dachshund 
gene families have been shown to be essential for eye development (Wawersik 
and Maas 2000).
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Recently, new data has further enlightened the role of Pax6 in ocular and 
retinal development, with the creation of conditional Cre-mediate knockout mice 
(Marquardt et al. 2001). Pax6 functions in several capacities in eye 
development, with lack of early ocular Pax6 expression restricting growth of the 
optic vesicle, and a failure of the neuroectoderm to adopt identity of neuroretinal 
progenitor cells. The authors note that following ablation of neuroretinal 
expression of Pax6, progenitor cells maintain expression of early retinal 
determinants (Rxl, Six3, Six6 and Hesi) and lose their multipotency. In the 
normal retina, once the retinal progenitor identity is established, Pax6 function 
becomes dispensable in the differentiation of specific retinal cell types. This is 
exemplified by the absence of Pax6 expression in all but amacrine (and a 
proportion of ganglion) cells. However, in the mouse in which Pax6 expression 
was ablated after the establishment of a retinal progenitor pool, only amacrine 
cells differentiated, demonstrating the dispensability of Pax6 for the generation 
of this cell type.
The identification of ChxW, a gene that when mutated causes profound 
ocular defects in the o /  mouse (Burmeister et al. 1996) and similar defects in 
humans (Ferda-Percin et al. 2000), revealed another transcription factor that is 
essential in multiple stages of eye development. Its expression pattern and the 
phenotype suggest that ChxIO has several roles in retinal genesis, but the 
apparent absence of bipolar cells in the o /  retina suggested a determining 
factor for bipolar cell specification. However, crossing the Chx10 mutation onto 
a different mouse strain resulted not only in the alleviation of the ocular
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phenotype overall, but in the recovered expression of a bipolar-specific cell 
marker (Bone-Larson et al. 2000). Therefore, if one defines a specific cell type 
by the expression of a set of markers that are unique to that cell, then Chx10 
cannot be regarded as the single molecular determinant of retinal bipolar cells. 
Indeed, Hatakeyama at al. (2001) suggest that ChxIO is crucial for the 
specification of the inner nuclear layer, rather than just bipolar cells. They note 
that in mice that are double mutants for the bHLH genes Mash1 and Math3, 
although bipolar cells are absent, ChxIO expression is maintained in Müller glia. 
Moreover, In vitro, only the combined misexpression of Mashi or MathS with 
ChxIO results in a co-ordinated increase of bipolar cells.
Nevertheless, Ferda-Percin at al. (2000) (see Appendix 3) with data 
presented in Chapter 3 demonstrated the significance of CHXIO in human eye 
development, with the identification of mutations that cause congenital 
microphthalmia. These patients suffer a clinically heterogeneous developmental 
disorder featuring small eyes, iris colobomas or absent pupils, partial optic 
nerves, cataracts and blindness. Moreover, data presented in Chapter 5 
regarding the reduced period of proliferation of Chxl 0-negative retinal 
progenitor cells adds to the existing data on the mechanisms that cause the 
observed retinal hypoplasia in the o /  mouse, and by extrapolation, in patients 
with microphthalmia.
In investigating the effect that lack of expression of ChxIO had on the 
expression of other transcription factors known also to be essential for retinal 
development, I observed a delay in the onset of expression of the
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photoreceptor-specific gene Crx. This result was unexpected, given that ChxIO 
was not known to be expressed in photoreceptor cells. However, evidence 
presented here indicates that ChxIO does not co-express with Crx at any point, 
and that a signalling mechanism, possibly directed by ChxIO is crucial for the 
correct onset of Crx in developing photoreceptors. The fact that Crx expression 
is delayed, rather than absent, suggests that there may be two waves of Crx 
expression, and that the second is not dependent on ChxIO. Nevertheless, 
without the initial phase of Crx expression, a crucial window is missed, and the 
cell cannot develop normally. This is reflected in the photoreceptors of the o /  
retina, which are present but morphologically abnormal. Furthermore, part of the 
abnormality is short or absent inner and outer segments (Burmeister et al 
1996). Data presented here and by Livesey et al. (2000) indicate that many of 
the genes whose expression is dependent on Crx are molecules expressed in 
the inner and outer segments. This model is summarised in Figure 7.1. 
Although there is no direct evidence for two waves of Crx expression during 
photoreceptor development, there is direct evidence that there are indeed two 
phases of photoreceptor development (Morrow et al. 1998) (discussed in 
Chapter 1.7).
CRX has revealed itself as a gene that can harbour many disease- 
causing mutations (Sohocki et al. 1998, 2001). In this thesis, I have presented 
data that suggest a previously unknown player in the regulation of Crx 
expression. Silva et al. (2000) describes a putative null mutation in CRX that is 
associated with both a Leber congenital amaurosis phenotype (in homozygotes)
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Figure 7.1. Model of Chxl 0-dependent photoreceptor and bipolar cell differentiation. P ho torecepto r birthing (show n by expression  of IR B P , peripherin  and possibly  
arrestin ) occurs in th e  ab s e n c e  of C h x IO , but C rx  expression  is de laye d . A signalling m olecu le , w hich is ab sen t in the ab s e n c e  of C h x IO  an d  m a y  or m ay  not b e  retinoic  
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th e re  is a  seco n d  w a v e  of C rx  express ion  th a t is in d ep en d en t of C h x fO . H ow ever, continuous C rx  expression  is required for correct d ifferen tia tion . In vitro, addition of 
ciliary neurotrophic  fac to r (C N T F ) resp ecifies  ce lls  that w ould  d ifferen tia te  as  rods into b ipolar cells.
and a normal ocular phenotype (in heterozygotes), suggesting that 
haploinsufficiency is not a disease-causing mechanism in this case. This 
conclusion leads the authors to speculate that the disease mechanism is almost 
certainly multigenic. Therefore, information about the complex networks of 
regulatory pathways involving Crx will reveal important information about retinal 
disorders.
During the course of this thesis, retinal stem cells were identified 
(Tropepe et al. 2000 and Ahmad et al. 2000). Both of these studies isolated 
individual pigmented cells from the ciliary margins of the retina, which under 
specific culture conditions, formed spheres of undifferentiated retinal progenitor 
cells that expressed ChxIO, and were capable of differentiating into a variety of 
retinal cells. Interestingly, despite the reduction in total number of retinal cells in 
the o /  retina, Tropope et al recorded a fivefold increase in the number of 
primary retinal stem cell cultures from the o /  mouse eye, although these 
spheres were significantly smaller than that of the wild-type cultures. The 
reduction in size of the cultures reinforces the role of ChxIO as a factor that 
promotes cellular proliferation in the retina. These data suggest that in the 
absence of ChxIO, there are more retinal stem cells, although their proliferation 
and potential is restricted. The authors postulate that the numbers of neural 
retinal cells during development determines the numbers of retinal stem cells by 
inhibiting the expansion of the stem cell population. The identification of these 
cells has raised the possibility of stem cell therapy for retinal disorders, and 
indeed, Sakaguchi et al. (Iowa State University, USA) reported at the American
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Society of Neuroscience annual meeting (New Orleans, November 2000) 
successful implantation, integration and differentiation of genetically modified 
stem cells in the eyes of postnatal Brazilian opossums. Young et al. (2000) also 
successfully integrated rat hippocampal cells into the retinae of rats with genetic 
retinal degeneration, which subsequently differentiated and expressed mature 
neuronal markers and showed synaptic profiles. This type of experiment 
introduces a real prospect for the treatment of retinopathies such as glaucoma 
and macular degeneration in the future.
Clearly, ChxIO has multiple roles in the development of the retina, and 
interacts with a number of other factors to implement these roles. Livesey at al. 
(2000) used microarray technology to identify downstream targets of Crx by 
comparing expression of retinal cDNAs in the wild-type and Crx"'^" mouse. This 
technique unveiled several novel downstream targets, as well as many 
previously known photoreceptor genes, many of which are disease-causing 
genes. This same technique could easily be applied to the o /  mouse to identify 
bipolar specific markers that are regulated by ChxIO (if carried out using cDNA 
from retinal cells from late development, i.e. when bipolar cells are developing), 
or to identify the targets of ChxIO that regulate cellular proliferation during early 
development. The identification of the ChxIO preferred binding site (Ferda- 
Percin at al. (2000) will provide further evidence for the direct regulation of 
genes by ChxIO. The finding that RA may be involved in the Chxl 0-dependent 
onset of Crx expression should be investigated using a system designed by 
Enwright and Grainger (2000). These authors used a transgenic mouse strain
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harbouring retinoic acid response element (RARE) fused to p-galactosidase. By 
examining RARE transgene expression in the sey mouse (nullizygous for 
Pax6), levels of RA activity were examined. Reduction or absence of RA by 
analysing RARE transgene expression in the o /  retina during development 
would reinforce the notion that this signalling molecule has a role in this system.
The identification of novel homeobox transcription factor presented here, 
VSX1 (Semina et al. 2000 and Hayashi et al. 2000), also introduces another 
molecule into the complex network of genes involved in retinal development. Its 
expression pattern, in both the inner and outer nuclear layers, raises many 
possibilities for a role in cell specification, and putative interactions with ChxIO 
and Crx, as well as many other genes. Furthermore, mutations in VSX1 may 
cause ocular disease. This field is yet to be explored.
One of the direct challenges following on from work presented here will 
be increasing the survival rates of o /  cells in culture. The low numbers of o /  
cells renders cultures of equivalent density to that of wild-type cells difficult to 
establish, and therefore manipulation of these cells is similarly difficult. 
Nevertheless, data presented here does suggest that the absence of ChxIO 
lowers the survival rate of retinal cells in culture conditions in which wild-type 
cells thrive. One way round this problem would be to investigate the use of 
retinal explants in order to manipulate gene expression in vitro. Growth and 
subsequent manipulation of retinal cells has been successfully achieved at the 
early stages of murine eye development (E9-10.5) (Furuta et al. 1997, Furuta
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and Hogan 1998), and could make the basis of experiments in which extrinsic 
factors alter the behaviour and fate of o /  retinae.
Furthermore, the transgenic experiment begun during the course of this 
thesis and described in Appendix A would provide valuable information about 
the ability of ChxIO expression to affect cellular fate while being driven by a 
photoreceptor-specific promoter. This experiment will help to unravel the 
complex pathways involving ChxIO that determines retinal growth and specific 
cell fates.
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A p p e n d ix  A
T r a n s g e n ic  m a n ip u l a t io n  o f  e x p r e s s io n  
A.1 In troduction
In chapter 4 of this thesis, it is described how the absence of Chx10 in the o /  
mouse retina results in (amongst other things) expression of the photoreceptor 
specific transcription factor gene Crx and some of its putative downstream 
targets being delayed by up to seven days. Chx10 is expressed neither in 
mature photoreceptors, nor in the photoreceptor layer during development.
As exemplified by the use of the o /  mouse for the understanding of 
retinal development, animal models are extremely useful in the analysis of 
developmental pathways. To further examine the role of Chx10 in the 
development of the retina, and more specifically to experimentally test the effect 
that Chx10 has on the development of photoreceptors, I instigated a project to 
manipulate Chx10 expression by genetic manipulation using transgenic DNA 
constructs.
As described in Chapter 4.6, interphotoreceptor retinoid binding protein 
(IRBP) is a secreted glycolipoprotein that is localised to the interphotoreceptor 
matrix surrounding the inner and outer segments (Liou et al. 1994). There is 
evidence that the function of IRBP is to transport vitamin A across the 
hydrophilic subretinal space. Expression is first detected as early as E l l ,  and 
thus may precede onset of Crx expression, which, first recorded at E12.5, is
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presumed to be earliest known genetic marker for photoreceptors is Crx, first 
detectable at E12.5 (Freund et al. 1997). There is some evidence that IRBP co- 
localises with BrdU incorporation in dissociated P2/3 retinal cultures (Liou at al. 
1994). This suggests that IRBP either is expressed in non-committed cells, or 
may be a pre-terminal mitosis marker of a photoreceptor fate. The 5’ promoter 
region of IRBP also contains a Crx preferred binding site (Livesey at al. 2000), 
suggesting that Crx is involved with transcription of this photoreceptor specific 
gene. Results shown in Chapter 4.6 indicate that IRBP expression is unaffected 
by the absence of ChxIO and Crx, and therefore, although in possession of a 
Crx-binding site, is not dependent on its activity.
Photoreceptor genesis begins at approximately E l0.5 in the mouse 
(Young 1985), according to studies of ^Thymidine incorporation during 
development. Several studies have investigated the expression of IRBP during 
development, and have shown certain inconsistencies. IRBP mRNA has been 
detected as early as E l 1 by RNA protection assay (RPA), and Chloramphenicol 
acetyl transferase expression driven under the control of the human IRBP 
promoter is detectable at E l3, in photoreceptors. Considered together, these 
data indicate that IRBP is one of the earliest expressed photoreceptor genes.
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A.2 Transgenic IRBP-ChxIO construct
A 1.329kb fragment of DNA from the 5’ upstream region of the human IRBP 
coding sequence was isolated and characterised, and shown to contain a 
promoter for the IRBP gene that was capable of directing photoreceptor-specific 
gene expression in the mouse (Yokoyama et al. 1992). This promoter, cloned 
into pBluescript plasmid was a kind gift from Paul Overbeek (Baylor College of 
Medicine, Houston, Texas, USA).
The general hypothesis was that expression of Chx10 in the mouse, 
under the control of a photoreceptor-specific promoter, would generate a retinal 
phenotype that would reflect aspects of the function of Chx10 during retinal 
development.
The initial idea was to ligate the human IRBP promoter to the coding 
sequence of murine ChxIO, ligated to an 3^40  polyadenylation signal. In 
parallel, a transgene construct would be built that contains a genetic marker to 
enable visualisation of the exogenous Chx10 expression, as distinct from the 
endogenous ChxIO (see Figures A.1 a and b). Use of both transgenes is 
important as a means of investigating how the presence of a fused marker 
sequence might affect expression of the transgene. To prepare the tagged gene 
construct, I used a t/St/-tag (Soldati et al. 1991), by amplifying ChxIO  cDNA 
from a ChxIO  cDNA-containing plasmid, but using a Chx70-specific reverse 
primer with a \/S\/-tag (see Figure A .ib).
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Figure A .I. IRBP-Chx10 tran sge n ic  constructs. Constructs were made by ligating the human /EBP promotor to the coding sequence of 
murine ChxW , which in turn was ligated to the SWCpolyadenylation signal. A second construct was made using ChxIO cDNA amplified by PCR 
with a t/SKtag on it 3’ tail, using primers F and R.
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Both constructs were to be micro-injected into single-cell fertilised mouse 
embryos, which were grown in culture, then re-implanted into pseudo-pregnant 
female mice. Founder offspring would be bred to establish transgenic lines, and 
any ocular phenotype in their offspring analysed using similar methods to those 
described in Chapters 4 and 5 of this thesis.
A.3 Speculative predictions of transgenic phenotype
Given the photoreceptor-specific nature of the IRBP promoter, and the 
understood expression and function of ChxIO in retinal development, several 
predictions can be made about the possible phenotype of a transgenic mouse 
carrying a construct in which ChxIO was driven by the IRBP promoter.
1. Due to the misexpression of ChxIO, postmitotic fated photoreceptors are 
prevented from differentiating into mature photoreceptors, and thus fail to 
mature into a recognisable cell. This situation would preclude the presence 
of normal photoreceptors in the transgenic eye (but these cells may express 
both photoreceptor and bipolar cell markers).
2. Due to the continued or re-instigated expression of ChxIO past the terminal 
mitosis, transgene-expressing cells differentiate as bipolar cells. This 
presupposes a fulfilment of ChxIO’s role as a determinant of bipolar cell 
differentiation.
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3. Postmitotic fated photoreceptors de-differentiate and return to a mitotic 
state, resulting in a hypercellular or undifferentiated retina.
4. Given the possibility of IRBP expression in a proportion of mitotic cells, a 
maintenance of ChxIO in these cells results in their sustaining mitosis, thus 
generating an over-proliferation of a small subset of cells.
5. Conversely, maintained ChxIO expression in the mitotic IRBP-expressing 
cells may result in a disproportionately high number of bipolar cells.
6. IRBP-driven expression of ChxIO in the pineal gland might generate a 
phenotype, given that ChxIO is not found in this tissue normally.
Both constructs were prepared by subcloning PCR amplified ChxIO cDNA into 
a plasmid containing both the IRBP promoter and the SV40 polyadenylation 
signal. Although high-fidelity Tag polymerase was used in amplifications, 
sequence analysis revealed a 3bp deletion that altered the ChxIO  reading 
frame. Efforts to remake these constructs were not completed within the time 
frame of this study.
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A p p e n d ix  B
R S 1, A GENE CAUSING RETINOSCHISIS, IS EXPRESSED IN THE INNER NUCLEAR LAYER
X-linked retinoschisis is a macular degeneration characterised by splitting of the 
inner retinal layers (the inner limiting membrane and nerve fibre layer) and 
lesions in the peripheral retina (George et al. 1995). This disorder presents in 
juvenile males with visual impairment progressing between 5 and 10 years of 
age, leading to vitreal haemorrhage, retinal detachment, retinal atrophy and 
blindness.
Linkage studies revealed that the gene causing X-linked juvenile 
retinoschisis maps to Xp22, and was identified by positional cloning in 1997 
(Sauer et ai. 1997). RS1 was found to encode a retina-specific 224-amino acid 
protein of unknown function, predominantly comprising a discoidin domain. 
Discoidin domains are associated with extracellular or transmembrane proteins. 
Given that the location of the retinal splitting in retinoschisis is an acellular 
region of the retina, it has been suggested that retinoschisin acts as a secreted 
protein. This is supported by the presence of the discoidin domain (Grayson et 
al. 2000).
I examined the expression pattern by In situ hybridisation of RS1 and its 
mouse orthologue in PFA-fixed, paraffin-embedded adult human and mouse 
retinal sections. Expression in the adult human retina was limited to the 
photoreceptor layer, in the outer nuclear layer and inner segments, and was 
absent from the inner plexiform layer -  the site of the pathology. A similar
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pattern was generated in the adult mouse retina (see Appendix C, Grayson et 
al. 2000).
Grayson et ai. (2000) also performed immunohistochemistry using an 
antibody raised against retinoschisin. Immunolabelling was detected in the inner 
segments of the photoreceptors, the inner nuclear layer and in the ganglion cell 
layer. These data indicate that indeed retinoschisin is synthesised in 
photoreceptors, and is secreted to other layers in the retina.
Interestingly, sequence analysis of the upstream promotor region of the 
murine Rs1 gene revealed a putative Crx binding site (Gehrig et al. 1999), 
suggesting that Rs1 expression, like other genes investigated in Chapter 4, is 
regulated by Crx. Livesey et ai. (2000) analysed the expression of a number of 
photoreceptor-specific genes in a mouse with targeted deletion of Crx, and 
found that although expression of RS1 was not absent it was notably reduced in 
the Crx~^~ homozygous knockout mouse. This suggests that expression of Rs1 
is at least partially regulated by Crx.
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Human microphthalmia associated with mutations in the 
retinal homeobox gene CHXIO
E. Ferda Percin^’^ *, Lynda A. Ploder^*, Jessica J. Yu ,^ Kemal Arici ,^ D. Jonathan Horsford^-^ Adam 
Rutherford®, Bharati Bapat ,^ Diane W. Cox®, Alessandra M.V. Duncan®, Vitauts I. Kalnins*®, Aysegul Kocak- 
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Isolated human microphthalmia/anophthalmia, a cause of con­
genital blindness, is a clinically and genetically heterogeneous 
developmental disorder characterized by a small eye and other 
ocular abnormalities. Three microphthalmia/anophthalmia loci 
have been identified’* ,^ and two others have been inferred by 
the co-segregation of translocations with the phenotype^-®. We 
previously found that mice with ocular retardation (the or-J 
allele), a microphthalmia phenotype®, have a null mutation in 
the retinal homeobox gene ChxIO (refs 7,8). We report here the 
mapping of a human microphthalmia locus on chromosome 
14q24.3, the cloning of CHXIO ai this locus and the identifica­
tion of recessive CHXIO mutations in two families with non- 
syndromic microphthalmia (MIM 251600), cataracts and severe 
abnormalities of the iris. In affected individuals, a highly con­
served arginine residue in the DNA-recognition helix of the 
homeodomain is replaced by glutamine or proline (R200Q and 
R200P, respectively). Identification of the CHXIO consensus 
DNA-binding sequence (TAATTAGG) allowed us to demonstrate 
that both mutations severely disrupt CHXIO function. Human 
CHXW is expressed in progenitor cells of the developing neu­
roretina and in the inner nuclear layer of the mature retina. The 
strong conservation in vertebrates of the CHXIO sequence, pat­
tern of expression and loss-of-function phenotypes demon­
strates the evolutionary importance of the genetic network 
through which this gene regulates eye development.
To evaluate the role of CHXW in developmental eye defects, we 
first cloned human CHXWcDNAs (ref. 8). The cDNA detected a 
3.3-kb transcript in retinal RNA (data not shown), and encoded 
an ORF of 1,083 bp (for nucleotide and predicted protein 
sequences, see http://genetics.nature.com/supplementary_info/). 
The deduced human C H XW O ^  encodes a polypeptide of 361 
amino acids with a predicted mass of 39 kD. It is 97% identical to 
mouse ChxW (ref. 8) and is completely identical in the home­
odomain and CVC domain. To allow genetic analysis of CHXW 
in humans, we determined the exon-intron structure of the gene 
from genomic clones (Fig. 1).
To determine the expression pattern of human CHXW and to 
compare it with that of other species, we first used polyclonal 
antibodies specific for CHXIO (ref. 8) to identify the CHXIO- 
expressing cells in adult retina. CHXIO was restricted to nuclei of 
the inner nuclear layer (INL; Fig. 2a). Within this layer, as in 
mouse retina®, a gradient of expression was apparent: the outer 
nuclei, where bipolar cells predominate, stained strongly: 
whereas the inner aspect, where amacrine cell nuclei are located, 
stained weakly. This expression pattern is identical to that in 
mouse, except that in mouse, staining of ganglion cell nuclei was 
occasionally observed  ^®.
We examined the developmental expression of CHXIO by in 
situ hybridization of human fetal retinal sections (Fig. 2b-g). 
CHXW is expressed in retinal neuroblasts at all stages examined
Fig. 1 The human CHXIOgene and cDNA structure. The 
genomic organization of CHXIO is identical to that of 
the mouse orthologue’ . The five known exons are rep­
resented as numbered boxes, and the introns as lines.
The exact location of the 5 end of exon 1 is unknown 
(dotted lines), and it may not be the most 5 exon. A 
restriction map was generated from the genomic CHXIO 
inserts of X.DASH clones 8 (22 kb) and 9 (22 kb): B,
BamHl: E, EcoRI; H, HindWl The polymorphic CA repeat 
in intron 2 is indicated; 18 alleles were observed and 31 
predicted, with 86% observed heterozygosity. Intron 3 
was not fully characterized (dashed line). The exons are 
projected onto the schematic of the CHXIOcDNA. Cod­
ing sequences are shown as large, open boxes. The HD is 
encoded by exons 2, 3 and 4, and is represented as a 
light grey box. The CVC domain is shown as a dark grey 
box, the octapeptide as a hatched box, and the OAR
domain as a black box. The numbers below the cDNA refer to the nucleotides of the coding sequence (1 indicates the translation start, 1086 the translation stop; the
number at the end of each exon is the last bp of the exon). The position of the 5 end of the transcribed sequence is unknown, and is represented by a dotted line.
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(Fig. 2b-i, outer layer). The lighter staining in the inner layer of 
retinas obtained 8-10 weeks post-conception (Fig. 2c,e) reflects 
the presence of post-mitotic ganglion cells (identified by a cell- 
specific marker; data not shown) in this population; mature gan­
glion cells do not express CHXIO (Fig. 2a,i). At 13 weeks 
post-conception (Fig. 2^), the cells in the outer aspect of the 
outer layer, which are morphologically indistinguishable from 
other cells of this layer, did not express CHXIO, in contrast with 
the cells on the inner aspect of this layer. This pattern of cellular 
heterogeneity in the developmental expression of CHXlOhas not 
been reported in other vertebrates. The outermost cells may rep­
resent a mitotic or immediately post-mitotic population com­
mitted to photoreceptor cell fate, consistent with the fact that 
CHXIO is not expressed in mature photoreceptors (Fig. 2a,i). 
Because of the similarity of both the CHXIO protein sequence 
and the pattern of expression of the gene between verte- 
brates '^ '^^ ,^ we initiated a search for CHXW mutations in 
humans with developmental eye phenotypes similar to those 
seen in the Chx 1 mouse  ^and zebrafish’®.
To examine the role of CHXW in genetic disease, we first 
mapped the gene to chromosome 14q band 24.3 (data not
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10 weeks pc
13 weeks pc
—  g
¥
opi
ini
Si
adult
shown). This region has conserved synteny with the part of 
mouse chromosome 12 where ChxWis located .^ To facilitate seg­
regation analysis of CHXW, we identified a complex 
(CT)j,.(CA)„ repeat in the second intron (Fig. 1). This repeat was 
analysed in CEPH families, indicating the order; 
centromere-D/ 4S71- CHXIO- D14S2 7J-telomere. Radiation 
hybrid (RH) mapping of the CA-repeat positioned CHXW 
approximately 1.71 cR telomeric to D14S71. On the basis of this 
RH and linkage data, we determined that the order is 
ceu-D14S71-DI4SW25-CHX10-DI4SW47-D14S273-te\.
We identified mutations in CHXW in two unrelated families 
(Fig. 3). Family 1 is a consanguineous kindred from Turkey (Fig. 
3a), and we examined two microphthalmic family members; the 
phenotype of one is shown (Fig. 4a-c). The second proband, from 
family 2, was also the offspring of a consanguineous marriage 
(Fig. 36). His phenotype (Fig. 4d) is similar to that of the affected 
members of family 1. All three subjects had microphthalmia, 
cataracts and iris colobomas or absent pupils. Notable, given the 
absence of optic nerves in ChxlŒ'^ '^ ''°'^ '-^  mice^, was the presence of 
optic nerves in the one affected individual examined (Fig. 4c).
We used a candidate gene approach to determine whether 
genes associated with developmental eye defects in other mam­
mals, or known to be expressed at early stages of eye formation, 
were associated with the microphthalmia of family 1 (Fig. 3a). 
We excluded co-segregation of the phenotype with the anoph­
thalmia locus at 14q32 (ref. 3). Co-segregation of microph­
thalmia was observed only with DNA markers flanking CHXW 
on 14q24.3. Genotyping of the CHXWCk repeat and 18 markers 
in this location defined a critical region between DI4S77 and 
D14S61, within a genetic interval of 6.3 cM (Fig. 3a). We 
obtained a maximum lod score of Z=2.81 at t=0.00 for the mark­
ers D14S77, the CHXWCk repeat and D14SW47. The next high­
est value, Z=2.51, was observed with marker D14SW25. The 
evidence of linkage did not improve when several markers were 
analysed together in a multi point analysis. Eight markers (Fig. 
3a), including the CHXWCk repeat, showed complete homozy­
gosity in the affected subjects.
To identify mutations in CHXW, we used single-stranded con­
formational polymorphism analysis. Analysis of genomic DNA 
from the two affected subjects of family 1 revealed a single, 
homozygous, G—>A transition (Fig. 5a) in the homeobox of 
CHXW in both individuals (Fig. 3a, 11-3 and lV-5). This muta­
tion, which changes Arg200 to Gin (R200Q), co-segregated with 
the disease (Fig. 36). It was not observed in 365 other subjects 
from various ethnic backgrounds and with a range of eye anom­
alies, nor in 110 control chromosomes from Turkish subjects, 
indicating that it is not a polymorphism.
We also screened for CHXW mutations in 365 DNA samples 
from patients with various developmental eye defects. One addi­
tional proband (family 2; Fig. 3c) was found to have a CHXW 
mutation, a G—>C transversion converting arginine 200 to pro-
Fig. 2 CHX70 is abundantly expressed in the inner nuclear layer of human adult 
retina, and in retinal neuroblasts during eye development, a, Micrograph of a 
cryostat section of adult human retina showing immunoflluorescent iabellin 
of the inner nuclear layer with affiinity-purifiied antibodies to CHXIO. La belli 
was examined by laser confocal microscopy (right). The corresponding phase 
contrast micrograph is shown on the left. The preimmune sera did not show 
any retinal staining (not shown). ONL, outer nuclear layer; INL, inner nuclear 
layer. Bar, 30 pm. b -i, CHXW in  s itu  hybridization of developing and mature 
human retina, b,d,f,h, Haematoxylin and eosin stained sections. c,e,g,i, Sec­
tions hybridized with an antisense digoxygenin-labelled CHXW  riboprobe. 
Fetal ages are shown as weeks post-conception (weeks pc). ol, Outer layer; il, 
inner layer; ipl, inner plexiform layer; gel, ganglion cell layer; rpe, retinal pig­
mented epithelium; os, outer segments; is, inner segments; ont, outer nuclear 
layer; opI, outer plexiform layer; ini, inner nuclear layer. Scale bars, 100 pm.
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Fig. 3 Pedigrees of two families with autosomal reœssive microphthalmia, a, The Turkish kindred (family 1), in which the disease mapped to chromosome 
14q24.3. Affected subjects are identifiied by fiilled symbols, carriers by half-fiilled symbols, and the d-type allele by open symbols. Individuals shown without 
haplotypes were not examined or tested, but were rep>orted to have normal eyes and vision. The order of markers used is shown at the top left. The solid vertical 
bars below each subject indicate the disease-carrying haplotype, whereas all other vertical bars indicate the haplotypes of unaffected individuals, b, The R200Q 
mutation was identifiied in members of family 1 byTagI digestion of PCR products, as the mutation abolishes a Tacf site. In controls, digestion of a 329-bp wild- 
type DNA PCR product generated fragments of 105 bp and 224 bp; in heterozygous carriers, both the undigested fragment (329 bp) and digested fragments (224 
bp and 105 bp); and in the two microphthalmic subjects (11-3 and IV-5), only the 329-bp fragment, c, Family 2, a consanguineous family from the United Arab Emi­
rates with one affected individual (fiilled square)
line (R200P; Fig. 5a). This mutation was not observed in 365 
other subjects from diverse ethnic backgrounds and with various 
eye anomalies, nor in 220 alleles from normal subjects, indicating 
that it is not a polymorphism. That both of the CHA'/Omutations 
we identified occur in the same CGA codon may reflect the fact 
that the CG doublet is a well-known mutation hot spot'^.
Arginine 200 of the CHXIO protein is residue 53 of the home­
odomain, within the DNA recognition helix .^ In other paired-like 
homeodomains, this arginine contacts the phosphate backbone of 
the DNA (ref. 14). To determine whether the R200P and R200Q 
mutations confer a loss of function, we first identified the DNA- 
binding site preferentially used in vitro by the CHXIO protein, using 
a binding site selection assay^ ’^*®. An 8-bp consensus, Ti\ATTAGC,
V -
was identified: the first 6 bp had an occurrence of greater than 90% 
in the selected oligonucleotide pool, whereas the last 2 bp, GC, had 
occurrences of 80% and 68%, respectively. The TAATTAGG target 
differs from that of other paired class homeodomains'^’’ .^ Because 
the TAAT sequence is present in many homeodomain binding sites, 
it may be the core recognition element for CHXIO, with further 
specificity being conferred by the bases TAGC.
We used gel mobility shift assays to demonstrate that the 
R200Q and R200P substitutions impaired the binding of the 
mutant CHXIO proteins to the consensus binding site. We first 
established that wild-type and mutant proteins were present at 
comparable concentrations by immunoblot analysis (Fig. 56, 
top). The c-myc-tagged wild-type and mutant proteins each 
migrated to a position consistent with a molecular 
weight of approximately 55 kD, whereas no protein 
was detected on blots using unprogrammed lysate (Fig. 
56, top). In gel mobility shift assays, binding of CHXIO 
to the consensus oligonucleotide was detected by the 
indicated band shift, but no specific binding was 
obtained with either R200Q or R200P mutant CHXIO
Fig. 4 Clinical presentation of patients with CHXIO mutations. 
a-c, The phenotype of the proband of family 1 with the R200Q 
mutation, a. Bilateral microphthalmia at 1 y; the cataract in the 
right eye is visible. b,c, Computerized tomography of the eyes of 
the R200Q proband at 1 y, showing the microphthalmia in both 
images, in (b) the dislocated lenses (arrow) and increased thick­
ness of the sclera (arrowhead) and in (c) the normally sized optic 
nerves (arrow), d, The left eye of the patient with the R200P 
mutation at age 2 months, showing a poorly defiined limbus an 
conjunctivalization of the corneal epithelium. There was no pupil­
lary aperature. The dark brown circular structure in the upper part 
of the cornea is the iris (arrow). A funnel shaped retinal detach­
ment inserted into the optic disc was observed 00, and a lesion 
compatible with a dislocated lens with surrounding membrane 
formation or localized retinal detachment was noted OS.
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c-myc CHXIOFig. 5 Two missense homeo­domain mutations in Arg200 
of the CHXIO protein reduce 
binding to the CHXIO DNA 
consensus binding sequence.
a, The wild-type sequence 
(right) and mutant CHXIO 
sequence (left) of the 
proband of family 1 were 
identical except in exon 4, in 
which a homozygous G^A 
transition (asterisk) changed 
codon 200 from arginine 
(CGA) to glutamine (CAA).
Similarly, in the proband of 
family 2, the only sequence 
abnormality (second from 
left) was in exon 4, in which a
homozygous G->C transversion (asterisk) altered codon 200 to proline (C£A). Parental DNA from family 2 was not available for study.
b, Reduced DNA binding by R200Q and R200P mutant c-myc-CHX10 fusion proteins. Top, an immunoblot of wild-type c-myc-CHXI 0 
and the two mutant protein lysates. The blot was probed with the c-myc monoclonal antibody, each lane contained 10 |tl of protein 
lysate. Each c-myc fusion protein (CHXIO wild-type, CHXIO R200Q and CHXIO R200P) migrated at -55 kD. No proteins were detected 
in the unprogrammed lysate, which contained all the in  v itro  translation reaction components except the c-myc-CHXIO expression 
construct. Bottom, a gel mobility shift assay of wild-type c-myc-CHXIO and the c-myc-CHXI 0 mutants. A complementary pair of rep­
resentative oligonucleotides from the selection screen, CHXW1 and CHXW2, was used as the probe in the assay. A clear shift of the
probe (arrow) is observed with wild-type c-myc-CHXIO, but no shift is detected using c-myc-CHXIO R200Q, c-myc-CHXIO R200P or the unprogrammed (no DNA) 
lysate. Background bands seen in the mutant lanes are the same as ones seen in the unprogrammed lysate lane, indicating that these bands are non-specifiic
proteins (Fig. 5, bottom). These results demonstrate that both 
mutations at residue 200 disrupt the binding of CHXIO to DNA.
We have demonstrated that CHXW is the gene at a fourth non- 
syndromic microphthalmia/anophthalmia locus, making it the 
only microphthalmia gene identified so far. CHXW mutations 
accounted for only approximately 2% (2/117) of the patients 
with non-syndromic microphthalmia studied. Although the ocu­
lar expression of CHXW is limited to the neuroretina in human 
(Fig. 2, and data not shown) and mouse®, the loss of CHXIO 
function is panocular in its effects: the growth of the eye and the 
integrity of the lens and iris, in addition to the retina, are all dis­
rupted. These non-retinal phenotypes suggest that the develop­
ing neuroretina may produce a Cf/A'/O-dependent factor 
essential for eye formation.
The eye abnormalities we observed probably result from a loss 
of CHXW function. The R200Q and R200P CHXW alleles are 
likely to be null alleles because their DNA binding is greatly 
impaired (Fig. 5b) ; position 53 of the homeodomain is almost 
always (344/346 in one survey*®) an arginine*^ reflecting its role 
in contacting the DNA phosphate backbone* ;^ and an R53C sub­
stitution in the HESXl paired-like homeodomain also ablates 
DNA binding*®. Thus, a severe loss of CHXIO function leads to 
virtually orthologous phenotypes in human, mouse^ '^ ** and 
zebrafish***. Because the CHXIO loss-of-function phenotype is 
restricted to the eye in mouse  ^and human, CHXIO appears not 
to be essential for the development of the other—largely 
neural—tissues in which it is expressed®.
Methods
Case reports. Family 1 consists of 35 subjects, with 4 affected individuals (2 
are deceased). The proband’s parents were clinically normal. The abnor­
malities of the proband at 9 months of age, and of the other affected subject 
at age 49 y, were strictly ocular. Both had bilateral microphthalmia, con­
genital cataracts and bilateral inferior colobomas of the iris; neither had 
light perception. By ultrasound, the proband’s eyes had an axial length of 
12.0 OD and 10.0 mm OS (<1*%; ref. 21).
In family 2, the proband was the only child of clinically normal par­
ents. At two months of age, he had bilateral small globes (axial lengths: 
10.9 mm OD and 13.6 mm OS by ultrasonagraphy, <1‘*’%; ref. 21). Other 
eye phenotypes were noted. His only non-ocular abnormalities were 
undescended testes.
Linkage analysis and genotyping of family 1. The pedigree provides a 
maximum of 30 potentially informative meioses. We performed geno­
typing and linkage analysis as described (see http://genetics.nature.com/ 
supplementaryjnfo/). The order of markers we identified was consis­
tent with a PAG clone (AC005519) which contains CHXW, this clone is 
part of a contig containing the DI4SW47 marker.
CHXWcDNPl and genomic cloning. We isolated CHXIO clones from an 
adult human retina XgtlO cDNA library as described*. To identify CHXIO 
genomic clones, we screened a human genomic library (made from a 
5au3Al partial digest) in the X DASH vector with the CHXWcDHh using 
standard methods. We generated restriction maps of clones 8 and 9, identi­
fied exon-containing fragments with the cDNA probe, and compared 
sequences with those in GenBank**.
Chromosome, RH and microsatellite mapping. We first mapped CHXW 
using autoradiographic in situ hybridization with a tritium-labelled 
C//X/OcDNA probe on blood lymphocytes as described**. We performed 
RH mapping of the CHXI0 intron 2 CA repeat using the GeneBridge 4 RH 
panel. We used standard methods*  ^to identify the CA repeat in the gene. 
The methods we used for amplification of the CHXIO CA repeat are 
described (see http://genetics.nature.com/supplementary_info/).
Immunoblot analysis, immunofluorescent labelling and /ns/fu hybridiza­
tion of CHXIO in human retina. We fixed human eyes obtained within 24 
h of death in 2.5% paraformaldehyde for 2 h at 4 “C and stored them 
overnight in 30% sucrose. We prepared retinas and performed 
immunoblots, immmunofluorescence labelling* and in situ hybridiza­
tion** as described. We generated CHXIO riboprobes from a linearized 
pBluescript KS plasmid containing the CHXIO cDN\. We determined fetal 
age by measurement of the foot- or crown-rump length. We obtained 
htunan tissue after informed consent from the MRC Tissue Bank, Royal 
Postgraduate Medical School, Hammersmith Hospital.
Mutation screening. We screened for CHXIO mutations in the DNA of 
88 patients with microphthalmia, 28 with anophthalmia, 10 with 
microphthalmia with systemic phenotypes, 8 with optic nerve aplasia or 
hypoplasia, 71 with Leber congenital amaurosis, and 160 patients with a 
range of other eye defects, including 39 with anterior segment anom­
alies. We amplified CHXIO in five fragments spanning the coding and 
flanking intonic sequences as described (see http://genetics.nature.com/ 
supplementaryjnfo/). We performed SSCP analysis and direct sequenc­
ing of PCR products as described**
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In vitro translation of wild-type and mutant CHXIO proteins. We used 
the plasmid pT7tagN (ref. 16) for in vitro transcription and translation 
of wild-type and mutant (R200Q and R200P) CHXIO proteins with an 
amino-terminal c-myc epitope tag. We performed site-directed PCR 
mutagenesis^  ^to generate the mutants R200Q and R200P, documented 
the presence of each mutation and the absence of other changes in the 
cDNA by sequencing, and expressed the fusion proteins from CHXIO 
plasmid (1 pg) using the TNT T7 coupled reticulocyte lysate system 
(Promega). To examine the abundance of the translated CHXIO pro­
teins, we performed immunoblotting of the lysate reaction (see http;// 
genetics.nature.com/supplementary_info/)
CHXIO DNA-binding site selection. We selected the preferred CHXIO 
binding site from a random sequence 26-mer oligonucleotide pool^ ®. We 
used the CHXIO protein in four rounds of selection to enrich for 
oligonucleotides to which CHXIO bound with high affinity, and 
sequenced 31 oligonucleotide inserts from the selected transformants to 
identify a consensus binding site. We performed gel mobility shift assays
to compare the DNA binding of wild-type and mutant CHXIO (see 
http://genetics.nature.com/supplementaryJnfo/).
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X-linked retinoschisis is characterized by micro- 
cystic-iike changes of the macular region and schisis 
within the inner retinal layers, leading to visual dete­
rioration in males. Many missense and protein-trun­
cating mutations of the causative gene R SI have now 
been identified and are thought to be inactivating. 
RSI encodes a 224 amino acid protein, retinoschisin, 
which contains a discoidin domain but is of unknown 
function. We have generated a polyclonal antibody 
against a peptide from a unique region within retino­
schisin, which detects a protein of -28 kDa in retinal 
samples reduced with dithiothreitol, but muitimers 
sized >40 kDa under non-reducing conditions. A 
screen of human tissues with this antibody reveals 
retinoschisin to be retina specific and the antibody 
detects a protein of similar size in bovine and murine 
retinae. We investigated the expression pattern in the 
retina of both R SI mRNA (using in situ hybridization 
with riboprobes) and retinoschisin (using immuno- 
histochemistry). The antisense riboprobe detected 
RS1 mRNA only in the photoreceptor layer but the 
protein product of the gene was present both in the 
photoreceptors and within the inner portions of the 
retina. Furthermore, differentiated retinoblastoma 
cells (Weri-Rb1 cells) were found to express RSI 
mRNA and to release retinoschisin. These results 
suggest that retinoschisin is released by photo­
receptors and has functions within the inner retinal 
layers. Thus, X-linked retinoschisis is caused by 
abnormalities in a putative secreted photoreceptor 
protein and is the first example of a secreted photo­
receptor protein associated with a retinal dystrophy.
INTRODUCTION
X-linked juvenile retinoschisis is the leading cause o f juvenile 
macular degeneration in males (1) and is characterized by schisis 
(splitting) of the inner retinal layers [inner limiting membrane 
^LM) and nerve fibre layers] resulting in cystic degeneration 
‘retinoschisis’ of the central retina (2,3). Peripheral retinal 
lesions are also present in -50% of cases (3). Clinically the 
condition is variable, with most patients presenting with 
progressive visual impairment between 5 and 10 years of age, 
but a proportion o f patients present in infancy with squint, 
nystagmus and bilateral and highly elevated bullous retino­
schisis (4,5). In the later stages of retinoschisis complications 
include vitreal haemorrhage, choroidal sclerosis, retinal detach­
ment and in rare cases, retinal atrophy resulting in blindness (6).
Previously it had been suggested that an underlying defect in 
the Müller cell, the retinal glial cell, could explain the combi­
nation o f features (2,7-9). Histological reports describe the 
characteristic abnormality as a schisis within the superficial 
retinal layers, the ILM, the nerve fibre layer and the ganglion 
cell layer (2,10,11). The inner leaflet o f the schisis consists of 
ILM, fragments of Muller cells and blood vessels and a thinned 
ganglion cell layer. Degeneration o f the overlying photorecep­
tors is also observed (11). The schisis cavity and surrounding 
retina are described as containing an amorphous eosinophilic 
PAS-positive filamentous material thought to originate from 
Müller cells (2,11). The electroretinogram of patients affected 
with retinoschisis shows a reduced b-wave [suggesting an 
inner retinal abnormality (3)], consistent with a Müller cell 
abnormality. Furthermore, these patients exhibit the ‘Mizou 
phenomenon’, a change in colour of the dark-adapted retina 
from red to gold shortly after exposure to light, which is 
thought to be due to a potassium imbalance in the inner retina 
(9). Photoreceptor hyperpolarization occurs in response to 
light leading to a rise in extracellular potassium, which is 
distributed to the vitreous fluid via the Müller cells. Thus, an 
abnormality in these cells might lead to a build up of potassium 
ions in the extracellular space (9).
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Figure 1. (A ) Immunoblot o f  human retinal proteins reacted w ith  antibody RS24-37. Lanes I and 2, samples w ithout and w ith  the addition o f  DTT, respectively. 
In the reduced samples the antihixly recognizes a predominant hand at -2 8  kDa hut in the non-reduced sample it recognizes muitimers sized >40 kDa. None o f  
these hands were detected when the anti serum had been adsorbed by the peptide prio r to immunohIotting(lanes 3 and 4), (B) Immunoblot o f proteins from different 
human tissues using RS24-37. This antibody recognizes a specific hand in retina only (upper panel). An antibody against actin was used together w ith  RS24-37, 
which had been previously adsorbed by the peptide that was used to generate it (lower panel). Actin  is detected in all lanes and the specific retinal band is no longer 
detected by RS24-37.
The gene causing X -linked juvenile retinoschisis, RSI, maps 
to Xp22 and was identified recently (12) after an extensive 
positional cloning effort by several groups ( 13-15). The mouse 
orthologue gene has also been cloned (16). RSJ has six exons 
and encodes a 224 amino acid protein, retinoschisin. The func­
tion o f  retinoschisin is unknown. Almost the entire protein 
consists o f  a discoidin domain, and disease-causing mutations 
are clustered in regions that encode this domain, suggesting 
that it is crucial for the normal function o f  retinoschisin (17). 
D iscoidin domains are present in extracellular or trans­
membrane proteins implicated in cell adhesion or cell-ee ll 
interactions (18). These proteins include, for example: 
(i) neuropilin 1 and II (receptors for the semaphorin fam ily o f 
cell adhesion molecules) (19); ( ii)  neurexin IV/easpr (axon- 
glial interactions in septate junctions) (20); ( i i i)  P47 (binding 
o f sperm to the zona pellucida during fertilization) (21); (iv ) 
del-1 (a ligand for the aV p3 integrin receptor which induces 
integrin signalling and angiogenesis) (22); and (v) the receptor 
tyrosine kinases D D R l and DDR2 (for which collagen acts as 
a ligand) (23). Therefore, it has been speculated that retino­
schisin could be a secreted protein involved in either ce ll-ce ll 
interaction or adhesion and that w ith  this function it could 
contribute to the maintenance o f the cellular architecture o f  the 
retina (16). In mice the retinoschisis gene is expressed in the 
photoreeeptors which are loeated far from the site o f  pathology 
0 6 ). This eell expression needs to be confirmed in the human 
retina. Since the schisis occurs at a site other than the site o f 
synthesis o f  retinoschisin, this suggests that the protein is 
secreted by the photoreceptors. The purpose o f  this study was 
to investigate these issues. Our results are consistent w ith the 
notion that retinosehisin is a secreted photoreceptor protein 
and that it performs a funetion w ith in  the inner retina.
RESULTS
A f T i n i t y - p u r i f i e d  a n t i b o d y  a g a i n s t  r e t i n o s c h i s i n
Rabbit polyclonal antiserum was raised against peptide 
STEDEGEDPW YQKA (amino acid residues 24-37) eonju-
gated to keyhole limpet haemocyanin (K LH ) and a ffin ity- 
purified (24). The resulting antibody RS24 37 was charaeter- 
ized against human, bovine and murine retinal tissues. In 
samples o f  human retinal proteins reduced w ith dith iothreitol 
(DTT), RS24-37 recognized a protein o f -2 8  kDa but under 
non-reducing conditions it bound muitimers o f >40 kDa (Fig. 
1 A). Pre-immune serum showed no cross reactivity (data not 
shown), and the band was not detected when RS24-37 was 
incubated w ith the peptide against which it was generated prior 
to im munoblotting (Fig. 1 A). These results indicate that the 
bands detected by RS24-37 were specific. RS24-37 also 
reacted w ith specific proteins o f sim ilar sizes from reduced 
bovine and murine retinal samples w ith proteins o f  much 
higher molecular weight from non-reduced samples (data not 
shown). Im mmunoblotting w ith RS24-37 against a panel o f  10 
other human tissues, including ovary, cerebellum, eerebral 
cortex, lung, liver, plaeenta, spleen, kidney, adrenal and heart, 
confirmed and extended this finding. RS24-37 detected a 
speeific band only from retinal tissue (Fig. IB ). This 
confirmed previous analyses using cDN A RSI probes and 
multi-tissue northern blots which revealed m RNA expression 
in retina only (12,16).
R e t i n o s c h i s i n  e x p r e s s i o n  p a t t e r n  w i t h i n  t h e  r e t i n a
The expression pattern o f the RSI m RNA and its encoded 
protein, retinoschisin, were investigated using retinal sections 
from adult human and mouse [the gene is first expressed at day 
5 postnatally in mouse (16)]. D igoxigenin-labelled sense and 
antisense riboprobes were generated from the full-length RSI 
cDN A (including the open reading frame o f  642 bp). 
Consistent w ith  previous findings in mice (16), staining in 
human retina was detected only w ith in  the photoreceptor cell 
layer and was most prominent w ith in  the inner segments o f  the 
photoreeeptors (Fig. 2A). It was absent from the inner plexi- 
form layers (where the retinosehisis pathology is most prom i­
nent) and the inner nuclear layer [which contains the eell 
bodies o f the M üller cells, previously implicated in retino­
schisis pathology (3-5 ,11)]. The pattern o f  expression was
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Figure  2. h i .<iitu hybridization o f  retina w ith  digoxigenin-labelled antisense RSJ riboprobes. (A ) mRNA transcripts are readily detectable in the inner segments o f 
the photoreceptors only in adult human (iv) and mouse ( i i)  (shown fo r comparison), ( i) and ( i ii)  are adjacent sections from the same specimens stained w ith  
haematoxylin and eosin to show the histology, and labelled as fo llows; rpe, retinal pigment epithelium; os, outer segment o f  photoreceptor; is, inner segment o f  
photoreceptor; onl, outer nuclear layer; opl, outer piexiform  layer; ini, inner nuclear layer; ip l, inner piexiform  layer; gel, ganglion cell layer. (B ) Immuno- 
histochemistry in mouse and human retina using RS24-37. Immunolabelling is found in the inner segment o f  the photoreceptors, the inner nuclear layer, the inner 
piexiform  layer and the ganglion cell layer in both mouse and human peripheral sections. The staining in the inner nuclear layer is patchy. In the human macula, 
there is patchy staining in both nuclear layers and more homogeneous staining in the inner piexiform  layer. The immunoreaction was not observed when the 
primary antibody was omitted, using pre-immune serum or the peptide-epitope pre-absorbed RS24-37.
sim ilar in mouse and in human samples (Fig. 2A). No staining 
was detected w ith  the sense riboprobe.
I m m u n o h i s t o c h e m i s t r y
In mice, immunolabelling w ith RS24-37 was found in the 
inner segment o f the photoreceptors, the inner nuclear layer, 
the inner p lexifonn layer and the ganglion cell layer. The
staining in the inner nuclear layer was patchy (Fig. 2B). This 
pattern was also found in the peripheral portion o f  the human 
retina (Fig. 2B). A t the macula, there was patchy immunoreac- 
t iv ity  in both the outer and inner nuclear layers and more 
homogeneous staining in the inner piexiform  layer (Fig. 2B). 
No reaction was observed when the primary antibody was 
omitted (Fig. 2B) or when pre-immune serum or serum pre­
absorbed w ith  the original peptide was used.
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E x p r e s s i o n  o f  r e t i n o s c h i s i n  i n  W e r i - R b l  c e l l s
Expression o f  retinoschisin was investigated in the W eri-R b l 
cell line using a combination o f RT-PCR w ith  exonic primers 
from w ith in  the RSI gene (designed so that the products would 
span introns) and im m unoblotting w ith the antibody RS24-37 
(to detect the presence o f  the protein w ith in the W e ri-R b l cells 
and/or in the media in which cells had grown). Retinoblastoma 
cells are precursors o f photoreceptors and are an appropriate in 
vitro  photoreceptor cell model since photoreceptor cell lines 
are not available (25).
RT-PCR using RNA from undifferentiated W e ri-R b l cells 
and two sets o f  primers [RSPEPIO and RSPEP5 from  exons 2 
and 4, respectively (product size 262 bp), and RSPEP3 and 
RSPEP6 from  exons 4 and 6, respectively (product size 406 
bp)] gave products o f  the expected size. Figure 3 shows only 
the products from primers RSPEPIO and RSPEP5. These 
results indicate that the RSI gene is expressed in the W eri-R b l 
cell line.
Undifferentiated and differentiated W eri-R b l cells were 
investigated by im m unoblotting w ith the RS24-37 antibody. 
Undifferentiated W e ri-R b l cells were grown in suspension 
and differentiation was induced by coating culture dishes w ith 
poly-D-lysine and fibronectin to induce adhesion and adding 
d i-butyry l cyclic A M P  (D B cA M P) to the culture media. 
D ifferentiation was detected by a change in morphology o f the 
cells. Antibody RS24-37 detected a specific band o f  -2 8  kDa 
in both cell lysates and conditioned medium from diffe renti­
ated and undifferentiated W e ri-R b l cells (Fig. 3B) indicating 
that retinoschisin is secreted from these cells. A more intensely 
labelled band in the lanes loaded w ith  proteins isolated from 
the differentiated cells showed that expression o f retinoschisin 
appeared to be enhanced by cell differentiation (Fig. 3). The 
antibody detected a clean monomeric band in the W eri-R b l 
cells and the media which contrasts w ith  the results from 
reduced retina in the same western blot showing additional 
bands o f  higher molecular weight and may indicate differences 
in oligomerization.
DISCUSSION
The identification o f  the retinoschisis gene (12) enabled 
computer analysis o f  its sequence and o f  that o f  the predicted 
protein. These analyses suggested that retinoschisin could be a 
secreted globular protein. Moreover, they showed that its 
sequence contains: a putative signal peptide w ith an endopepti- 
dase cleavage site; 10 cysteine residues which may form  disul­
phide bridges (rare in intracellular proteins); and a discoidin 
domain which functions in the extracellular environment in 
other proteins (18). The disease-causing mutations described 
in the RSI gene are most commonly missense mutations and 
cluster w ith in  the discoidin domain residues (17) o f  retino­
schisin, suggesting that this functional domain o f  the protein is 
responsible fo r interaction w ith  other proteins.
The results o f our studies confirm  that the expression o f  the 
RSI gene is restricted to photoreceptors in human retinae. They 
also suggest that retinoschisin is produced by photoreceptors in 
adult retinae and that it is secreted by these cells. Thus, the 
intriguing result showing RSI expression w ith in  photo­
receptors at some distance from the site o f retinoschisis
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Figure 3. (A ) RT-PCR o f W e ri-R b l cells using primers from RSJ exons 2 and
4. Lanes 1-3, RT-PCR using o ligo(dT) primers for the in itia l RT, W eri-R b l 
cells (lane l), water control (lane 2), W e ri-R b l cells w ithout RT 9 (lane 3); 
lanes 4 -6 , RT-PCR using random hexamer primers fo r RT, W eri-Rb 1 cells 
(lane 4), water control (lane 5), W eri-R b l cells w ithout RT (lane 6); lane 7, 
RSJ cD NA; lane 8, genomic D N A ; lane 9, water; lane 10, 1 kb ladder. Bands 
o f the expected size (262 bp) were observed w ith  W eri-R b l cells and the 
cD NA only, and not in any negative control, indicating that the cell line 
expresses the RSJ gene. (B) Immunoblot containing proteins o f  the W eri-R b l 
cells reacted w ith  RS24-37: results obtained w ith  proteins o f human retina 
(Hum Ret), W eri-R b l cells undifferentiated (U D) and differentiated (D), 
medium from  W eri-R b l cells undifferentiated (U D ) and differentiated (D), 
and unused medium used as control (control). RS24—37 recognizes a band ol 
-28  kDa in both undifferentiated and differentiated W eri-R b l cells and in 
medium from each. No band was observed in control medium. Thus, retino­
schisin is present in both undifferentiated and differentiated W eri-R b l cells 
and is released from  the cells into the medium.
pathology can be explained by secretion o f  retinoschisin into 
these layers.
The role o f  retinosehisin w ith in  the inner retina has yet to be 
established. Proteins containing discoidin domains are thought 
to be involved w ith ce ll-ce ll interactions, and discoidin, in 
Dictyostelium discoideum, from which this class o f  proteins 
drives its name, is a lectin involved in cell aggregation 
(18,23,26). The discoidin domain is present in a variety o f 
proteins but its interactions w ith ligands (either other protein 
domains or phospholipids) have not been fu lly  elucidated. The 
discoidin domain receptors (D D R l and DDR2), w ith  extracel­
lu lar discoidin domains and intracellular tyrosine kinase 
domains, are known to be activated by collagens, although the 
discoidin-binding domains w ith in  the collagen molecules are 
not yet defined (27,28). Blood coagulation factors V  and V III  
contain discoidin domains which are thought to interact with
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phospholipids on the surface o f platelets (29), and the secreted 
protein dell, which contains two discoidin domains, interacts 
with the aVpS integrin receptor (although this interaction is 
dependent on the RGD motif within an EGF repeat rather than 
the discoidin domain (30). Retinoschisin is a small protein 
consisting almost entirely o f one discoidin domain (and no 
other recognized domains), and thus elucidating its interac­
tions with cell surface receptors or the extracellular matrix may 
yield information applicable to the whole family of proteins 
about how this domain functions. The results we discuss here, 
which are consistent with secretion and interactions within the 
inner retina, are an important first stage of this work.
The pathological changes described in X-linked retinoschisis 
have previously been attributed to abnormalities in the Müller 
glial cell. The interaction o f retinoschisin with a Müller cell 
receptor such as an integrin receptor would be in keeping with 
its discoidin domain and an abnormality in this interaction 
could account for all the recognized findings. Alternatively, 
the pathology could be occurring secondarily to architectural 
disruption within the inner retinal layers leading to abnormal 
Müller and bipolar cell function resulting in, for example, a 
reduced b-wave in the electroretinogram. This may be the case 
if  retinoschisin interacts with components o f the extracellular 
matrix and could explain the detection of the high molecular 
weight bands when immunoblotting retinal extracts but bands 
of the expected size o f retinoschisin (in keeping with mono­
mers) when investigating protein secreted by Weri-Rbl cells. 
The high molecular weight bands detected in retinal extracts 
might represent protein complexes in which the other proteins 
originate from retinal cells distinct from photoreceptors (or 
Weri-Rbl cells). Further investigation of these protein inter­
actions may give insight into the processes leading to cell 
adhesion and architectural integrity within these retinal layers. 
Furthermore, investigation o f mutant retinoschisin will deter­
mine firstly whether it is successfully secreted from photo­
receptors and subsequently targeted appropriately within the 
retina, or secondly whether the different mutations interfere 
with crucial protein^rotein interactions within the inner 
retinal layers by interfering with the structure o f the discoidin 
domain.
In conclusion, retinoschisin, the protein causing X-linked 
retinoschisis, is the first example of a secreted protein leading 
to retinal dystrophy. Further evaluation o f its function may 
give insight into the processes leading to cell adhesion and 
architectural integrity within the retina.
MATERIALS AND METHODS
In situ hybridization
Sections (8 |xm) were cut fi'om paraffin embedded mouse 
retina and mounted on glass slides. The sections were dewaxed 
with xylene (twice for 10 min at room temperature) and the 
following steps used for preparation of the sections. The 
sections were rehydrated for 2 min in each of seven ethanol 
solutions at decreasing concentrations (100 to 30%), washed 
with phosphate-buffered saline (PBS), fixed with 4% para­
formaldehyde at room temperature for 20 min, treated for 10 
min with 0.2 M HClg, rinsed in PBS, acetylated with 0.5% 
acetic anhydride (10 min at room temperature) rinsed with 
PBS, treated with proteinase K (50 pg/ml in PBS supple­
mented with 0.02 M CaClj for 10 min at 37°C), washed in PBS 
and dehydrated for 2 min each in solutions of increasing 
ethanol concentration. The sections were then dried.
Sense and antisense probes were generated from a full-length 
RSI cDNA clone in Bluescript KS^ (a generous gift o f Dr B.H.F. 
Weber, Universitat Würzburg, Germany). Plasmid DNA was 
linearized using either Notl or //m din and digoxigenin-labelled 
riboprobes synthesized using T7 or T3 RNA polymerase 
(Boehringer Mannheim, Lewes, UK), respectively.
For hybridization, probes were diluted in hybridization 
buffer (2x SSC, 5% dextran, 0.2% Marvel, 50% deionized 
formamide) and denatured at 80°C for 2 min. Hybridization 
reactions were left overnight at 60°C and then washed in 
decreasing concentrations o f 2x SSC at 60°C for 45 min, Ix 
SSC 50% formamide at 60°C for 45 min and two 10 min 
washes in Ix and 0.5x SSC, respectively, at room temperature. 
Signals were detected by firstly soaking in buffer 1 (100 mM 
Tris-HCl pH 7.5, 100 mM NaCl, 2 mM MgClj, 0.05% Triton 
X-100, 0.3% Tween), blocking in buffer 2 for 30 min [0.5-1%  
blocking reagent (Boehringer Mannheim)] then incubating 
with 400 pi o f anti-digoxigenin alkaline phosphatase-conju­
gated antibody diluted to 1:500 in blocking buffer for 1 h. 
Sections were washed once in buffer 1 and soaked in buffer 3 
for 5 min (100 mM Tris-HCl pH 9.5, 100 mM NaCl, 50 mM 
MgCl2). Sections were incubated with colour change solution 
(4.5 pi o f nitroblue tétrazolium salt, 3.5 pi o f 3-bromo-3- 
indoyl-phosphate in 1 ml of buffer 3) in darkness until colour 
development and the slides mounted.
Antibody, SDS-PAGE and immunoblotting
Rabbit polyclonal antiserum was raised against peptide 
STEDEGEDPWYQKA (amino acid residues 24-37) conju­
gated to KLH (Genosys Biotechnologies, Pampisford, UK) 
and affinity-purified on the peptide (24), yielding antibody 
RS24-37. The Pierce (Rockford, IL) BCA kit was used to 
assay protein levels in tissue and cell samples to ensure even 
loading on gels. Protein samples were prepared by homogeni­
zation of tissues or cells in sample buffer (200 mM Tris-HCl, 
5 mM EDTA, 1 M sucrose, 0.1% bromophenol blue) 
containing 4% SDS (with the addition o f DTT to a final 
concentration of 10 mM for reduced samples), subjected to 
SDS-PAGE on 15% gels and electroblotted on to ECL nitro­
cellulose (Amersham, Little Chalfont, UK). Following 
blocking in 6% Marvel/Ix PBS/0.1% Tween 20 (blocking 
buffer) for 1 h at room temperature blots were hybridized over­
night with the affinity-purified primary antibody RS24-37 
(1:1000 dilution) at 4°C. Subsequently, anti-rabbit polyclonal 
secondary antibody conjugated to peroxidase (Amersham) was 
used at 1:3000 for 2 hat room temperature. Bands were visual­
ized using enhanced chemiluminescence (Amersham). When 
pre-adsorbed RS24-37 was used as a probe, 1 |ig/ml of the 
peptide used to generate the antibody was incubated with 
RS24-37 at 1:750 dilution for 4 h on ice in blocking buffer. 
These blots were then reacted with anti-actin antibody (Sigma, 
Poole, UK) at a dilution o f 1:2000.
Immunohistochemistry
After deep anaesthetic, mice were perfused with lactated 
Ringer’s (20-50 ml) and fixative (4% paraformaldehyde in 
0.066 M PBS at pH 7.4,100 ml). After dissection, retinae were
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further fixed in fixative, cryoprotected in 30% sucrose-PBS 
(pH 7.4, 4°C), frozen on dry ice and stored at -80°C. Paraffin 
embedded human retina sections were gifts o f Prof. Philip 
Luthert (Institute o f Ophthalmology, London, UK). Cryostat 
mouse retina sections (10 pm) were mounted on glass slides, 
permeabilized with cold methanol (-80°C, 3 min), blocked 
with 2% fish gelatin (1 h, room temperature), incubated with 
RS24-37 in 2% fish gelatin (1:1000, 4°C, overnight), and 
finally with biotin-conjugated goat anti-rabbit IgG in 2% fish 
gelatin (1:200,25°C, 1 h). The immunoreaction was visualized 
with the biotin-avidin^eroxidase (Vector Laboratories, Burl­
ingame, CA) and 3',3"-diaminobenzidine (DAB, 1 mg/ml; 
H2 O2 , 0.03%) (Sigma). The human retina sections were de­
paraffined successively with xylene, 100% ethanol and 95% 
ethanol before proceeding with the immunohistochemistry. 
Control (omitting the primary antiserum) was included 
included in each experiment. To verify the specificity o f the 
immunostaining, retina sections were also stained with pre- 
immune serum and RS24-37 pre-absorbed with the peptide 
epitope (25 pg/pl).
RT-PCR
RNA was extracted from undifferentiated cells using the 
RNeasy kit from Qiagen (Crawley, UK), following the 
manufacturer’s instructions. RT-PCR was performed using 
Superscript Preamplification System (Gibco BRL, Paisley, 
UK) to obtain the first strand cDNA with either random 
hexamer primers or oligo(dT) primers as per the manu­
facturer’s protocol. PCR was performed using exonic primers 
RSPEP10 (TTTTGAATTCCATATGTCTACCGAGGATG- 
AAGGC) and RSPEP5 (TTTTGTCGACCTCGAGTCAGTT- 
TGCAGTCCACGA) from exons 2 and 4, respectively 
(product size 262 bp), and primers RSPEP3 (TTTTGGATC- 
CCATATGGCCCGGCTCAACAGTCAA) and RSPEP6 
(TTTTGTCGACCTCGAGTCCGGCACAGTTGC) from 
exons 4 and 6, respectively. The following conditions were 
used: 94°C for 5 min, then 40 cycles at 94°C for 30 s, 55°C for 
30 s, 72°C for 1 min and a final extension o f 72°C for 10 min.
Retinoblastoma cell culture
Weri-Rbl human retinoblastoma cells (31) were obtained 
from the American Type Tissue Culture Collection 
(Manassas, VA). Cells were maintained in suspension culture 
in RPMI 1640 (Gibco BRL) supplemented with 10% fetal 
bovine serum, 2 mM L-glutamine, 100 U penicillin/ml and 
100 pg streptomycin/ml (Sigma), with medium changes 
every 2-3 days. For analysis by western blotting, cells were 
transferred to 30 mm six-well dishes for attachment and 
differentiation. The dishes were treated with 0.2 mg/ml poly- 
D-lysine (Sigma) for 30 min at room temperature and rinsed 
with distilled water before 5 pg/ml fibronectin (Sigma) was 
added for 1 h at room temperature. After this time the excess 
fibronectin was removed and the cells were seeded directly 
on to the adhesive surface at a density o f  1 x 10^  cells/well. 
Cells were grown as monolayer cultures for 7 days before the 
addition o f DBcAMP (Sigma) at a final concentration of 
2 mM. DBcAMP was readministered every 2-3 days with the 
medium changes. A sample o f the medium in which the cells 
had grown was taken at these times. Differentiation was 
assessed by the change in morphology o f the cells (25). After
9 days o f treatment the cells were gently scraped o ff the 
bottom of the wells and prepared for western blot analysis or 
determination o f protein concentration.
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Cone-rod homeobox {CRX), a paired-like homeobox 
transcription factor, plays a major role in photo­
receptor development and maintenance of the retina. 
Fifteen different mutations in the CRX gene have 
been identified as a cause of blinding retinal 
dystrophy. As a step towards characterizing the 
underlying pathophysiology of disease, temporal 
and spatial gene expression patterns during human 
and mouse eye development were investigated for 
CRX and for downstream retinally expressed genes, 
postulated to be transactivated by CRX. We found 
that human CRX was expressed at 10.5 weeks post­
conception (p.c.). This was significantly later than 
observed in mouse development. Immunocytochem- 
istry in human retina showed that CRX protein was 
not detected until >4 weeks later at 15 weeks p.c., 
implying that it would be unable to transactivate 
PDEB, IRBP and arrestin, which were all expressed 
before 15 weeks. These data therefore eliminate CRX 
as the major transcriptional activator of these three 
genes from a wide group of retinal genes that can be 
transactivated by CRX in vitro. Additionally, PDEB 
was expressed 2 weeks before CRX whereas murine 
Pdeb was expressed after Crx, highlighting a poten­
tial difference for the role of PDEB in human eye 
development. Previous data had shown CRX expres­
sion in the adult human retina to be photoreceptor- 
specific; however, we demonstrate that this gene is 
also expressed in the inner nuclear layer (INL) of the 
human and mouse retina by in situ hybridization and 
immunocytochemistry. INL localization of murine 
Crx was confirmed in rd/rd,ci mice, as in this mouse 
model the photoreceptors are absent. We have found 
important differences in the temporal expression of
this gene in human and mouse retina, although 
spatial expression of the CRX gene appears to be 
conserved. In addition, downstream targets of CRX 
in vitro might not represent in vivo function during 
development. These data support concerns about 
the extent to which we can extrapolate from rodent 
models regarding embryonic development and 
disease pathophysiology.
INTRODUCTION
The process of retinal development involves a hierarchy of 
transcription factors regulating increasingly complex 
programmes of gene expression and cell fate determination 
(1,2). One such transcription factor is the cone-rod homeobox 
(CRX) gene (3-5). CRX is a member of the OTX-like 
homeobox gene family, a group of transcription factors that 
encode paired-like (prd) homeodomain proteins. The OTX 
proteins are involved in the regulation of anterior head 
structure and sensory organ development (6). Localized to 
human chromosome 19ql3.3, mutations in the CRX gene have 
been found to cause autosomal dominant cone-rod dystrophy 
(4,7-9) and autosomal recessive Leber congenital amaurosis 
(8,10-12). Both these diseases are clinically and genetically 
heterogeneous. Cone-rod dystrophy is a severe form of retinal 
dystrophy, which often begins in the second decade of life and 
is untreatable and incurable (13). Leber congenital amaurosis 
is characterized by total blindness at birth or shortly thereafter 
(14), with no detectable electroretinogram (derived from 
photoreceptor cells).
The CRX protein binds to a conserved site or CRX-binding 
element (CBE 1), C/TTAATC/T, which is present in the 
upstream region of many photoreceptor-specific genes such as 
rhodopsin, arrestin and interphotoreceptor retinoid-binding 
protein (IRBP) (3,5). Recently, a second and weaker CBE-like 
motif has been identified, giving an 11-base motif in a head-to-tail
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Figure  1. RT-PCR analysis during early human eye development. Lanes 1-5 are cD NA samples from 8.5, 9.5, 10.5, 11.0, and 13.5 weeks p.c., respectively. Lane 
6 is adult cD N A and lane 7 is a negative control. The retinally expressed genes tested by RT-PCR were (A ) SIX3, (B) CRX. (C ) arrestin, (D) IRBR, (E ) PDEB, (F) 
rhodopsin, (G ) RSI, (H ) PDEA, ( I)  PDEG, (J) red/green cone opsin, (K ) blue cone opsin and ( I,)  NRL. The D NA marker for (A ) and (H—L) is <|)X 174 (Gibco) and 
fo r (B—G) is UX) bp ladder (Gibco).
arrangement with C B E l (CnTAATC/TG/AGA/CTT/C). This 
m o tif has been identified in the upstream regions o f retinally 
expressed genes, which are down-regulated in the absence o f 
Crx  in mouse retina (15,16). Jn vitro, CRX is capable o f 
transactivating retinal gene reporter-constructs carrying the 
C/TTAATC/T binding site (3,5); however, transactivation by 
CRX in vivo remains to be confirmed.
The CRX transcription factor has been shown to be critical 
for the differentiation o f photoreceptors during retinal develop­
ment and also the maintenance o f these structures in adult 
tissue (3). Over-expression o f retroviral Crx in developing 
retinal cells results in a marked increase in rod photoreceptors 
and an almost complete absence o f amacrine interneurons (3), 
h ighlighting the importance o f this transcription factor in 
morphogenesis and the determination o f cell function. 
Targeted disruption o f murine Crx results in the failure o f 
photoreceptor outer segment (OS) growth and thus the absence 
o f phototransduction (16). Characterization o f gene expression 
in the Crx null mouse has indicated that a number o f photo­
receptor genes are down-regulated in the absence o f Crx (16), 
and the m ajority o f these genes are crucial either to phototrans­
duction or to the structural formation o f the photoreceptor 
cells.
Studying the temporal and spatial expression o f develop­
mental genes can be used for dissecting biological develop­
ment and disease pathophysiology (17). To date in adult 
tissues, CRX expression has been shown to be specific to the 
photoreceptor cell layer o f the retina (3 -5 ) and the pinea- 
locytes o f the brain (5). In the developing murine retina, Crx 
expression, as detected by in situ hybridization, is observed at 
embryonic day (E)12.5, coinciding w ith cone photoreceptor 
cell genesis (3). A t postnatal day 6 (P6), peak expression is 
seen in correlation w ith the increase in photoreceptor cells 
expressing rhodopsin and other phototransduction genes. The 
expression pattern o f CRX during human development has not 
been reported, and the data on expression o f some o f the retinal 
genes that CRX is believed to regulate is lim ited. In the present 
study, RT-PCR and in situ hybridization analysis were carried 
out to evaluate temporal and spatial gene expression during 
human retinal development, and immunœ ytochemistry was 
undertaken to confirm  protein expression. Much o f what is
reported about this gene’s function is based on mouse studies. 
Comparative gene expression patterns in the retina were there­
fore investigated to highlight any potential human/mouse 
differences in the expression o f this and related genes during 
development.
RESULTS
R T - P C R  a n a l y s i s  o f  CRX  e x p r e s s i o n  i n  t h e  h u m a n  a n d  
m o u s e  d e v e l o p i n g  e y e
To identify the point during human eye development at which 
CRX is expressed, RT-PCR analysis was carried out on total 
RNA extracted from human fetal and adult eyes. In itia lly , the 
sine oculis homeobox gene 3 {SlX3/Six3) was am plified from 
both human and mouse cDN A as a positive control. S1X3 is 
expressed in the developing human eye as early as 5 -7  weeks 
gestation and expression is also maintained in mature ocular 
tissue (18). In the mouse, SLx3 expression is seen in the optic 
vesicles at E9.5 and by E l 1.5 expression is observed in the 
neural retina (19). SIX3/Six3 was present in all ages tested o f 
both human (Fig. 1 A ) and mouse cDN A (Fig. 2A), confirm ing 
RNA integrity o f all samples. Exonic primers were designed to 
span intron I o f the CRX gene, to avoid the possib ility o f 
am plify ing from contaminating genomic DNA. A m plification 
o f the CRX gene produced positive results from 10.5, 11.0 and
13.5 weeks post-conception (p.c.) and from  the adult control 
(Fig. IB ). It was not possible to am plify CRX from either o f the 
two younger fetal samples (8.5 and 9.5 weeks p.c.) and there­
fore the onset o f CRX expression must occur between 9.5 and
10.5 weeks o f development. Gene expression is presumably 
maintained from  10.5 weeks to adult, as shown w ith CRX 
expression studies in the mouse (3). An identical procedure 
was used to am plify Crx from  embryonic mouse eyes. Expres­
sion was seen first at E l 0.5 and this expression was maintained 
in all cDNAs tested, both embryonic and postnatal (Fig. 2B).
R e t i n a l - s p e c i f i c  g e n e  e x p r e s s i o n
A number o f retinal-specific genes containing CRX binding 
sites in their promoter were also analysed by RT-PCR to
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Figure 2. RT-PCR analysis during mouse eye development. Lanes 1—6 are cD N A  samples from E9.5, E1Ü.5, E l 1.5, E l2.5. E13.5 and E14.5, respectively. Lane 
7 is adult cD N A and lane 8 is a negative control. I^nes 9-20  are cDNA samples from  P1-P12, respectively. I^ n e  21 is adult cDNA and lane 22 is a negative 
control. The genes tested by RT-PCR were (A ) Six3. (B) Crx, (C ) arrestin, (D) Irhp, (E) Fdeh, (F) rhodopsin, (G ) R sl, (H) Pdea, (1) Prfeg, (J) green opsin, (K) 
blue opsin and (L ) N rl. The DNA marker used was 0X174 (Gibco).
determine their onset o f expression relative to that o f CRX. I f  
CRX was expressed before these genes, it is possible that CRX 
could transactivate them in vivo. Arrestin was expressed at
13.5 weeks p.c. in the human eye (Fig. 1C) and at E l4.5 in the 
mouse eye (Fig. 2C), although a low level o f expression was 
observed. Human IRBP  is expressed at the same time as CRX 
(10.5 weeks), therefore CRX could potentially transactivate 
IRBP in vivo (Fig. 1 D). Irhp  in mouse was detected at E l0.5, 
the same time as Cr.x is first expressed (Fig. 2D), thus showing 
conserved temporal expression o f IRBPHrbp and CRX/Cr.x 
between man and mouse. A striking result was obtained fo r 
PDEB  in the human retina, where it was expressed from  an 
early stage (8.5 weeks p.c.) o f development (Fig. IE ) 
preceding CRX expression by 2 weeks, whereas expression o f 
Pdeb in the murine retina begins at E l 1.5 (Fig. 2E), after Crx 
gene expression was first detected. Hence, comparative 
temporal expression o f PDEB/Pdeb and CRXICrx is not 
conserved between species.
Rhodopsin expression was absent from all human fetal 
cDNAs, but was observed in the adult retinal control cDN A 
(Fig. IF). In the mouse, rhodopsin expression was only 
observed postnatally, from P5 onwards, corresponding with 
rod photoreceptor OS development (Fig. 2F). In other species 
such as rat (20) and in human fetal retina (21 ) opsins have been 
detected before birth by immuncx-ytochemical studies. Other 
studies in rats report later onset o f expression (22). These
differences may be due in part to detecting cell-specific 
expression, rather than a more global RT-PCR approach. We 
have tested our 13.5 and 15 week retinal sections fo r rhodopsin 
expression by in situ hybridization and found no expression 
(data not shown). Retinoschisin [RS I) was not expressed in 
any o f the human fetal ages tested and neither were the a -  and 
y-subunits o f phosphodiesterase (PDEA/PDEG), nor green or 
blue cone opsin (Fig. IG -K ). Comparable results were 
observed w ith mouse samples, with each gene having a 
specific time-of-onset during postnatal retinal maturation 
(Fig. 2G -K ). Expression o f NRL was not seen at any o f the 
developmental stages tested in human fetal retina (Fig. IE ) and 
in mouse it was first observed at PI (Fig. 2L).
In  situ a n a l y s i s  o f  CRX  e x p r e s s i o n  i n  h u m a n  f e t a l  a n d  
a d u l t  r e t i n a
The expression o f CRX was further investigated in the devel­
oping human retina by in situ hybridization analysis. Retinal 
sections o f 10 and 12 weeks o f development were tested, since 
the RT-PCR data had shown CRX expression at these times. 
However, we were unable to detect expression o f CRX, ind i­
cating that it is like ly  that the in situ analysis was not sensitive 
enough to detect CRX expression at low levels. A t 13 weeks 
p.c., CRX expression was observed in the neural retina adjacent 
to the retinal pigment epithelium (RPE), where newly born
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Figure 3. In .situ hybridization analysis o f CRX expression in human fetal and 
adult retina. Left panels are haematoxylin and eosin (H & E ) stained sections 
adjacent to corresponding in situ in right panels. (A ) In human fetal retina at 13 
weeks p.c., staining is observed in newly born photoreceptors (NBPR). lying 
just vitreal to the RPE. N BL, neurohlastic layer; PGCL, presumptive ganglion 
cell layer. (B) In human fetal retina at 15 weeks p.c., expression is seen 
throughout the developing O N L, and is absent from the developing IN L . (C) In 
adult human retina, CRX is localized to both O NL and INL. Scale bars, 100 pm.
photoreeeptors are present (Fig. 3A). A t 15 weeks p.c,, CRX 
expression was much stronger and was localized specifically to 
the developing outer nuclear layer (O N L) o f the retina 
(Fig, 3B), consistent w ith the in situ expression pattern in 
mouse embryonic retina (3). In adult tissue CRX is expressed 
in the O N L o f the retina, which contains the nuclei o f the rod 
and eone eells (Fig. 3C). However, expression was not lim ited 
to the O N L o f the adult retina, as staining was also detected 
w ith in the inner nuclear layer (IN L ) o f the retina. Whereas the 
staining in the O N L was strong and diffuse, presumably in 
both the rtxi and cone nuclei, staining in the IN L  was weaker 
and punctate, suggesting that CRX expression in the IN L  may 
be localized to a particular subset o f retinal cells,
CRX immunocytochemistry in human retina
We generated an N-term inal peptide antibody, which detected 
a specific 37 kDa band by western blotting o f total mouse 
retinal extract (Fig, 4A), The specificity o f detection was 
confirmed by western blotting with pre-immune serum (which 
did not detect this band) and pre-incubation o f the antibody 
with the peptide used to generate it (this removed the ab ility  o f 
the antibody to detect the band; data not shown). Using this 
antibody we first saw immunochemieal localization o f CRX 
protein in the fetal retina at 15 weeks p.c,, where strong 
staining was present in the photoreceptor cells adjacent to the
RPE (Fig, 4B). Weak staining o f the ganglion cell layer (G CL) 
was also noted at 15 weeks p.c. S im ilar GCL staining was 
present in controls w ithout primary antibody, suggesting non­
specific staining by the secondary antibody. No staining o f the 
G CL was detected by in situ hybridization (Fig. 3B) in the 
same age embryos. Using the same conditions for immuno­
histochemistry, we did not detect protein at 13 weeks p.c. 
(Fig. 4C). Thus, CRX protein was only detected 2 weeks after 
we eould detect CRX m RNA by in situ hybridization (at 13 
weeks p.c.). This apparent interval between mRNA expression 
and protein localization may, however, reflect a difference in 
threshold o f sensitivity o f in situ hybridization compared w ith 
the immunocytochemistry technique.
Crx gene and protein expression in rod less coneless (rd/rd,cf) 
retina
To corroborate CRX expression in the IN L  o f human retina, we 
took advantage o f the rd /rd ,c l mouse, where the O N L o f the 
retina degenerates completely by P80 due to a lesion o f rods 
(rd/rd) and a transgenic ablation (c l) o f cone photoreceptors 
(23). Crx was am plified from rd /rd ,c l retinal cDN A and also 
from wild-type mouse retinal cDNA isolated at P80. Crx R T - 
PCR products were observed in both samples, confirm ing that 
Crx expression is not confined to the O N L o f the retina 
(Fig. 5A). It was not possible to am plify rhodopsin, green or 
blue cone opsin from  the rd /rd ,c l mice (Fig. 5B), inferring that 
the RT-PCR products were not due to any remaining rod and 
cone photoreceptor nuclei.
To confirm  that Crx  expression in rd /rd ,c l mice was local­
ized to the INL, in situ hybridization was performed on eyes 
taken from adult rd /rd ,c l mice, which were then compared 
with w ild-type eyes. The spatial expression o f Crx in w ild-type 
eyes reflected that o f the human adult retina, as staining was 
observed in both the O N L and IN L  o f the retina (Fig. 6A). It 
was evident that IN L  Crx staining was noticeably weaker than 
that o f the O NL, consistent w ith the human data (compaie Fig. 
6A with Fig. 3C). Expression was also observed in the IN L  o f 
the rd /rd ,c l mice (Fig. 6B), confirm ing the RT-PCR data. By 
immunocytochemistry, Crx protein was localized to both the 
O N L and IN L  in w ild-type adult mouse retina (Fig. 6C). In the 
rd/rd,c l mouse retina, Crx protein was localized to the IN L  
(Fig. 6D). Interestingly, by both in situ hybridization and 
immunocytœ hemistry, the IN L  staining o f the rd /rd ,c l retina 
was stronger than previously observed in either the IN L  o f the 
adult human sections or the w ild-type mouse. This suggests 
that either the O NL acts as a competitor for the Crx probe 
during hybridization or, alternatively, that Crx expression is 
up-regulated in mice lacking rod and cone photoreceptors. To 
investigate this possib ility, sections o f rd /rd ,c l eyes were taken 
before (P9) and after (P I 3) retinal degeneration had started. By 
immunocytochemistry we were unable to detect up-regulation 
o f Crx protein, w ith sim ilar levels o f Crx detected at each time 
point examined (data not shown),
DISCUSSION
Between 8 and 20 weeks o f fetal development, the human 
retina progresses from  a basic two-layered structure 
comprising the inner and outer neurohlastic layers to a highly 
differentiated and m ulticellu lar structure (24,25). During this
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Figure 4. Immunocytochemical localization o f CRX in fetal human retina. (A ) Western blot o f N-terminal peptide antibody showing a single band at 37 kDa. 
(R ) Le ft panel. H & E  staining; right panel, antibody localization at 15 weeks p.c. Green fluorescence present in newly formed photoreceptors. (C) No antibody 
detected at 13 weeks p.c. Scale bars. 100 pm.
time the cells destined to become photoreceptors begin to 
develop in the outer neural layer o f the retina. Cone nuclei are 
born earlier than those o f rod photoreceptors, first appearing at 
-1 0  weeks o f development during formation o f the fovea (21 ). 
Rod nuclei, however, are bom a little  later than this and are 
subsequently not present until -1 2  weeks o f development 
(24,25). Our own observations show that CRX is not expressed 
until 10.5 weeks in the human retina. Therefore, it is like ly  that 
the first cells to express CRX in the developing human retina 
are the newly born cone photoreceptor nuclei. Continued CRX 
expression in the outer retina coincides w ith cone and rod 
specification and structural maturation o f the photoreceptors. It 
is important to note that the onset o f expression ixzcurs later in 
human development than it does in the mouse. In the mouse 
retina we detected Cr.x expression at E l0.5. This equates to 
-3 0  days ( -4  weeks) in human development based on Carnegie 
comparisons, highlighting a difference in temporal CRX 
expression between species. At birth the photoreceptors are 
fu lly  differentiated in the human retina. In mouse retina, 
however, rod maturation is not complete until - P I 6 (26). The 
role o f CRX in the tim ing o f differentiation is therefore 
different in mouse than human, suggesting that other factors/ 
cues are involved.
The early expression o f PDEB  was unexpected and suggests 
that transactivation o f PDEB occurs independently o f CRX. 
Furthermore, presence o f a CRX binding site in the promoter 
region o f a gene, as is the case for PDEB, should not be 
regarded as evidence that CRX transactivates the gene in vivo, 
even though it is possible to drive expression o f a PDEB 
reporter constmct w ith CRX (5). Previous work on PDEB  has 
indicated the presence o f a conserved AP-1 element in both the 
human and the mouse proximal 5' regions o f the gene (27). 
A dditionally, mutation o f the CRX binding site in the PDEB 
promoter had no effect on transcription o f a reporter gene, 
suggesting that CRX is not important in transactivation o f 
PDEB (27). The reason for such an early expression o f PDEB  
is unclear, although this observation suggests that the PDEB  
may have a role during the development o f the human retina 
that is alternative to its role in phototransduction in mature 
retina. The early expression o f Pdeb is not mirrored w ithin 
mouse retinal development, where it occurs after Crx gene 
expression. This highlights a potential difference fo r the role o f 
PDEB!Pdeb between these two species.
The expression pattern o f NRL was included in this study, as 
previous work has suggested that CRX and NRL work 
synergistically in the activation o f a number o f retinal targets 
(5). Expression o f NRL was not detected in any o f the fetal 
tissues we tested. Therefore, i f  CRX is responsible for activa­
tion o f retinal genes expressed at 13.5 weeks or earlier, such as 
IRBP  and arrestin, then it must do so independently o f NRL. 
Very recent data have shown that N rl null mice completely 
lack rod photoreceptors and im ply that N rl plays an important 
role in directing gene expression in rod photoreceptors (28). 
N rl expression has been detected slightly earlier than in our 
study at E l 8.5 in mice, in line w ith our view that Crx is acting 
independently o f N rl early in development. Another anomaly 
we found w ith N rl expression was that in mouse, N rl was 
expressed much later (P I) than Pdeb ( E l2). However, in rat 
retina it has been shown by northern blotting that N rl expres­
sion precedes Pdeb by two postnatal days (22). Thus, even 
between species o f tbe rodent lineage there seem to be d iffe r­
ences in temporal gene expression.
Although, IRBP  has a CRX binding site in its promoter, it 
seems unlikely that IRBP  is itself regulated by CRX in vivo 
since it is not down-regulated in the absence o f Cr.x in the null 
mouse (16). Furthermore, it has been shown recently that 0TX2 
binds specifically to the IRBP promoter in yeast one-hybrid 
studies, whereas CRX was not identified (29). Thus, IRBP  is 
another example o f a gene containing a CRX binding site in its 
promoter, which can be transactivated by CRX in vitro\ 
however, other studies show that CRX is unlikely to be the 
main transcription factor involved in IRBP gene expression.
Whether CRX can function as a transcriptional activator in 
vivo relies on the protein being present, rather than just 
evidence that the gene is being expressed. We detected CRX 
expression by RT-PCR at 10.5 weeks p.c. and by in situ 
hybridization at 13 weeks. In contrast, significant levels of 
CRX protein were only detected at 15 weeks p.c., whereas no 
protein was detectable at 13 weeks p.c. using the same 
immunohistochemical conditions. Although lim itations to the 
sensitivity o f the immunostaining mean that we cannot rule out 
the presence o f low levels o f protein before 15 weeks, our data 
does point to the possib ility o f post-transcriptional control of 
CRX expression.
Transcript localization and translational regulation are two 
post-transcriptional mechanisms for the spatial and temporal 
regulation o f protein production (30). There are a number o f
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Figure 5. RT-PCR analysis from  w ild-type and rd/rd.cl mouse retinal cDNA. Lane 1, rd/rd.cl cDHN, lane 3, w ild-type cD N A ; lanes 2 and 4 are negative controls. 
The genes amplified were (A ) CRX, (B ) rhodopsin, green opsin and hlue opsin, respectively. The DNA marker used was 0X174 (Gihco).
examples showing that even though a gene is transcribed 
(e.g. nanos and oskar mRNAs), and is localized in the right 
cells, it is translationally repressed by proteins binding to cis- 
acting elements in 3'-untranslatcd region (3 '-UTR) sequences 
(31,32). Translation is activated at the appropriate time by 
proteins binding to 5 '-UTR sequences (33,34). Thus, we 
propose that retinally-expressed genes transcribed before 
15 weeks p.c. in human fetal retina occur independently o f 
CRX. Thus, in addition to PDEB  and IRBP, we would exclude 
arrestin from transactivation by CRX in vivo.
The in situ hybridization and immunocytochemistry data 
convincingly demonstrate that the CRX gene and protein are 
expressed in the IN L  o f both human and mouse retina. This is 
consistent w ith previous expression data observed in mouse 
(35) and zehrafish retina (36). IN L  expression o f CRX has been 
previously dœumentcd in the retina o f P6 mice (3) and this 
was thought to correspond to developing photoreceptors 
trapped on the vitreal side o f the inner piexiform  layer (37). 
However, we have clearly shown IN L  layer CRX expression in 
human adult retina. This was verified in the n i/rd ,c l mouse 
retina which has no photoreceptor cells present. It is clear that 
expression o f retinal CRX is not exclusive to the photorecep­
tors o f the O NL and that its role in development may not he 
lim ited to differentiation and regulation o f the photoreceptors 
as previously thought. The exact role o f CRX in the inner 
retina remains to be determined. However, in Crx null mice 
cireadian entrainment is attenuated ( 16). This is the only retinal 
modifieation, other than complete lesion, that has been shown 
to impair circadian photo-entrainment in mammals. This 
suggests that Crx may have a role, directly or indirectly, in 
circadian rhythm icity, and perhaps this is mediated via cells o f 
the inner retina. We are fo llow ing a number o f lines o f investi­
gation to test this hypothesis.
The reliance on extrapolation from  rodent embryonic 
expression studies to humans has been justified by strong s im i­
larities in the organization, morphology and evolutionary 
conservation o f many key genes. However, recent studies have 
shown that there are both temporal and spatial differences 
between species (38). This could explain why attempts to make 
mouse models by gene targeting often prcxluce either no 
phenotype or phenotypes that do not resemble the human 
condition (39). The extent to which our findings represent true 
functional differences fo r CRX remains to he determined. The 
Cr.r null mouse shows attenuated circadian photo-entrainment, 
whereby it takes approximately twice as long to entrain to a 
new light stimulus compared with w ild-type mice (16). No 
circadian rhythm disturbance, sueh as abnormal sleep pattern 
or symptoms akin to prolonged ‘je t-lag ’ , has been reported. 
Such disturbances, however, have not been thoroughly
investigated in humans w ith the CRX mutation. I f  humans do 
not have these disturbances it would suggest, in the mouse, that 
Crx has other functions, or in humans, that there is a compen­
satory mechanism. Species differences in longevity or m odifier 
genes could he involved in this human/mouse difference; 
however, this deserves further investigation. The current work 
emphasizes the value o f comparative studies in validating 
animal models o f human disease and the lim ited degree o f 
extrapolation that can he drawn from in vitro experiments.
MATERIALS AND METHODS
Tissues utilized for studies
Human fetal tissue collected from social terminations o f preg­
nancy was obtained from the MRC Tissue Bank, Hammersmith 
Hospital, London, w ith ethical approval. Staging o f fetal 
embryos was by last menstrual pericxl and crow n-rum p length. 
Specimens were transferred, <4 h post-operatively, to liquid N , 
fo r RT-PCR, or to 4% (w /v) parafonnaldchyde in phosphate- 
buffered saline (PBS) fo r fixation at 4°C for 18 h fo r in situ 
hybridization analysis. Mouse embryos were obtained from 
matings o f C57BL/6 x  CBA mice. The day on which the 
vaginal plug was detected was designated as EÜ.5. Tissue from 
rd/rd,c l mice was taken at P80 and tissue from age-matched 
wild-type eyes was taken when the O N L was absent by histo­
logical analysis.
Expression analysis using RT-PCR
Total RNA was extracted from human eyes using the RNAzol 
RNA extraction kit (Biogenesis), whilst TR Izol (G ibco BRL) 
was used to isolate total RNA from mouse eyes according to 
the manufacturer’s instructions. The Superscript pre-am plifi­
cation system (Gibco BRL) was used to generate cDN A for 
PCR from 1 pg o f total RNA. Identical aliquots o f cD N A  were 
used for amplifieation using gene-specific primers. The CRX 
exon 1 forward primer (5 '-CC CTG AC TTG G G CC TCAG T-3') 
and exon 2 reverse primer (5'-CCACCTCCTCACGGGCATA-3') 
were designed to span intron 1 and am plify a product o f 
250 bp. The PCR profile  typ ica lly incorporated an in itia l 
denaturing step at 94°C for 5 min followed by 30 cycles o f 
dénaturation at 94°C for 45 s, annealing at 55°C fo r 45 s and 
extension at 72°C fo r 45 s, w ith  a fina l extension at 72°C for 
5 min. The time o f expression for each gene was tested on 
three independent tissue samples at each time point. Primers 
used to am plify other retinal genes were as follows:
Rhodopsin (436 bp), 5 '-AC C AG A TC A C C TG C TC TA A C /5 '- 
TCTTG G ACACG G TAG CAG AG G ;
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F igure  6. In situ hybridization and immunocytochemical (ICC) analyses in w ild-type and rd/rd.cl retinal sections. (A ) Crx mRNA expression in w ild-type retina 
present in O N L and more weakly in IN L. I ^ f t  panel, I I& E ; right panel, in situ. (B ) Crx mRNA expression in /-(i/rri.c/retina present in IN L . Left panel, I I& E ; right 
panel, in situ. (C) CRX antibody localization in w ild-type retina. lx ;ft panel, phase contrast; right panel. ICC. (D ) CRX antibody localization in rd /rd .c l retina in 
the IN L. Left panel, phase contrast; right panel, ICC. (A and B), lOx magnification; (C and D), 20x magnification.
PDEB (425 bp), 5 -AGGAGACCCTGAACATCTACC/5'-ATG-
AAGCCCACITGCAGC;
PDEA (464 bp), 5'-CTCCATGGG rCCTCTATC/5'-CCGACTT-
GAAGCTTAGGG;
PDEG (594 bp), 5'-GCAGCAGGAGGGAG ra5 '-G A C C A AG C - 
crcrcrG iG G ;
arrestin (406 bp), 5'-AAAAAGTGCCACCAAACAGC/5'-GCG- 
iC A  i r c r r G  r c T C T c n c c ;
RSI (434 bp), 5 '-ACC AG ATCAC CrG CTCTAAC/5'-ACAC rr- 
GCTGACGCACTCC;
IRBP (1097 bp), 5 '-CC lTTG CAC ACACC AïG C/5 '- CATGAT- 
ATAGG TGAACrCC;
NRL (287 bp), 5'-GTGCCrCCTrCACCCACC/5'-CAGACATC- 
GAGACCAGCG;
green opsin (231 bp), 5'-GCCCAGACGTGTl CAGCG/5'-GACC- 
ATCACCACCACCAT;
blue opsin ( 1 76 b p ) ,  5'-GGTCACTGGCCTTCC3'GG/5'-'rGCAG- 
GCCCTCAGGGAIG;
SIX3 (242 bp), 5'-AGTCCACACACACTCCCAC/5'-CGTCATG- 
CAGGTGGGGTCG.
Where primers designed against the human gene sequence were 
not compatible with mouse, specific primers to mouse homologous 
genes were used:
Pdeg (282 bp), 5'-GTCTCTGCCAGCCTCACC/5'-CTA AATGA- 
IGCCATACTGGG;
Pdea (717 bp). 5'-CTCCATGGGTCCTCCATC/5'-CTGGATGC- 
AACAGGACTT;
Rsl (434 bp), 5 '-ATCAG ATCACTrGCACCA/5'-ACACTrG C- 
CGGCACACTC;
blue opsin (339 bp), 5'-CAGCCrrCAd’GGGA4Td'G/5'-GTGCA- 
rG CrrG G AG ITG A;
Irhp (427 bp), 5'-CCCrCCCCAGAAGTCTTT/5'-CAGCCTCr-
TC A ÏG A TG TA ;
Ar/(287 bp), 5'-GTGCCTCCTrCACCCACa5'-GCTGCCGGC- 
AACTCGC;
arrestin (390 bp), 5 '-A A A A A G T G C A G C C A A A C A G C /5 '- 
C A T C TrTC TTC C C TTC TG TG ,
In situ h y b r i d i z a t i o n
Fresh human or murine eyes were fixed overnight in 4% para- 
foiTnaldehyde in PBS and incubated overnight again in 20% 
sucrose in PBS at 4°C, The eyes were orientated and flash 
frozen in O C T, compound (BDH ) using a chamber o f dry ice 
and isopentane. In situ hybridization analysis was performed 
w ith digoxigenin-labelled riboprobes on 10 fim  cryostat sagital 
sections through the central retina. The probes were generated 
from a pG EM -T plasmid (Promega) into which either a 445 bp 
fragment o f the human 3' CRX cDN A (forward primer, 5'- 
G G A C TA C A A G G A TC A G A G TG C C TG -3 '; reverse primer, 
5 '-G TTA A G TTA TC A A G C C C C C C TAC C -3 ') or a 300 bp 3' 
Crx mouse fragment (forward primer, 5'-CTCCTCCAG CTT- 
A G ATTC -3 '; reverse primer, 5 '-CC CG G AG TTC TAAG - 
C C A A -3 ') had been cloned. The plasmids were linearized w ith  
either N otl (fo r antisense probe) or Ncol (for sense probe). 
Digoxigenin-labelled riboprobes were generated using either 
SP6 RNA polymerase (antisense) or T7 RNA polymerase 
(sense) in the presence o f digoxigenin RNA labelling m ix 
(Roche) in accordance with the manufacturer’ s instructions. 
Immediately before use, the probes were diluted to a concen­
tration o f 1 ng/gl in hybridization buffer (10 m M  T ris -H C l pH 
7,5, 200 m M  NaCl, 5 mM NaH^PO^, 5 m M  Na^HPO^, 5 mM 
EDTA, 1 mg/ml tRNA, 50% formamide, 10% dextran 
sulphate, Ix  Denhardt’ s), The probes were denatured fo r 5 min 
at 70°C and quenched on ice. Hybridization was performed 
overnight at 65°C in a hum idified chamber o f 50% formamide 
and 2x SSC, Immuncxietection was carried out using a 1:1000 
dilution o f anti-digoxigenin alkaline phosphatase-conjugated 
Eab fragments (Roche), Hybrids were visualized w ith the 
BCIP/NBT substrate (Roche), Images were viewed using a 
Leitz Aristoplan microscope with digita l image capture
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(Olympus DPIO camera). In situ experiments were repeated on 
three different eyes at each time point.
Generation of an N-terminal antibody to human CRX
A peptide was synthesized commercially using Fmoc chem­
istry (Sigma-Genosys) corresponding to the first 24 amino 
acids of CRX protein. The peptide was conjugated to keyhole 
limpet hemocyanin and then used to generate a rabbit poly­
clonal antibody by standard protocols. Serum samples were 
desalted prior to IgG fraction by DEAE affi-gel chromato­
graphy (Bio-Rad). Protein concentrations were estimated using 
a Bradford assay (Pierce).
Western blotting
Mouse retinal tissue was dissected in ice-cold PBS, added to 
solubilization buffer (150 mM NaCl, 1% Tergitol, 0.5% 
sodium deoxycholate, 0.1% SDS, 50 mM Tris-HCl pH 8.0) 
containing protease inhibitor cocktail (Sigma) and kept on ice 
for 15 min. Tissue was sonicated, placed on ice for 10 min and 
then centrifuged at 10 000 g for 2 min. The supernatant was 
then mixed 1:1 with Laemmli sample buffer, denatured for 
5 min at 100°C and the proteins were separated by 12% SDS- 
PAGE relative to low molecular weight standards (Biorad). 
Each sample loaded on a gel contained protein equivalent to 
one mouse retina in a 10 pi volume. Proteins were electro- 
phoretically transferred onto nitrocellulose membrane 
(Schleicher and Schuell) using a Tris-glycine buffer system 
(48 mM Tris, 39 mM glycine, 0.037% SDS, 20% methanol). 
The membrane was pre-incubated in blocking buffer (5% non­
fat milk, 0.1% Tween-20 in PBS) at 4°C for several hours 
followed by incubation with primary CRX antibody (diluted 
1:250 in blocking buffer) for 1 h at room temperature. After 
three washes in PBS, 0.1% Tween-20, the membrane was 
incubated for 1 h at room temperature with a 1:3000 dilution of 
goat anti-rabbit conjugated-HRP in blocking buffer. After 
three final washes the peroxidase reaction was visualized by 
enhanced chemiluminescence (Amersham Pharmacia Biotech).
Immunocytochemistry
The sections for immunocytochemistry were taken from the 
same eyes that were used for in situ hybridization at each time 
point. To reduce non-specific labelling, 10 pm cryostat 
sections were incubated for 2 h at room temperature in 
blocking solution (PBS, 0.5% bovine serum albumin, 0.2% 
Triton X-100, 0.5% sodium azide) containing 2% normal 
donkey serum (Sigma). The sections were incubated with the 
primary CRX antibody in the same buffer (1:40) for 16 h at 
4°C, rinsed in blocking solution and then incubated for 30 min 
at room temperature in secondary antibody (1:200) conjugated 
to fluorescein isothiocyanate (affinity-purified and species- 
absorbed donkey anti-rabbit IgG, Chemicon). Immunolabelled 
sections were mounted with Immunofluore (ICN) and were 
examined with a Leica laser scanning confocal microscope. 
Phase and fluorescence confocal images were exported to 
Photoshop 4.0 (Adobe) for annotation and dye-sublimation 
prints were generated.
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NOTE ADDED IN PROOF
A novel 12 bp deletion mutation in CRX has been identified by 
Tzekov, R.T. et al. (40).
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Co r r ec tio ns  to  text
Page 43: PaxBT'’  mice develop incorrectly patterned forebrains and morphologically normal optic vesicles. However, optic cups 
are not formed because lens induction fails when the vesicle meets the mutant surface ectoderm, and homozygous mice are 
neonataily fatal owing to CNS defects (Grindiey etal. 1997).
Page 51 : Retinoic acid (RA), which is known to regulate many aspects of development (Ross at al. 2000), is produced is large 
quantities in the developing vertebrate retina, although its role is poorly understood (Drager etal. 2001) (see Appendix D).
Page 121 : in the adult retina, ChxIO expression is restricted to ceiis within the outer aspect of the inner nuclear layer (ini).
Page 124a: At this stage the retina is divided into two layers (a), and while BRN3B expression can be readily detected in both (b), 
it is certainly expressed at lower levels in the outer layer.
Page 124b: PAX6 expression (c) is uniform throughout both layers, possibly reflecting both the presence of dividing cells and 
ganglion cells.
Page 134: Histological analysis of the adult o/and wild-type retina.
Page 170: The o / phenotype is on the sv129 background, and this demonstrates that the observed phenotype of delayed Crx 
expression in the o / retina is not caused by an effect of its strain.
Page 180: (a) shows H and E stained postnatal (P) day 2 retinal section.
Page 219: As predicted by the RT-PCR experiments described above, where fragments of the novel ChxIO-like cDNA were, at 
best, only very weakly amplified from developmental eye tissue from 9 to 15 weeks pc, no in situ hybridisation was observed in 
foetal eyes or retina (data not shown).
Page 243 (and in all text references): Furukawa, T., Kozak, C. A., & Cepko, C. L. rax, a novel paired-type homeobox gene, 
shows expression in the anterior neural fold and developing retina. Proc.Natl.Acad.Sci.U.S.A 94,3088-3093 (1997a).
Furukawa, T., Morrow, E. M., & Cepko, C. L. Crx, a novel otx-like homeobox gene, shows photoreceptor-specific expression and 
regulates photoreceptor differentiation. Ce//91,531-541 (1997b).
Page 258: Expression is first detected as early as El 1, and thus may precede onset of C/x expression, which, first detected at 
El 2.5, is presumed to be the earliest known genetic marker for photoreceptors (Freund et al. 1997).
Pages 259 and 166: The 5' promoter region of Irbp also contains a Crx preferred binding site (although the match is not perfect) 
(Livesey etal. 2000), suggesting that Crx might be involved with transcription of this photoreceptor specific gene.
Page 267: Appendix D -  The r o le  o f  retinoids in developm ent (Ross e t a l  2000).
The application of knockout mouse models to retinoid ligands has demonstrated that vitamin A and its derivatives are essential for 
normal embryonic development. Retinoic acid (RA), the oxidised form of retinol, regulates developmental processes by activation 
of gene transcription, predominantly by a signal transduction cascade prompted by the retinoic acid receptor families RAR and 
RXR. However, gene specific transcriptional activation is dependent not only on the presence of a RA receptor, but also on the 
concentration of RA in the cellular milieu [shown by the RARE mouse, see main text for details (Enwright and Grainger, 2000)]. 
Distribution of RA and its receptors is not homogeneous in developing tissue, exemplified, as shown by Drager etal. (2001), in the 
retina. Analysis of specific members of the RA catabolic pathway, such as the retlnaidehyde dehydrogenases AHD2 and VI, show 
well characterised specific areas of expression: AHD1 in the dorsal and VI in the ventral retina. These regions represent specific 
levels of RA synthesis, which are clearly demarcated by a stripe of expression of another RA catabolic enzyme CYP26. The 
tyrosine receptor kinase EphB2 and its ligand ephrin B2 are thought to regulate the targeted outgrowth of retinal axons in a dorso- 
ventraliy-patterned manner. Ephrin B2 has an expression pattern restricted to the dorsal retina, whereas EphB2 is ventrally 
expressed. Although the specific pathways are yet to be elucidated, the similarities in expression patterns of regulators of ceil- 
speclflc differentiation and RA catabolltes suggest that RA is involved in this level of differentiation in a precise concentration- 
dependent fashion.
- The intricate but highly organised nature of the retina suggests that patterning retinal tissue is very complex. The 
information that RA receptors form homo- and hetero-dimers with other receptors suggests a level of complexity for regulating 
differentiation of myriad ceil types. RXR can form heterodimers with RAR, the thyroid receptor TR, the vitamin D3 receptor VDR, 
and others. Transcription of specific genes is dependent not only on the heterodimeric RXR partner, but also on the presence of 
the partner’s ligand. These levels of complex analysis are required to fully understand the potential role of RA in the differentiation 
of photoreceptors, as suggested in this thesis.
Chx 10 sense Crx sense
CHXIO sense BRN3B sense
Figure addendum. In situ hybridisation sense riboprobe controis. When 
performing in situ hybridisation experiments with antisense riboprobes transcribed from 
specific genes, tissue from the same specimens was also incubated with sense probes 
from the same gene. This internal control was designed to determine whether the 
expression patterns observed with the antisense riboprobes were not an artefact 
caused by non-specific binding. Tissue was processed identically to the antisense 
experiments, and invariably, sense controls showed no digoxygenin labelling, (a) and 
(b) show Chx70 and Crx sense riboprobes, respectively, on adult mouse retina, (c) and 
(d) show CHX10 and BRN3B sense riboprobes on 8wpc human retina. Scale bars = 
100pm.
